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ABSTRACT 
 
Protein adsorption under physiological conditions was recognised to be the key step in 
the modulation of biological responses between materials and an osseous environment. 
Many studies have shown variation of adsorption behaviour on medical materials but 
most experiments were performed under non-physiological idealised conditions with 
idealised samples.  
The aim of this thesis was to develop a method to analyse protein adsorption on real 
clinically relevant samples under physiologically relevant conditions. The use of 
fluorescent probes was identified as a methodology which would facilitate analysis 
under a range of conditions including fully competitive with real samples that required 
no specialised surface pre-treatment. Fluoresceinthiureidoaminocaproic acid (FTCA) 
and a sulforhodamine derivative (SR101), were identified as suitable for coupling to 
proteins. FTCA labelled bovine serum albumin (BSA) was initially used to validate the 
technique and found to have several advantages over commercially available total 
protein assays; including greater sensitivity and facilitate its use under competitive 
conditions. These experiments also confirmed sensitivity to temperature and test media 
as well as demonstrating that the technique could be used on idealised dense and real 
porous granular (as used clinically) samples. Conformational changes associated with 
protein-surface interactions were observed through variation in protein auto-
fluorescence and confirmed with CD analysis, therefore, care in selection of appropriate 
experimental conditions and fluorophore probes was required. Additionally, labelling 
facilitated the visualisation in differences in the morphological habit of the surface 
adsorbed protein species. Investigation of differential response in protein exchange with 
hydroxyapatite (HA) and 0.8wt% silicon substituted hydroxyapatite (SA) with more 
biologically relevant proteins; such as bone morphogenetic protein-2 (BMP-2), 
fibronectin (FN) and osteopontin (OPN) individually and/or competitively in phosphate 
buffered saline (PBS) or minimum Eagles medium (MEM) supplemented with 10 % 
foetal bovine serum (FBS) demonstrated SA to have a greater capacity to adsorb 
selected osteogenic proteins under competitive conditions as compared to HA.  
Particularly interesting was the BMP-2 findings, which highlighted the role of media in 
promoting BMP-2 adsorption and the conformation sensitivity of traditional ELISA 
assays giving rise to unreliable results.  
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1.1 Introduction 
 
Bones are rigid organs that form part of the endoskeleton of vertebrates. Bone is made 
principally of the fibrous protein collagen, impregnated with a mineral closely 
resembling calcium phosphate (Currey 2002; Kuhn, Fink, et al. 1996; Weiner and 
Wagner 1998). Bone is produced inside the body and is usually covered with cells 
throughout life. Bone is a hard material, but it has the tendency to break and form with 
defects. When bone broke, it was most likely replaced by off the shelf materials such as 
wooden chair legs or metal rods (Park and Lakes 2007); which were not developed for 
bioactivity or biocompatibility. Scientists during that time realised how biocompatibility 
for better healing or repair was important; thus, they started investigating both the 
human bone and suitability of the material used as implants. Over the years up until the 
1960s, the materials used proved inadequate, therefore,  the science of biomaterials was 
developed (Ratner, Hoffman, et al. 2004). 
 
Biomaterial science is a science that applies the properties and applications of materials 
(either synthetic or natural) that are used in contact with biological environments. These 
materials are known as biomaterials and they address aspects of chemistry, biology, 
material science, engineering and medicine. This science is based on the foundation of 
tissue engineering principles to create biological substitutes for lost or defective native 
tissues; the most successful approach involves generating an undeveloped but functional 
tissue graft in vitro, which will then mature after implantation in vivo (Vunjak-
Novakovic and Freshney 2006). In tissue engineering, it is important that regeneration 
is provided, rather than repair, which should then lead to orderly remodelling of the 
tissue in response to the environmental factors, surrounding the tissue; and this principle 
to be applied with the use of biomaterials in biological systems. Apatite materials have 
been used in this manner for coating on implant or as bone grafts for bony defects. 
Hydroxyapatite (HA) and its other ion-substituted products are already commercially 
available (Apatech ltd, Biomet or CeramIsys) and have been shown to be efficient and 
successful as bone grafts towards bone repair. (Hing, Revell, et al. 2006) The material‟s 
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bioactivity and biocompatibility are linked to test environment factors such as proteins 
and other cells present and structural factors of the biomaterials, but also physio-
chemical properties of the materials used (Hing, Annaz, et al. 2005) during the 
implantation of the engineered tissue, may inhibit or prohibit the structure and 
composition of the tissue, which in turn may alter the functional properties of that 
tissue. These key factors are important to a successful implantation, where it is essential 
to know how they interact and influence the engineered tissue. In addition, it is believed 
that if cell and/or protein adhesion is understood further, then the interface between 
tissue/cell/protein and material can thus be optimised. 
 
Cell and/or protein labelling in biomaterial studies is an important part in interpreting 
the bioactivity and biocompatibility of the biomaterials in buffers or sera. It allows for 
the cells or proteins to be quantified or imaged. Monitoring protein adsorption and 
desorption behaviour on biomaterials‟ surfaces is an important factor into quantitatively 
and qualitatively collecting information on the mechanism and processes that occur 
between an implant and a material‟s surface (Ducheyne and Qui 1999). This can be 
achieved via several routes such as electrophoresis (i.e. SDS-PAGE) with staining for 
imaging (Matsuura , Hosokawa, et al. 2000), heavy metal labelling also known as 
radiolabelling or radioimmunoassay (Bolton and Hunter 1973; Fabrizius-Homan and 
Cooper "A comparison of the adsorption of three adhesive proteins to biomaterial 
sufaces" 1991; Fabrizius-Homan and Cooper "Competitive adsorption of vitronectin 
with albumin, fibrinogen, and fibronectin on polymeric biomaterials" 1991) or using 
assaying kits.  Kits fall broadly into two categories, enzyme-linked immunosorbent 
assay (ELISA) or total protein type assays, where both colourimetric and fluorimetric 
tools can be employed.  The latter assays all proteins present irrespective of species or 
conformations.  ELISA, on the other hand, is limited to measurement of a specific 
protein and can be conformation dependent.  Therefore, in order to carry out a 
competitive study multiple analyses must be performed. In addition, the two-step nature 
of the ELISA methodology makes it susceptible to human errors such as when 
aspirating solutions or loss of analyte through inverting the plate.  To date the only 
method for true competitive analysis is electrophoresis, sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) (Takami, Yamane, et al. 1998), often 
used in conjunction with staining reagents (i.e. Coomassie or silver) to image proteins 
(Ellingsen 1991), however, quantification by this route requires a high degree of 
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operating skill. Other existing methods of competitive protein analysis are ellipsometry, 
used for real-time adsorption kinetics, and requires no labelling of the protein (Elwing 
1998), use of matrix-assisted laser desorption ionisation mass spectrometry (MALDI-
MS) adapted for surface analysis determination (Griessera, Kingshottb, et al. 2004); this 
also requires no labelling of proteins. However, these methods require expensive set ups 
and instruments with highly skilled operator. 
 
The objective of this thesis was to develop a method to facilitate the competitive 
evaluation of protein adsorption to dense and porous apatites via labelling of the species 
of interest with a fluorescent probe so that it may be monitored independently of other 
protein species in the local environment. The emphasis of the study was monitoring and 
recording the influences of protein species on the adsorption and desorption processes 
on the biomaterials in different media conditions, not its mechanistic view; but also 
taking into account the biomaterial‟s chemistry. The use of real samples representative 
of existing pre-clinical specimen towards osteoinduction study, further, allowed for the 
study to closely mimic true behaviour of the biomaterials in media, especially observed 
in the recombinant human bone morphogenetic protein (rhBMP-2) study in Chapter 5. 
 
Chapter 1 of this thesis will give a short overview of bone biology, biomaterials used 
for the application of bone repair and remodelling, protein labelling used during 
biomaterial studies, along with the interactions observed and the methods of monitoring 
and quantifying the behaviour seen. And finally the competitive binding on biomaterials 
and the work done so far, which will then lead to the thesis hypotheses. 
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1.2 Bone Biology 
A bone is made up of several different tissues working together: bone, cartilage, dense 
connective tissues, epithelium, adipose tissue and nervous tissue. (Tortora and 
Derrickson 2009) It functions to move, support and protect the organs of the body, 
produce red and white blood cells to act as a reservoir (Hing 2004), and stores minerals 
(for example, calcium) for a wide range of metabolic functions. (Weiner and Wagner 
1998)  Therefore it is important to know more about bone, proteins and cells involved, 
and their mechanism towards nourishing, maintaining and repairing bone. This is 
known as bone biology.  
 
1.2.1 Structure & Histology of Bone and its tissue 
 
The typical structure of bone is usually represented via analysing the macroscopic 
components of parts of a long bone as shown in Figure 1.1, consisting of the following 
parts: diaphysis, epiphyses, metaphyses, articular cartilage, periosteum, the medullary 
cavity and endosteum. The diaphysis is the bone‟s shaft (also known as body); the 
epiphyses are the ends of the bone known as proximal and distal, top and bottom parts, 
respectively. To connect both regions of the bone, the metaphyses are necessary. The 
thin layer covering the epiphysis is called the articular cartilage. It is usually formed 
where bone forms a joint to reduce friction and absorb impact.  When bone is not 
covered by articular cartilage, it is covered by the periosteum, this is a tough sheet of 
connective tissue (most likely to be irregular) (Currey 2002; Miller, St-George, et al. 
1989). It protects bone, assists in fracture repair, helps nourish the bone tissue and 
serves as an attachment point for ligaments and tendons. The space within the diaphysis 
is called medullary cavity or the marrow cavity. It is most likely to contain yellow 
marrow, especially in adults. And the final component of bone is known as the 
endosteum. It is a thin membrane, which lines the marrow cavity. It contains a single 
layer of bone-forming cells and small amount of connective tissue. As each bone in the 
body has so many components, it is usually regarded as an organ.  
 
Looking at the histology of bone tissue allows for the microscopic components of bone 
to be defined. Bone is made up of a mineralised tissue known as bone tissue (or osseous 
tissue). This, in turn, contains an abundant extracellular matrix (ECM) which is a major 
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constituent of bone in which separated cells are embedded. It is produced by cells and 
secreted into the surrounding medium. It is extensive, where its properties depend on 
the properties of the tissue. There are three major components to the ECM: (1) the 
fibrous elements (for example, collagen, elastin or reticulin), (2) the link proteins 
(fibronectin) and (3) the space-filling molecules (glycosaminoglycan (Schwartz 1973)) 
(Lackie and Dow 1995). 
 
 
Figure 1.1 – Structure of (a) parts of long bone with spongy bone tissue of the epiphyses 
and metaphysic contains red bone marrow and (b) human femur copied from Tortora et 
al. (Tortora and Derrickson 2009 copyright permission granted)  
 
The extracellular matrix (ECM) of bone is composed of 25% water and collagen fibres, 
and 50% crystallised mineral salts (Tortora and Derrickson 2009). Within the collagen 
fibres are various proteins of which 90 % are collagenic proteins (CP) containing type I 
collagen and type V collagen. The remaining 10 % are non-collagenous proteins (NCP) 
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such as osteocalcin (OC), osteonectin (ON), bone sialoproteins (BSP), proteoglycans 
(PG), osteopontin (OP), fibronectin (FN), vitronectin (VN), growth factors (GFs) and 
bone morphologenetic proteins (BMPs) (Hollinger, Einhorn, et al. 2005; Raynaud, 
Champion, et al. "Calcium phosphate apatites with variable Ca/P atomic ration III. 
Mechanical properties and degradation in solution of hot pressed ceramics" 2002)  
 
C
O
HN NHC
O
NH2
C
O
OH
CHO
O
HN
NH2  
Figure 1.2- Chemical Structure of the arginine, glycine and aspartic (RGD) sequence 
 
Some of these NCPs are known as adhesive proteins. They get their adhesive properties 
because they contain the Arg-Gly-Asp (RGD) sequence as shown in Figure 1.2, which 
is specific to the fixation of cell membrane receptors like integrin (fibronectin, 
vitronectin, type I collagen, bone sialoprotein) (Ruoslahti 1996; Sawyer, Hennessy, et 
al. 2005; Schaffner and Dard 2003). The matrix can be mineralised as bone or tendon, 
depending on the compression used on the fibres to produce the necessary tissue 
(Lebaron and Athanasiou 2000). As the crystals form, they combine with other mineral 
salts like calcium carbonate (CaCO3), and ions such as magnesium (Mg
2+
), fluoride (F
-
), 
potassium (K
+
) or sulphate (SO4
4-
). When the mineral salts get deposited in the 
framework formed by the collagen fibres of the ECM, they crystallise and the tissue 
becomes harder. This process is called calcification, which is initiated by building cells 
named osteoblasts. There are four type of cells associated with bone, as they are 
responsible for production, maintenance and resorption of bone called osteogenic cells, 
osteoblasts, osteocytes (Colopy, Benz-Dean, et al. 2004) and osteoclasts, respectively. 
Osteogenic cells are unspecialised stem cells derived from mesenchyme, the tissue from 
which all connective tissues are formed. (Tortora and Derrickson 2009) These are the 
only cells that undergo cell division. The resulting cells develop into osteoblasts. 
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Osteoblasts are bone-forming cells (Anselme 2000; Lackie and Dow 1995), which 
produce and secrete collagen fibers and other components needed to build the ECM of 
bone tissue. They initiate calcification. As they become trapped in their secretion, they 
become osteocytes. Osteocytes are mature bone cells, which are the main cells in bone 
tissue. They maintain the bone‟s daily metabolism, for example, the exchange of 
nutrients and waste removal via the blood by connecting with neighbouring osteocytes. 
As part of the normal development of bone through growth, maintenance and repair, 
bone also breaks down, a process known as resorption (Alberts, Bray, et al. 1994). This 
process is controlled via multinuclear osteoclasts. Osteoclasts, also known as bone-
resorbing cells, are large cells, concentrated in the endosteum. They secrete powerful 
enzymes and acids that breakdown both mineral salts and collagen fibers. 
 
1.2.2 Bone formation  
 
Bone develops into two distinct forms: compact or cortical and spongy (cancellous or 
trabecular) bone (Figure 1.3). Compact bone is the strongest form of bone, found 
beneath the periosteum and makes up the bulk of the diaphyses. It provides protection, 
support and resistance to the stresses produced by weight and movement. Blood vessels, 
lymphatic vessels and nerves from the periosteum penetrate the compact bone through 
canals known as “Volkmann’s canals”. These canals then connect with those of the 
marrow cavity, periosteum and Haversian canals, also known as central canals. Around 
these central canals are concentric lamellae rings of calcified ECM (much like rings of a 
tree trunk as observed in Figure 1.3). Between those lamellae are small spaces named 
lacunae (Currey 2002) containing osteocytes. The final layer just before the periosteum 
is called the circumferential lamellae. 
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Figure 1.3 – Microscopic structure of a bone where (a) the osteons (Haversian systems) in 
compact bone and trabeculae in spongy bone, (b) the enlarged aspect of spongy trabeculae 
and (c) the detailed section of a trabeculae (Tortora and Derrickson 2009 copyright 
permission granted) 
 
In contrast, the spongy bone is a very porous form of bone. It consists of lamellae of 
thin columns named trabeculae. The spaces between trabeculae help make bone lighter 
and also can sometimes be filled with red bone marrow (or yellow in adults). Within 
each trabeculae are lacunae that contain osteocytes, they receive nutrients directly from 
circulating in the marrow cavity. In all directions from the lacunae are small canaliculi 
filled with ECM fluid with slender finger-like processes of osteocytes. (Colopy, Benz-
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Dean, et al. 2004; Taylor, Hazenberg, et al. 2007) The components of compact bone 
tissue are arranged into repeating units called osteons (or Haversian systems). Areas 
between them are known as the interstitial lamellae, they are fragments of older osteons 
that have been partially destroyed during bone rebuilding and growth.  
 
The process of bone formation occurs as described, starting with osteoblasts getting 
embedded in the matrix to form a random, unorganised protein mixture known as 
osteoid, which then mineralises to become bone. This involves the secretion of vesicles 
containing alkaline phosphatase, which cleaves the phosphate groups and acts as the 
foci for calcium and phosphate deposition. There are many elements that may play a 
significant role in bone formation such as calcium (Ca
2+
), magnesium (Mg
2+
), zinc 
(Zn
2+
) and strontium (Sr
2+
). However, it has been found that silicon is an element of 
particular interest. The presence of silicon in bone graft substitutes has been 
investigated since the early 1960s, and since, it has been shown to have some influence 
in bone calcification and formation. Therefore, the substitution of silicon in bone grafts 
can also be expected to influence porosity, chemistry of the grafts when implanted in 
bone defects of white rabbits, and result in improved bone healing due to its 
characteristic effect on bone calcification and formation (Hing 2004; Hing, Annaz, et al. 
2005; Hing, Wilson, et al. 2007). 
 
1.2.2.1 The Importance of Silicon in Bone Formation 
 
Silicon (Si) is the most abundant element in the earth‟s crust; therefore it can be 
expected to exist at least in trace amounts, in living organisms. The effect of silicon in 
normal metabolism, therefore, had to be investigated to define any role in vital 
processes in mammals. Bone formation and restoration studies in experimental 
fractures` in rabbits in the work of Belous et al. (Belous and Skoblin 1962) have 
demonstrated that the relationship between silicon content and structural changes at the 
site of fracture can be observed and quantitatively identified, using emission spectral 
analysis. The study showed that the percentage of Si increased in bone callus on the 4-
6
th
 day after the fracture, corresponding to maturation of the organic matrix via the 
formation of collagenous fibers and the multiplication of cells. The study further 
showed that after several days, changes in the percentage of Si content corresponded 
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directly to the structural changes (i.e. reorganization and replacement) of the bone 
callus, up until the point where complete restoration of bone over the whole length of 
the fracture occurred. Thus from this initial study, it can be argued that silicon as an 
element is necessary in bone callus. Since then, further studies have been undertaken to 
show the importance of silicon in bone calcification and formation. It has been 
suggested by Carlisle that silicon could be associated with calcium in the early stages of 
calcification (Carlisle 1970). In 1970, she demonstrated that silicon has been localised 
in the active calcification site in young mice and rats bone, thus showing silicon to be an 
important factor in bone formation (Carlisle 1970). Her studies found that the amount of 
silicon was related to the maturity of the bone mineral, further confirming Belous‟ 
findings. She has shown that silicon levels falls below the detection limit once the ratio 
of Ca to P approaches hydroxyapatite formation. Over the years (1970-1991), her 
studies have confirmed the importance of silicon in bone formation. Silicon deficient 
chicks were found to be deformed and weak, while chicks given silicon supplement 
showed 50% growth and normal development (Carlisle 1972). Further experiments 
(Carlisle 1976; Carlisle "Biochemical and Morphological-changes associated with 
Long-bone Abnormalities in Silicon Deficiency" 1980; Carlisle "Silicon requirement for 
Normal Skul Formation in Chicks" 1980; Carlisle 1981; Carlisle 1988; Carlisle and 
Everly 1991) have proved that silicon is essential to bone formation, growth and 
development.  
Furthermore, it was found that silicon appears to be present in connective tissue and its 
related structures by Schwartz in 1973, who found a bound form of silicon in 
glycosaminoglycans in the form of silanoate (ether or ester). Glycosaminoglycans 
consist of a repeating disaccharide unit (Trowbridge and Gallo 2002) within the family 
of carbohydrates, are essential and found in the extracellular matrix, which is one of the 
major components involved in bone formation with osteoblasts.  
These findings, thus, confirm the importance of silicon in bone formation. This can then 
be used to suggest that silicon incorporation in biomaterials will improve bone 
calcification and formation via dissolution of Si from ECM and surface chemistry of the 
bone graft for cell adhesion, and thus mineralisation. 
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1.2.2.2 Proteins involved in Bone formation 
 
These proteins are examples of non-collageneous proteins (NCP), which represent 
approximately 10% of the ECM. There are three proteins of particular interest in this 
respect, osteocalcin (OCN), bone sialoprotein (BSP) and osteopontin (OPN).  All have 
the calcium (Ca)- and hydroxyapatite (HA)-binding properties (Young, Kerr, et al. 
1992) and have been the centre of intense investigations because of their potential 
influence on cell attachment, Ca
2+
, HA- binding and mineralisation of bone tissue. 
Osteocalcin (OCN), also known as bone Gla protein (BGP), is a polypeptide of 49 
residues that contains 2 or 3 γ-carboxyglutamic acid (Gla) amino acids (Figure 1.4). 
(Hauschka, Lian, et al. 1975; Hunter, Hauschka, et al. 1996) It is a protein formed from 
a 76-77 amino acid precursor (Lackie and Dow 1995). The protein (Figure 1.5) has a 
strong affinity with hydroxyapatite (Hauschka, Lian, et al. 1989). Therefore, it plays a 
major role in mineralisation and calcium ion homeostasis to regulate remodelling 
(Dowd, Rosen, et al. 2003).  
 
Osteocalcin (OCN) is one of the most abundant NCPs in bone, covering up to 20% of 
the total NCPs in bone. OCN binds to HA by orientating its γ-carboxyglutamic acid 
(Gla) residues to interact with calcium ions in the mineral lattice (Hoang, Sicheri, et al. 
2003). It also functions in cell signalling and the recruitment of osteoclasts and 
osteoblasts. Hence, this protein can nucleate HA. 
 
 
Figure 1.4 – Structure of the amino acid, -carboxyglutamic acid (Gla) 
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Figure 1.5 – Molecular ribbon diagram of the osteocalcin protein (Hoang, Sicheri, et al. 
2003) where the C and N termini are labelled, the green sticks represent the side chains of 
Ca
2+
 coordinating residues and the orange ribbons are the 3 alpha helices. 
 
Bone sialoprotein (BSP) is an acidic sialoprotein. It is a highly post-translationally 
modified protein consisting of 40-50 % carbohydrate and 13-14 % sialic acid. (Young, 
Kerr, et al. 1992) BSP constitutes approximately 15 % of the total NCPs in bone. BSP 
contains the RGD (see page 6) at its carboxy terminus, a region also rich in tyrosine 
residues, which are natural fluorophores and may be involved in autofluorescence, 
whereas in osteopontin (OPN), the RGD is located in the centre of the molecule (Hijya, 
Setoguchi, et al. 1994).  
 
OPN (see Figure 1.6), also known as BSP type I or secreted phosphoprotein I (SPPI), is 
composed of two peptides of 57 kDa that links cells and hydroxyapatite of mineralised 
matrix. (Lackie and Dow 1995) OPN  has calcium and hydroxyapatite binding sites for 
protein adsorption, to use towards bone formation (Puleo and Nanci 1999), and other 
components. (Fisher, Hawkins, et al. 1987; Oldberg, Franzen, et al. 1986; Reinhott, 
Hultenby, et al. 1990) OPN and BSP are both phosphorylated sialoproteins rich in 
acidic amino acid. 
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Figure 1.6 – Secondary structure of the osteopontin (Swiss Protein Database) with the key 
inset 
 
 
Figure 1.7 – Chemical Structures of the Amino acids: (a) aspartic and (b) glutamic amino 
acids 
 
OPN is known to have a higher proportion of aspartic acid (Asp) residues (Figure 1.7a), 
some of which may combine and form “polyaspartate” sites, whereas BSP has more 
glutamic acid (Figure 1.7b) residues to form 2 or 3 “polyglutamate” sites. The structural 
differences observed in these three proteins, thus, result in them showing different 
processes in which to regulate Ca- and HA-binding, leading to HA formation and bone 
mineralisation. (Denhardt and Guo 1993; Hunter, Hauschka, et al. 1996) 
 
The use of osteopontin for the thesis was favoured over osteocalcin due the position of 
the RGD sequence in the centre of the molecule. It is also considered being more 
important as it is secreted by the three most important bone cells osteoblasts, osteocytes 
and osteoclasts, (Denhardt and Guo 1993) i.e. both bone forming and bone resorbing 
cells and thus any effects observed from this protein could lead to better understanding 
and relevance to biomaterials‟ interactions with proteins. 
Through gene expression OPN was found to be significantly up regulated compared to 
OCN and BSP in bone of spine fusion in rats (Zhang, Domenicucci, et al. 1990). It 
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carries the same advantages as BSP, but its calcium-binding site may compete with the 
hydroxyapatite calcium-binding site and mimic a truly competitive environment. OPN 
has various functions  involved in gene expression, cell signalling and transcription, and 
bone-related functions (Denhardt and Guo 1993; Sodek, Ganss, et al. 2000), which thus 
lead to various effects such as influences on HA nucleation and crystal growth. (George 
and Veis 2008) OPN is known as a highly potent inhibitor of HA formation when 
phosphorylated (Denhardt and Guo 1993; George and Veis 2008; Hunter, Hauschka, et 
al. 1996), but promotes cell attachment and is involved in the regulation of osteoclast 
motility during bone resorption (Reinhott, Hultenby, et al. 1990). Therefore, it is more 
likely to further induce other proteins to attach on the surface of the biomaterial.  
 
1.2.3  Proteins that lead to Cell Adhesion on Bone 
 
Cell adhesion is involved in many natural processes in the human body. Cells in contact 
with a material surface will initially adhere and spread given appropriate environmental 
conditions. The quality of the adhesion will influence their morphology and future 
capacity for proliferation and differentiation. (Anselme, Noel, et al. 1999) Before 
adhesion on the material‟s surface, cell-cell adhesion must occur, for example a single 
detached fibroblast contacts an adhesive glycoprotein (fibronectin) and overlaps. This 
initial stage is the cell attachment. (Lebaron and Athanasiou 2000; Sawyer, Hennessy, 
et al. 2005) Once attached, the cell can bind more strongly to a surface (cell-material 
adhesion), and starts to flatten, so as to spread across the material‟s surface 
(proliferation), and take the shape that may be peculiar to the cell type, also influenced 
by the surface chemistry of the material. (Hamilton, Yuan, et al. 2007; Kowalczynska, 
Nowak-Wyrzykowska, et al. 2005)  
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1.2.3.1 Proteins involved in Cell Adhesion 
 
Blood proteins are regarded as important key factors in determining the in vivo 
acceptance of implants in hard tissue engineering (Raynaud, Champion, et al. "Calicum 
phosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation and 
thermal stability of powders" 2002). During implantation, proteins are adsorbed 
immediately onto the surface of foreign materials, and thus determining the material‟s 
in vivo outcome, for example, the activation of some cells (platelet) adherence and 
coagulation activities can become quite a challenge.  
Blood proteins such as fibronectin (FN) and vitronectin (VN), are present in blood 
plasma and known to interact and strongly affect several processes towards bone 
mineralisation, repair, regeneration and growth. All these proteins are synthesised by 
osteoblasts, and most are involved in adhesion. Thus, they are proteins of interest to use 
to help understand the competitive binding properties on biomaterial surfaces. Most 
adhesion proteins are characterised by their capacity to interact with a specific ligand, 
such as integrins. Integrins are cell-surface proteins that are involved in binding to ECM 
components. (Kowalczynska, Nowak-Wyrzykowska, et al. 2005; Lackie and Dow 
1995) 
Limitations to cell adhesion in bone biology often occur as a reaction to the topography 
of the biomaterials, i.e. surface roughness to which proteins have to adhere. Also, 
limitations can be observed due to the presence of other predominantly abundant 
proteins such as serum albumin.  There are several cell types and proteins present in 
blood plasma, which inhibit cell adhesion, protein adsorption and even bone formation 
and resorption processes.  
 
Serum albumin (SA), is a major protein component of the serum of veterbrates (Lackie 
and Dow 1995). It has a single polypeptide chain with multi-domain structure 
containing multiple binding sites. Albumin is a water-soluble globular protein (Itri, 
Caetano, et al. 2004), which is synthesised by the liver in mammals. It is the most 
abundant protein, corresponding to approximately 60 % of the total globular protein in 
blood plasma. Its function in the body is associated to the binding and transport of 
several small molecules such as amino acids. Serum albumin comes in various types 
(bovine, rat, rabbit or human). It is a protein that can be used in lab research as a diluent 
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or blocking agent or a standard in numerous applications. Bovine serum albumin (BSA) 
and human serum albumin (HSA) (see Figure 1.8) have been used to study the protein 
adsorption behaviour on different substrates.  
 
 
Figure 1.8 – Molecular ribbon diagram of human serum albumin (HSA) (Zunszain, 
Ghuman, et al. 2003) where the helical monomer contains 3 homologous domains where 
domain type I in red, type II in green and III in blue. 
 
Zeng et al. have shown that on different surfaces, such as calcium phosphate (CaP) and 
titanium (Ti), the protein adsorbed differently; according to how strongly it adsorbs, the 
protein itself may undergo some structural changes (Zeng, Chittur, et al. 1999). It has 
been suggested that these differences in protein adsorption behaviour could be 
accounted for the difference in the initial cellular behaviour on CaP and Ti surfaces. 
Other authors such as Xie et al.(Xie, Riley, et al. 2002) and Kilpadi et al. (Kilpadi, 
Chang, et al. 2001) have further confirmed these findings. The work of Kilpadi et al. 
has demonstrated that hydroxyapatite binds more serum proteins such as fibronectin and 
vitronectin than titanium or steel surfaces. This allowed for an increased 
accommodation of osteoblast precursors to adhere to these proteins through a suggested 
integrin-mediated mechanism on the different surfaces.  
 
BSA will be used, as it is readily available and inexpensive, thus for developing a model 
system. BSA has a molecular weight of 66,320 Daltons and 35 lysine residues available 
for covalent attachment (Harlow and Lane 1988). The protein interaction with 
biomaterials will be initially studied individually, and then followed in competitive 
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conditions in the presence of 10% foetal bovine serum (FBS) with BSA, BMP-2 and 
OPN.  
 
Fibronectin (FN) is a dimeric glycoprotein of high molecular mass with two subunits 
each 220 kDa linked by disulphide bonds near the C terminus, in total 440 kDa in size 
(Leahy, Aukhil, et al. 1996; Leahy, Hendrickson, et al. 1992). The subunits have 
identical N-terminal and C-terminal sequences, but show differences in mass due to the 
conditions used during protein processing (Skorstengaard, Jensen, et al. 1986). 
Fibronectin (Figure 1.9) is the most abundant extracellular matrix protein, and all 
connective cells produce it.  
 
 
Figure 1.9 – Ribbon diagram of fibronectin type III (FN-III) protein with the blue 
representing the G-F-C-C’ β-sheet strands of the FN7-10, yellow being the A-B-E strands 
and the red is the RGD loop (Leahy, Aukhil, et al. 1996) 
 
FN sequence is composed of repeats of three prototypical types of domains known as 
type I, II and III. Type III is the most common of the repeats and the largest. FN is a 
multi-domain glycoprotein found in a soluble form in blood plasma with a high 
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concentration of 300 µg/ml (Leahy, Aukhil, et al. 1996), and in an insoluble form in 
loose connective tissue and basement membranes (Lebaron and Athanasiou 2000; 
Skorstengaard, Jensen, et al. 1986). FN has a central cell-binding domain through the 
RGD motif important for cell adhesion (Rosengren, Pavlovic, et al. 2002), recognised 
by integrins. 
 
As a result, it is known to bind to many different biological compounds such as collagen 
and heparin. Due to the interaction properties of FN, it is therefore, involved in many 
biological activities, such as regulation of cellular adhesion, spreading and motility 
(Rosengren, Pavlovic, et al. 2002), wound healing and maintenance of normal cell 
morphology. (Mosher 1984; Yamada 1983) Fn has a molecular weight of 440 kDaltons 
and the presence of its 76 lysine residues available for covalent attachment to 
fluorescent labels (Skorstengaard, Jensen, et al. 1986). 
 
Vitronectin (VN) is a serum protein, a smaller glycoprotein of 70kDa, which consists of 
459 amino acid residues. It is also known as a serum spread factor protein (Lackie and 
Dow 1995) (or S-protein (Lakowicz 1999)) from its activity in promoting adhesion and 
spreading of tissue cells in culture. VN also binds through an interaction of the RGD 
motif in its cell-binding domain. Vitronectin consists of three domains but the one of 
interest is the N-terminal somatomedin b domain (SMB) with residues 1-5, (Xu, 
Baburaj, et al. 2001) also observed by other researchers (Kamikubo, De Guzman, et al. 
2004; Kamikubo, Okumura, et al. 2002; Mayasundari, Whittemore, et al. 2004; Zhou, 
Huntington, et al. 2003). The N-terminal of vitronectin is where most processes occur, 
as it is the domain where the RGD sequence is most likely to be contained in. SMB of 
vitronectin usually crystallises with its physiological binding partner; the plasminogen 
activator inhibitor-1 (PAI-1) to modulate cell migration (Zhou, Huntington, et al. 2003). 
 
In this thesis, fibronectin (bovine) is to be used due to its availability and its higher 
affinity associated with other proteins and cells, and the higher number of citations in 
respect to biomaterials‟ interaction and research potential. 
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1.2.3.2 Growth Factors 
 
Growth factors (GFs) are polypeptide hormones that regulate the division of cells. The 
major type of growth factor is transforming growth factors (TGFs). These are proteins 
secreted by transformed cells that can stimulate growth of normal cells, regulate 
function and motility. There are two common forms: TGF-α and TGF-β. TGF-α is 50 
amino acid polypeptide, containing an epidermal growth factor domain (EGF-domain), 
which binds to EGF-receptors, that stimulate growth of microvascular endothelial cells. 
TGF-β is a homodimer of two 112-residue amino acid chains, which is secreted by 
many different cell types; it stimulates wound healing. The TGF family includes many 
of the bone morphogenetic proteins (BMPs) (Klages, Kotzsch, et al. 2008). However, 
BMPs are different from GFs, as they are the only known GF to have the ability to 
stimulate the differentiation of mesenchymal cells towards the chondroblastic and 
osteoblastic phenotypes (Chen, Carrington, et al. 1991; Skinner, Kroon, et al. 2003). 
 
Bone Morphogenetic Proteins (BMPs) are secreted from osteoprogenitor cells and 
mature osteoblasts, as well as many other cells. As bone formation begins through 
adhesion of cells into clusters or condensations, bone morphogenetic proteins (BMPs) 
regulate bone growth (Hollinger, Einhorn, et al. 2005). In bone tissue engineering, 
BMPs are used via three methods (1) cell therapy, (2) gene therapy and (3) cytokine 
therapy depicted as shown in Figure 1.10. (Saito and Takaoka 2003) 
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Figure 1.10 – BMPs therapies that could be used towards bone tissue engineering (a) cell, 
(b) gene and (c) cytokine (Saito and Takaoka 2003) 
 
There are 20 individual BMPs that have been identified to date, as members of the 
TGF-β superfamily. BMP-7, -4 and -2 are of interest as they have been found most 
potent growth factors to be involved as activators in bone cell differentiation. They all 
have to be delivered via carriers such as collagen matrix, demineralised bone matrix 
(DBM), synthetic polymers or biomaterials to increase their efficiency towards 
osteoinduction. They play an important role in tissue development; growth and repair, 
they are mitogenic substances, which cause growth by stimulating cell division. 
(Tortora and Derrickson 2009) They are well established as osteoinductive proteins, 
especially BMP-2. (Hollinger, Einhorn, et al. 2005)  
 
BMP-2 is a powerful growth factor (GF) (see Figure 1.11) when combined with a 
collagenous (Col) scaffold (Hing, Best, et al. 2004; Pluhar, Turner, et al. 2006) It is 
used because the proximity and quality of the local bone is less of a factor in the 
regeneration of new tissue; for example, it has been shown to accelerate bone formation 
in the periosteum cranii (Hirata, Nomura, et al. 2007), an area in which it is very 
difficult to observe natural bone mineralisation. BMP-2 has also been  used successfully 
in clinical trials in conjunction with “Infuse” to demonstrate feasibility in a spine model 
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for controlled delivery and further expanding the understanding of its bioactivity in 
bone and other tissues (Hollinger, Einhorn, et al. 2005). 
 
 
Figure 1.11 – Molecular ribbon diagram of the ligand-receptor complex of wildtype BMP-
2 growth factor protein (Weber, Kotzsch, et al. 2007) where in yellow and blue are the 
wildtype representation of BMP-2, the red is the activin type IIB and in green the BMP 
type IA receptors 
 
However, BMP-2 loss of function or dysregulation can lead to severe diseases, and even 
death (Nickel, Dreyer, et al. 2001; Weber, Kotzsch, et al. 2007). Also, pharmacological 
levels in the order of 0.7-17 g per mg of Col of the GF are required to stimulate bone 
repair, compared to native BMP concentration in cortical bone (1-2 g per kg of bone) 
and these levels are sometimes associated with some side effects (Weber, Kotzsch, et al. 
2007) such as issues regarding cost, and factors affecting BMP activity in vivo 
(Hollinger, Einhorn, et al. 2005). The use of BMP-2 in this study is to provide evidence 
of its binding affinities and efficiency. 
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1.2.4 Characterisation Techniques for Proteins 
1.2.4.1 Fluorescence Spectroscopy and Microscopy 
 
Both these techniques rely on the fact that macromolecules (proteins) either act as 
fluorophores or can be attached to one to induce a fluorescent reading from the 
macromolecule in solution. Spectroscopy gives quantitative data, while microscopy 
gives qualitative data, respectively. 
Fluorescence spectroscopy uses either a four-sided transparent fluorescent cuvette for 
samples in the form of assays (solutions) or sample holder for samples in the form of 
solid compounds. For both sample types, the instrument technique is the same, which 
result in similar data collected, a value of fluorescence in arbitrary units (Cantor and 
Schimmel "Part II: Techniques for the study of biological structure and function" 1980). 
 
 
Figure 1.12 – Schematic of a Fluorimeter: cuvette reader 
 
A fluorescence spectrometer is typically arranged as shown in Figure 1.12.  M is the 
monochrometer where the integer 1 represents  the excitation and 2, the emission, where 
it can be used in two modes; (1) with M2 fixed and M1 varying, resulting in an 
excitation spectrum and alternatively (2) with M1 fixed and M2 varied to yield an 
emission spectrum.  
Fluorescence microscopy uses a conventional widefield microscope (see Figure 1.13) 
the entire specimen is bathed in light from a mercury source, and the image can be 
viewed directly by eye or projected directly onto an image capture device or 
photographic film. 
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Figure 1.13 - Illustration of the widefield scanning method of Fluorescence microscopy 
 
Specimens used are labelled protein and introduced to the biomaterial surface. The 
images obtained are bright and enable the protein to be seen according to the colour 
emitted by the tag. The image can also be used to measure the size of visible particles, 
as magnification and optical measuring accessories allow for accurate measurements. 
 
1.2.4.2 Circular Dichroism (CD) Spectroscopy 
 
This technique relies on the fact that macromolecules such as proteins have chiral 
centres or are optical isomers, which allow for the rotation of plane-polarised light 
through a solution as a function of the wavelength. (Thorpe and Thorpe 2000)  
CD uses circular polarized light, obtained by superimposing two plane-polarised light 
waves of the same wavelengths and amplitudes but differing in the phase by a quarter of 
a wavelength and in their planes of polarization by 90
o
. (Thorpe and Thorpe 2000)  
CD spectrum gives information about the relative proportions of secondary structure in 
a protein such as α-helixes, β-sheet and random coil in solution.  
The CD information is the difference between the absorption of the left (LCPL) and 
right- handed circularly polarized light (RCPL) (Drake 1994) and the data obtained 
from CD can then be analysed using an online server to generate the secondary 
information of the protein under investigation (Whitemore and Wallace 2004; 
Whitemore and Wallace 2007) 
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1.2.4.3 Other Techniques 
 
There are other techniques that could be used to further confirm protein conformation in 
solution and/or on the surface of the biomaterials such as ellipsometry (Elwing 1998) or 
matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) (Griessera, 
Kingshottb, et al. 2004) Both techniques do not require proteins to be labelled. 
 
 
1.3 Biomaterials: Calcium Phosphates 
 
Bone repair is an important subject of study as the demographic trends show a longer 
life expectancy of people, which may lead to higher risk of arthritis or osseous defects 
associated with longer life and lifestyle of these individuals.  Over 300,000 hip and knee 
implants are used each year in the United States to replace or restore function to 
diseased and damaged tissues (Puleo and Nanci 1999). Due to this growth, replacing 
missing bone will become increasingly difficult when using either patient‟s own body 
part (known as autograft) or a donor body part (known as allograft). (Anselme 2000; 
Hing 2005) Therefore, the use of synthetic bone graft substitutes (BGSs) (Hing 2004) 
will be strongly favoured over the previous methods, especially if the resulting implant 
performs significantly better. Biomaterials used as BGSs can be metallic such as 
titanium and its alloys (Ellingsen 1991), ceramics for example apatite and bioglasses 
(Hench 1991; Hench and Andersson 1993; Knowles 2003) or polymers/copolymers 
(Kowalczynska, Nowak-Wyrzykowska, et al. 2005) like polyethylene oxide (PEO) 
(Fabrizius-Homan and Cooper "A comparison of the adsorption of three adhesive 
proteins to biomaterial sufaces" 1991; Fabrizius-Homan and Cooper "Competitive 
adsorption of vitronectin with albumin, fibrinogen, and fibronectin on polymeric 
biomaterials" 1991). Several researchers have shown that surface physio-chemical 
properties such as surface roughness (Thomas, McFarland, et al. 1997), surface area 
(Harding, Rashid, et al. 2005), surface charge (Yin, Liu, et al. 2002), porosity (Hing, 
Best, et al. 1999) and chemistry (Gibson, Best, et al. 2002; Hing 2005; Thomas, 
McFarland, et al. 1997), of the implant (BGS) to be of great importance as well as the 
composition of the surrounding environment in generating observed differences in cell 
 Chapter 1 
25 
adhesion processes. Each factor affects the bioactivity, and thus biocompatibility of the 
material in vivo and in vitro in different ways (Ducheyne and Qui 1999).  
 
1.3.1 Hydroxyapatite (HA) 
 
HA is a bioactive biomaterial, also known as a bioceramic material, specifically, 
calcium phosphate. It is important for biological applications such as coatings, porous 
implants and fillers. Stoichiometric HA is used as a bioceramic due to its excellent 
biocompatibility, bioactivity, osteointegration and osteoconductivity properties in vivo; 
and its ability to bond directly to bone. HA has a hexagonal structure, see Figure 1.14, 
with a space group, P63/m, made up of PO4 tetrahedra, and CaO6 and CaO7 polyhedra 
with channels containing the hydroxyl anions running parallel to the c-axis, where its 
general empirical formula is Ca10(PO4)6(OH)2. (Cazalbou, Combes, et al. 2004) 
 
 
Figure 1.14 - Crystal lattice of Stoichiometric HA (Cazalbou, Combes, et al. 2004)  
 
There are four ways in which HA can be synthesized, described as follows according to 
the review of LeGeros et al. (LeGeros and LeGeros 1993); from calcium hydroxide and 
phosphoric acid; in alkaline conditions from calcium nitrate; via a sol-gel method or by 
mechanochemical process, and final by solid state. 
 
The preferred way is the first i.e. synthesise of HA is via an aqueous precipitation as it 
results in the formation of a one-phase product, when sintered at the optimum 
temperature for research or clinical applications. This consists of using calcium 
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hydroxide (Ca(OH)2) and orthophosphoric acid (H3PO4). The orthophosphoric acid is 
added dropwise to an aqueous solution of calcium hydroxide at high pH (Equation 1.1). 
Then the resulting precipitate is filtered, dried at 80 
o
C overnight and then ground, 
milled and sieved. 
 
    OHOHPOCaPOHOHCa 226410432 186)(10   
Equation 1.1  
 
This results in the production of the hydroxyapatite in the form of a salt. Using 
ammonium hydroxide, known as the alkaline reaction condition, can further modify this 
method, and help in producing a phase pure compound. The main advantage of using 
HA is its chemical similarity to the inorganic component of the bone. However, it has 
its limitations. HA lacks the mechanical properties for use in monolithic load-bearing 
implants. (Gibson, Best, et al. 1999) It is brittle and usually needs to be used as a 
coating or filler within another device rather than as a whole implant. While 
synthesising HA, the pH of the resulting suspension needs to be kept at pH 10.30 
because it will result in changes in the Ca/P ratio of 1.67. If the Ca/P ratio falls below or 
above 1.67, -tri-calcium phosphate (-TCP), Ca3(PO4)2, and other phases will be 
produced, which then lowers the phase purity of the HA, increases its solubility, and 
thus introduces other factors to consider when using that particular material in a 
research investigation. When the Ca/P ratio is higher than 1.67, calcium oxide (CaO) 
will be present in the HA, which will also alter the crystal structure of HA and result in 
changes to the surface chemistry of the material. Also, due to these slight changes, there 
could be minor and trace elements from the original reagents used to make the apatite 
powder. 
 
1.3.2 Silicate-Substituted Hydroxyapatite (SA) 
 
Silicate-substituted hydroxyapatite (SA) was produced and can exist in varying weight 
percentage of silicon content (0.2, 0.4, 0.8 and 1.5 wt%); knowing the empirical 
formula, Ca10(PO4)6-x(SiO4)x(OH)2-x, the actual weight percentage of the silicate (SiO4
4-
) 
groups which substitute site specifically for the phosphate groups in HA can be 
determined. The synthesis and characterisation of SA of different weight percentage 
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level has been researched and characterised by Gibson et al. (Gibson, Best, et al. 1999) 
and in the work of Hing et al.  (Hing, Revell, et al. 2006) The incorporation of a small 
amount of silicon (0.8 wt%) was introduced in the structure of hydroxyapatite lattice 
Ca10(PO4)6(OH)2 using an aqueous precipitation reaction.  This consists of using silicon 
acetate (Si(OAc)4) to retain the charge balance (Gibson, Best, et al. 1999) (Equation 
1.2): 
xxx OHSiOPOCaOHxxSiOPOxCa 
  246410
4
4
3
4
2 )()()()2()6(10  
Equation 1.2  
 
The appropriate quantities of the reactants to quantitatively produce stoichiometric HA, 
compared to SA are shown in Table 1.1  
 
Table 1.1 – Molar Quantities of Reactants needed for HA & SA material & Molar ratio of 
Ca/P equivalent (Gibson, Best, et al. 1999) 
Materials Wt% Si 
No. of moles 
Molar Ratio 
Ca(OH)2 H3PO4 Si(OAc)4 
HA - 0.500 0.2970 - 1.67  
SA 0.8 0.500 0.2850 0.0150 1.67 Ca/(Si+P) 
 
It was very important that the ionic substitution did not result in thermal instability of 
the material as this would affect the sintering of the material, which may result in 
decomposition to undesirable by-products. According to the review of Gibson several 
attempts have been made to produce a silicon-substituted hydroxyapatite by different 
methods such as sol gel found by Ruys et al. in 1993, hydrothermal methods in 1994 
and solid state in 1997by Tanizawa et al., however, none resulted in the formation of a 
single-phase silicon-substituted hydroxyapatite (Gibson, Best, et al. 1999). 
These different phases introduced further difficulties in clearly obtaining evidence that 
the silicon was incorporated site specifically for the phosphorus site in the HA lattice. 
The silicon-substituted hydroxyapatite formed by Gibson was one phase pure sample 
with no presence of decomposition or phase changes upon the sintering of the material 
into derivatives such as β-TCP or presence of impurities such as calcium oxide (CaO) 
compared to previous works. The work of Marques et al. have further demonstrated that 
single-phase silicon-substituted apatites with the crystal and chemical structure of HA 
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have been formed with silicon contents of up to 0.15 wt% by wet chemical route. 
(Marques, Magalhaes, et al. 2000) 
 
1.3.3 Other substitutions 
 
It is well known that bone has many apatite phases (Cazalbou, Combes, et al. 2004; 
Kuhn, Fink, et al. 1996), which may have different type and amount of ionic 
substitution (Ca
2+
, Mg
2+
, Sr
2+
 and CO3
2-
). These ions play an important role in bone 
mineralisation and other related functions. (Meyer and Wiesmann 2006) Therefore, 
using a synthetic apatite and other forms of ionic-substituted apatites, such as silicate 
(SiO4
4-
), carbonate (CO3
2-
) (Barralet, Best, et al. 2000; Landi, Tampieri, et al. 2004; 
Takemoto, Kusudo, et al. 2004) and/or fluoride (F
-
), will have an effect on the surface 
structure, surface charge, and solubility of the material; result in changes in the 
biological performance in vitro and in vivo.  
The work of Barralet et al. has investigated the effect of water, vapour during sintering, 
on the density and microstructure of varying carbonate content in HA to show that upon 
different sintering conditions the biomaterial will topographically be different. (Barralet, 
Best, et al. 2000) This could then lead to differences in protein adsorption as the 
material was modified to be more hydrophilic than hydrophobic. Heavy metal 
substitutions have been incorporated into HA to investigate cell adhesion and quantify 
the enhanced bioactivity of these new biomaterials. Magnesium (Mg
2+
), cadmium 
(Cd
2+
), zinc (Zn
2+
) and yttrium (Y
3+
) have been used to dope HA and found that 
osteoblast adhesion was increased significantly on HA doped with 2-7 mol% Y
3+
 
(Webster, Ergun, et al. 2002).  Other researchers have incorporated up to 2 wt% ion 
content of silicon and 1 wt% of magnesium, as a co-substitution to investigate sintering 
behaviours, which could lead to enhanced biocompatibility and bioactivity. (Kim, Lee, 
et al. 2003) Using about 5 % zinc doped in HA found an increased formation of a 
biologically active layer on its surface, which permitted a stronger chemical bond 
between the bone and ceramic work (Jallot, Nedelec, et al. 2005). 
 
Composites of hydroxyapatite and phosphates such as -tricalcium phosphate may also 
be an advantageous biomaterial. These are usually known as biphasic calcium 
phosphates (BCPs). They combine the excellent bioactivity of HA with the good bio-
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resorbability of -TCP, and are interesting materials for use in medical applications 
such as bone replacement. -TCP and HA characterisation and behaviour upon protein 
adsorption has been investigated (Gregori, Kleebe, et al. 2006). This team of researchers 
has demonstrated using electron energy-loss spectroscopy (EELS), that characterisation 
properties such as hydrophobicity/hydrophilicity, and heat-treatment strength, and 
resorption of the individual grains of the bioceramic material differ from when 
compared to composites made of the mixture. The composite had revealed to be an 
improvement to mechanical properties, where the work of Raynaud‟s group showed that 
a BCP containing just 10 wt% of -TCP exhibits double tensile strength compared to 
stoichiometric HA ceramics. (Raynaud, Champion, et al. "Calicum phosphate apatites 
with variable Ca/P atomic ratio I. Synthesis, characterisation and thermal stability of 
powders" 2002; Raynaud, Champion, et al. "Calcium phosphate apatites with variable 
Ca/P atomic ration III. Mechanical properties and degradation in solution of hot pressed 
ceramics" 2002) 
 
 
1.3.4 Characterisation Techniques for Ceramic Biomaterials 
1.3.4.1 X-ray Diffractometry (XRD) 
 
XRD involves the scattering of X-rays with λ ~ 1 Å by the repeating elements of a 
crystal lattice resulting in a diffraction from the crystal planes. XRD is also used for 
determining the crystal structure of a specimen. 
Bragg‟s Law indicates that diffraction is only observed when a set of planes make a 
very specific angle with the incoming X-ray beam (Callister and Rethwisch 2007; 
Cantor and Schimmel "Biophysical Chemistry Part II: Techniques for the study of 
Biological Strucutre and Function" 1980); a constructive interference (Figure 1.15). 
This angle depends on the inter-plane spacing d, which itself depends on the size of the 
atom which make up the structure. During XRD, diffraction is measured for a range of 
different angles, theta (θ), see Figure 1.16 for the schematic of a powder diffractometer. 
The amount of beam scattered depends on the atomic number of the element(s) present 
in the sample (specimen). The crystallographic directions and planes are expressed in 
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„Miller‟ indices where (x,y,z) indicates the location of a point, [hkl] indicates the 
direction from (0,0,0) to (x,y,z) in whole numbers. (Park and Lakes 2007) 
 
 
Figure 1.15 - Schematic diagram of Bragg's Law 
 
 
Figure 1.16 - Schematic of a Powder Diffractometer 
 
hklhklSindn  2  
Equation 1.3 
 
This relationship is further explained via Bragg‟s equation (see Equation 1.3) where the 
path difference between coherently reflected beams is related to the d-spacing between 
the crystal planes, dhkl, and the particular Bragg angle, θhkl, at which reflections from 
these planes are observed, the latter is detected and recorded against intensity as a XRD 
pattern. 
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1.3.4.2 Fourier Transform Infrared- Photoacoustic Spectroscopy (FITR-PAS) 
 
Photoacoustic spectroscopy (PAS) is commonly used in the analysis of a variety of 
materials. It is a non-destructive technique that is applicable to almost all types of 
samples, powder, films and even polymers. It offers minimal or no sample preparation 
and the capability to perform depth-profiling experiments. PAS can be used for both 
qualitative and quantitative analysis.  
 
In PAS, the transformation of an optical event to an acoustic one occurs. Initially, 
modulated light is absorbed by the sample located in a sealed chamber. The non-
radiative decay of this absorbed light produces a modulated transfer of heat to the 
surface of the sample. This modulated thermal gradient produces pressure waves in the 
gas (helium, He) inside the cell that can be detected by the attached microphone (Figure 
1.17). This microphone signal, when plotted as a function of wavelength, will give a 
spectrum proportional to the absorption (or transmittance or photo-acoustic unit) 
spectrum of the sample. 
 
 
Figure 1.17 - Depiction of a Photoacoustic Spectrometer (PAS) signal 
 
For PAS experiment conditions, a FT-IR spectrometer capable of operating in both 
continuous scan mode and in step-scan mode is used. A photo-acoustic cell is used as an 
accessory for containing the sample within the sample chamber. Helium gas is used as 
the transfer medium in the cell and to purge water vapour and carbon dioxide, and a 60 
% carbon black-filled polymer is often used as a reference sample. 
 
 Chapter 1 
32 
1.3.4.3 X-ray Fluorescence (XRF) 
 
X-ray fluorescence (XRF) spectroscopy is another characterisation technique, which has 
been used extensively to further quantify constituent distribution of calcium phosphate 
(CaP) biomaterials in order to determine the calcium to phosphate ratio or silicate ratio 
in the biomaterials under investigation. (Best, Sim, et al. 1997) It works on the basis of 
measuring the individual component wavelengths of the fluorescent emission produced 
by a sample when irradiated with X-rays. It is also a non-destructive technique. 
 
It works on the principle that excited atoms produced from a sample hit by high-energy 
electrons, will emit a x-ray fluorescence signal, which is characteristic to those elements 
present in the irradiated sample (Chen, Gibson, et al. 2008). 
 
1.3.4.4 Surface Area Analysis & Porosity  
 
Surface Area (S.A.) analysis of the powder and porous specimens is to be determined 
by performing multi-point analysis via helium intrusion into degassed specimens. This 
method involves measuring the amount of helium required to intrude into a sample at a 
particular rate, and using the Brunauer-Emmett-Teller (BET) equation, so as to measure 
the surface area. 
 
Strut porosity of the porous granules is usually measured using mercury intrusion 
porosimetry (MIP). This usually involves measuring how much pressure is required to 
push mercury through the specimen initially at low pressure, then followed at high 
pressure, calculated using a known standard of the pycnometer and its constant. 
Other methods require samples to be embedded in resin and imaged by SEM, and then 
the strut porosity will be determined by the scale of the image dimensions. 
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1.3.4.5 Scanning Electron Microscopy (SEM) 
 
SEM is a technique that uses electrons instead of light to form an image. A probe scans 
the surface of the object, under investigation. SEM has a large depth of field, which 
allows more of a specimen to be in focus at one time.  
It also has a high resolution with more control over the magnification due to the use of 
electromagnets rather than lenses, as a result, producing clear images. This technology 
is based on the television technique all in vacuum (see Figure 1.18 & Figure 1.19). 
The method is suitable for specimens with conductive surfaces. For imaging only of 
specimens, preparation of the surface needs to be made, where the specimen is coated 
with gold, for example palladium and gold/palladium also. 
 
 
Figure 1.18 – SEM Instrument in Nanovision Centre at QMUL (F.E.I., UK) 
 
Further analysis, such as energy dispersive spectroscopy (EDS) can be used in 
conjunction with SEM to obtain elemental composition of the material under 
investigation. EDS is a microanalysis technique that is performed by measuring the 
energy and intensity distribution of X-ray signals generated by a focused electron beam 
on the sample material. (Goldstein, Newbury, et al. 2003) 
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Figure 1.19 - Schematic of an SEM, slightly modified (Rochow and Tucker 1994) 
 
The surface of the object is scanned with the electron beam point by point, whereby the 
resultant signals are then fed to the amplifier. Various signals can be collected by the 
amplifier such as secondary electrons, back-scattered electrons, incident beam, visible 
light and X-rays. All can be monitored separately or simultaneously by the means of the 
appropriate detector. SEM thus constructs a pattern or map of the chosen resultant 
signals that can be interpreted as an image of the object under investigation. 
 
1.3.4.6 Other Techniques 
 
Atomic force microscopy (AFM) is a versatile technique (Figure 1.20 and Figure 1.21) 
that has been applied to a large number of research topics, and therefore, can be 
modified for specific application requirements.  
The technique has several modes of operation with the most commonly used one being 
the tapping mode, which is more of interest to this study. The tapping, also known as 
dynamic force or the intermittant-contact mode of AFM is a method used widely as it 
is advantageous over the others as it improves lateral resolution on soft samples, and 
eliminates lateral forces such as drag (obtained in contact mode) (Li, Xi, et al. 2006; 
Micic, Chen, et al. 1999; Smith, Connell, et al. 2003). It involves close proximity of the 
stiff cantilever as it oscillates closer to the sample than in a non-contact mode. 
As part of the oscillation extends into the repulsive region, the tip is known to 
intermittently touch the surface of the sample. A laser is placed at the tip of the 
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cantilever, as a way to accurately determine the oscillating measurements of the 
cantilever against the sample in any environment. 
 
 
Figure 1.20 – Atomic Force Microscope (AFM) at the Nanovision Centre at QMUL, 
London, UK 
 
 
Figure 1.21 – A schematic of the atomic force apparatus (Micic, Chen, et al. 1999) 
 
As the tip of the cantilever oscillates across the surface, the differences obtained from 
the laser are recorded. The data is then collected and from this, force constants, surface 
morphology and surface area can be determined. 
On biomaterials, AFM is usually used to show surface roughness and chemical 
homogenous or heterogeneous activity of the surface via phase analysis. It can also be 
used in a wet environment, i.e. with samples submerged into solutions, which may 
require tips to be functionalized for better resolution(Micic, Chen, et al. 1999). 
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1.4 Cell/ Protein Adhesion on Biomaterials 
1.4.1 Cell/Protein and Bone-Implant Interactions 
 
Cell adhesion is important in various natural physiological processes such as 
embryogenesis, maintenance of tissue structure, wound healing, immune response, and 
metastasis as well as tissue integration of biomaterials (Anselme 2000). In terms of 
biomaterials, adhesion covers different domains; (1), the attachment phase which occurs 
rapidly and involves short-term events like physicochemical linkages between cells and 
materials involving ionic forces, or van der Waals forces, for example; and (2), the 
adhesion phase occurring in the longer term and involving various biological molecules 
such as extracellular matrix proteins, and cytoskeleton proteins, which interact together 
to induce signal transduction, promoting the action of transcription factors, and 
consequently, regulating gene expression. These processes are devised to improve 
wound healing and efficient remodelling of the engineered implant.  
 
The bone-implant interface has been investigated to better understand the events that 
occur at the interface, as reviewed by Puleo and Nanci (1999). The study has enabled 
the determination of the host response via an assumption that the bone-implant 
interaction comprises of two components; (1) the response of the host to the implant and 
(2) the behaviour of the material in the host, summarized in Figure 1.22.  
This mechanism was further confirmed and observed by Anselme, when using 
osteoblast on different materials. (Anselme 2000; Anselme, Noel, et al. 1999) The study 
demonstrated that cells and proteins do not interact with pure material. The material 
needs to be conditioned by biological fluid components, first, which determine protein 
adsorption. Factors such as pH, as well as ionic composition and strength of solution 
(for example, the use of PBS or HEPES), temperature and the functional group of the 
proteins and other cells present used (for example, which type of bonding will they be 
forming with the surface) are also important in deriving a mechanism in protein 
adsorption. 
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Figure 1.22 – Modified representation of the events occurring at the bone-implant 
interface. The protein adsorption (a) from blood and tissue fluids begins the process, 
followed by the proteins desorption (b). This leads to surface changes and material release 
(c), which prepare the material to further changes and responses. The inflammatory and 
connective tissue cells (d) approach the implant where possible targeted release of matrix 
proteins and selected adsorption of proteins such as BSP and OPN (e) occurs. The 
formation of lamina limitans (f) and adhesion of osteogenic cells and bone deposition (g) on 
both the exposed bone and implant surfaces results in (h) the remodelling of newly formed 
bone. (Puleo and Nanci 1999) 
 
The interaction also depends very much on the surface aspects of the material used 
(titanium alloys, bioglass, hydroxyapatite and substituted-hydroxyapatite), which can be 
described according to their chemistry, surface energy or topography. These surface 
characteristics determine how biological molecules will adsorb to the surface, and more 
particularly determine the orientation of adsorbed molecules. Surface roughness of 
materials does affect the behaviour of different cells or proteins on the material, where 
generally it has been demonstrated that roughness modify greatly cell processes 
compared to smooth surfaces (Roach, Farrar, et al. 2005; Sawyer, Hennessy, et al. 
2005; Thomas, McFarland, et al. 1997). 
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1.4.2 Physiological, Morphological and Ionic Influences of HA and SA on 
Cell/Protein Adhesion 
 
Adsorption of protein on apatite depends largely on surface area and properties of the 
apatite before and during the sintering processes; the sample form (granules or discs), 
its density and porosity, its surface packing (microstructure) and the crystallinity of 
material. The chemistry occurs at the surface interface between the apatite material and 
the protein, solid-lipid (or liquid) interface, very much like for the metallic and bioglass 
surfaces. Grain structure, size and boundaries should be very similar.  
Another important factor for cell or protein adhesion is how the HA or SA has been 
produced and the Ca/P ratio in the material when sintered. In HA, it was shown that a 
ratio of 1.67 is the optimum ratio to which a stoichiometric HA forms as a single phase 
product, this was also found to be true when forming SA, (Gibson, Best, et al. 1999; 
Hing, Gibson, et al. 1998) where enhanced bioactivity was achieved. For a lower ratio 
both types form with beta-tricalcium phosphate (β-TCP), whereas for a higher ratio 
calcium oxide (CaO) becomes present in the samples. This may also result from poorly 
calcined materials (Patel, Gibson, et al. 2001) or sintered conditions used on the 
materials (Gibson, Ke, et al. 2001), which further may lead to changes in the 
biomaterials‟ hydrophobicity and hydrophilicity. These will, in turn, lead to changes in 
the surface charge and packing of the grain of the materials, which will subsequently 
affect the adsorption property of the proteins on the surface due to differing grain size 
and boundaries (Barralet, Best, et al. 2000). 
 
Introducing porosity into the HA and SA production has increased cell and protein 
adsorption due to differences in surface area. (Hing, Annaz, et al. 2005; Hing, Best, et 
al. 1999)  It also allowed for the samples to achieve micro- and macro-porous properties 
that introduce interconnectivity and ultimately enabling the sample to behave more like 
real bone, i.e. a good candidate to use as a synthetic bone graft substitute (BGS). 
Looking at Figure 1.23, it is evident that increased porosity increases volume of bone 
ingrowth. 
As a result, the protein attachment will be affected to these various heat-treatments and 
forms, as the surface chemistry would be different from the optimum condition for 
protein adsorption to occur. Secondary behaviours may occur, where due to the changes 
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on the surface, i.e. production of β-TCP instead of HA, results in the sample being more 
soluble, thus protein would react differently as they adsorb on the surface (Hing, Annaz, 
et al. 2005). The affinity may be lower or higher depending on the side chains available 
on the protein under investigation. 
 
 
Figure 1.23 – Variation in bone volume and morphology within the central porosity of (a) 
60% and (b) 80% porous hydroxyapatite (HA) bone graft substitutes after 12 weeks in 
vivo (lapine femoral condyle defect model) (Hing 2005) 
 
To conclude, the phenomenon of cell adhesion on biomaterials can be summarised in 
terms of the mediation of the biomaterial-cell interactions by the adsorbed proteins. 
Implanted materials are immediately coated with proteins from blood and fluids, and it 
is through the adsorbed protein layer that cells then sense the foreign surfaces. Surface 
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composition, pH and morphology thus interact with protein in the appropriate 
mechanism, depending also on temperature and time, which then result in proteins 
adopting particular conformations, which cells then respond to. This suggests that it is 
the adsorbed proteins, rather than the surface itself, to which cells initially respond, as 
reviewed by Wilson et al. (Wilson, Clegg, et al. 2005). 
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1.5 Competitive Binding of Proteins on Biomaterials 
 
Adsorption of proteins onto biomaterials does not occur randomly or sequentially. The 
binding is competitive, very much depending on the adhesive proteins present, their 
molecular weight, concentration, and the contact time the proteins have to adsorb onto a 
surface.  
Adsorption characteristics of adhesive proteins such as fibronectin (FN), vitronectin 
(VN) and others have been of special interest. Due to their abundance in plasma and 
their varying molecular weight and involvement in bone related functions, these 
adhesive proteins will always be present in and around any implant and thus may be 
involved in wound healing processes.  
So far protein competitive binding studies have been investigated using SDS-PAGE, 
known as sodium dodecyl sulfate polyacrylamide gel electrophoresis (Ellingsen 1991), 
in conjunction with enzyme-linked immunoadsorbent assay (ELISA); the first is used to 
analyse the proteins, while the other to identify specific proteins. Another method is via 
labelling, also known as radiolabelling, for example iodination with iodine isotopes (
125
I 
or 
131
I ions) (Fabrizius-Homan and Cooper "A comparison of the adsorption of three 
adhesive proteins to biomaterial sufaces" 1991; Fabrizius-Homan and Cooper 
"Competitive adsorption of vitronectin with albumin, fibrinogen, and fibronectin on 
polymeric biomaterials" 1991). This method both analyses and identifies the proteins 
under investigation. All methods have been used to quantify and study the potential 
mechanism of protein adsorption on biomaterials‟ surfaces.  
 
Radiolabelling has been more favoured over the others for the competitive studies, 
especially in the work of Fabrizius-Homan et al. They demonstrated that VN 
competitively adsorbed in the presence of human serum albumin (HSA), fibrinogen 
(FGN) and FN in very different ways compared to their relative individual affinities on 
polymeric biomaterials. The study was monitored by incubating radio-labelled protein 
solutions contained inside tubing fabricated from the polymeric biomaterials. The 
experiment revealed VN adsorbed more readily when competitively adsorbed at equal 
mass concentrations. However, when competitively adsorbed in the presence of 
increasing amounts of HSA, FGN and FN, the amount on VN adsorbed diminished. 
When HSA, FGN and FN were competitively adsorbed in the presence of increasing 
 Chapter 1 
42 
amounts of VN, VN diminished their adsorption on weight basis in the following trend: 
HSA > FN > FGN (Fabrizius-Homan and Cooper "A comparison of the adsorption of 
three adhesive proteins to biomaterial sufaces" 1991; Fabrizius-Homan and Cooper 
"Competitive adsorption of vitronectin with albumin, fibrinogen, and fibronectin on 
polymeric biomaterials" 1991). However, reproducing this type of study with more 
dense materials such as HA or SA could be problematic, where the overall idea is to 
mimic as close as possible the human bone environment.  
 
Further studies have shown that due to proteins being highly surface active, they must 
exhibit high affinity for interfaces. Adsorption can be promoted or opposed by a number 
of factors such as dehydration of proteins, or surfaces, redistribution of charged groups 
at the interface and the conformational changes of the protein molecule itself (Wilson, 
Clegg, et al. 2005). Adsorption may be seen to increase over time and protein 
concentration increases until a monolayer coverage is obtained on the material surface 
(Noh, Yohe, et al. 2008), this may be true of individual protein adsorption, thus 
intuitively can be expected for the adsorption of multiple proteins upon a surface. In the 
work of Noh et al. adsorption was also confined to the number of available binding sites 
that each protein would adhere to in preference to other sites on the material surface. As 
a result the adsorption rate would be affected over time, depending on how many 
binding sites are present. Given these factors, the relationship between adsorption rate 
and proteins is difficult to define when many proteins are present.  
 
1.5.1 The “Vroman” Effect 
 
During competitive binding and in the absence of cellular interactions, proteins are 
usually known to displace over time rather than simply desorb from the surface. This is 
known as the “Vroman” Effect (Green, Davies, et al. 1999; Gugala and Gogolewski 
2004). Proteins such as vitronectin (VN), fibronectin (FN) and fibrinogen (FBN) are 
believed to exhibit this behaviour, which occurs when the composition of the adsorbed 
layer changes as faster diffusing molecules (such as albumin) are displaced by proteins 
with higher affinity for the surface (such as FN or VN or BMP-2); this phenomenon 
being most pronounced on hydrophilic surfaces (Wilson, Clegg, et al. 2005). 
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1.5.2 Characterisation & Monitoring Techniques for Competitive Binding 
1.5.2.1 Principle of Colourimetry (Absorbance)  
 
Colourimetry involves the measurement of a compound or group of compounds present 
in a complex mixture by making use of the property that when light passes through a 
particular solution, some wavelengths are absorbed more than others. (Plummer 1987)  
It is a method widely used for determining the concentration of compounds, and when 
the compounds themselves are not coloured, they can be made to absorb light in the 
visible region by reaction with suitable reagents (Gordon 2000). These reactions can be 
very specific and sensitive.  
The depth of colour is proportional to the concentration of the compound being 
measured, while the amount of light absorbed is proportional to the intensity of colour 
and hence the concentration (Plummer 1987). This is expressed in terms of the Beer-
Lambert law, depicted in Figure 1.24. 
              
  
 
 
Equation 1.4 
 
A is the absorbance, where Io is the incident beam and I is the emerging beam; ε is the 
molar extinction coefficient, c is the concentration of the compound in solution and l is 
the optical pathway in cm. 
 
 
Figure 1.24 – Schematic of the colourimetric analysis 
 
There are several colourimetric assays available to analyse proteins, in terms of 
determining their concentration, most common ones are Lowry method, also known as 
Folin-Ciocalteau method, and which also includes the Biuret reaction, BCA reagent 
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(bicinchoninic acid) and Coomassie brilliant blue, also known as the Bradford method; 
each have distinct wavelengths, 660, 562 and 595 nm, respectively, thus will react 
specifically with particular proteins (Gordon 2000). 
 
All bind to proteins via an ionic bond to form strongly coloured complexes from blue-
purple, strong purple and dark blue, respectively, which then are quantified.  
But due to the ionic bond formed all three may be prone to interferences from 
zwitterionic buffers or media, which is then reflected on their individual sensitivity in 
the following trend: BCA > Lowry > Bradford; 0.5, 10 and 20 µg cm
-3
, respectively 
(Walker "Protein structure, purification and characterisation" 2000). 
 
1.5.2.2 Principle of Fluorimetry 
 
Fluorescence occurs spontaneously in numerous organic molecules, and the decay 
depends on the time, pH and temperature within the surrounding environment of the 
fluorescent molecule, which can affect quantum yield, Q (Equation 1.5) and 
fluorescence intensity (Equation 1.6) and lifetime.  
The fluorescence spectra give information about events that occur in less than 10
-8
 s, 
this ratio is known as the quantum yield, its efficiency, and is expressed as follows: 
 
  
                 
               
 
Equation 1.5 
 
This technique is most accurate at very low concentration, where the intensity of the 
fluorescence (If) is related to the intensity of the incident radiation (Io), expressed as 
follows: 
              
Equation 1.6 
 
where c is the concentration of the fluorescing solution, d is the light path in cm, ελ is the 
molar extinction coefficient for the absorbing material at wavelength (λ) in dm3mol-1cm-
1
(Gordon 2000).  
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It is a process that occurs upon transitions from the lowest spin singlet energy level (S1) 
to the ground state (S0), illustrated as F in Figure 1.25.  
 
 
Figure 1.25- Modified & Simplified Jablonski diagram, the blue line is the photon 
adsorption (A), the green line represents the fluorescence emission (F), the red line 
represents the phosphorescence (P; a rare event), S is the singlet state, T is the triplet state, 
IC is the internal conversion and ISC is the intersystem crossing. (Herman 1998) 
 
Fluorescence is also prone to quenching, which decreases quantum yield, Q. It can 
occur by interaction with the solvent and other molecules in the solution. Another event, 
which can occur, is called “delayed fluorescence”, which involves the transition from 
T1 back to S1 and relaxing back to S0 (also known as G0). IC and ISC are non-radiative 
deactivation processes. 
 
Fluorochromes, commonly used with proteins, are chosen as to readily form covalent 
links with amine groups on lysine residues (Thorpe and Thorpe 2000). Others may also 
be used depending on the kind of bond formed with the protein under investigation. The 
fluorescein and its derivative, fluorescein isothiocyanate (FITC) (Abuelyaman, Hudig, 
et al. 1994), or the rhodamine and its derivative, Texas red (TXR) (Titus, Haugland, et 
al. 1982) both illustrated in Figure 1.26 have been extensively used because of their 
reactive groups, which covalently form to make thiourea and sulfonamide bonds, 
respectively. FITC emits in the green, while TXR emits in the red regions of the visible 
spectrum. They are non-destructive to proteins and non-toxic to cells during in vitro or 
in vivo studies. Also, they have high quantum yields, in the order of 0.85 and 0.88, 
respectively, compared to their respective precursor, fluorescein and rhodamine B at 
0.79 and 0.71 (Myers 1980; Umberger and Lamber 1945). Both fluorophores can be 
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stored for a long period of time without any loss of fluorescent intensity under 
appropriate conditions.  
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Figure 1.26- Chemical Structures of (a) Fluorescein isothiocyanate-FITC & (b) Texas red-
TXR 
 
Other available fluorochromes are fluorescent proteins, also known as the visible 
fluorophores. The most common and widely used of these are green fluorescent 
proteins (GFPs) (dos Remedios and Moens 1999; Megley, Dickson, et al. 2009). They 
usually emit in the green region of the visible spectrum and require little synthesis, 
which allows for good quantitative data to be collected for in vivo or in vitro work 
(Maddalo and Zimmer 2006). Natural fluorophores are also available; again they require 
very little synthesis, they include the fluorescent amino acids tyrosine, (Massip, Riollet, 
et al. 2002) tryptophan and phenylalanine found in proteins, as well as some enzyme 
cofactors. They can be used to study cellular dynamics and proteins; however the 
presence of these residues in proteins means they can also give unwanted background 
emission known as “auto-fluorescence”, which then needs to be separated from the 
desired signal, if other labels are used. All three have low quantum efficiencies in the 
order of 0.14, 0.13 and 0.02 (Lakowicz 1999), respectively, which can be seen as 
insignificant when quantum efficiency ranges from 0 to 1. Also they emit in the ultra-
violet region (280-350 nm), which can be very difficult to work with. Therefore, they 
are not useful for this study, as it is a time-dependent study with the necessity for strong 
fluorescence properties. 
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Monitoring and characterising protein adsorption and desorption behaviour on surfaces 
is an important factor into quantitatively and qualitatively collecting information on the 
mechanism and processes that occur between an implant and a material‟s surface. It 
allows improving and increasing the biocompatibility of the material as an implant, 
further expanding our understanding of the processes during protein adsorption.  In this 
sub-section, electrophoresis, radiolabelling and assaying kits will be discussed, as they 
are the most commonly used methods. There are other methods of competitive proteins 
analysis such as ellipsometry which requires no labelling of the protein (Elwing 1998), 
however adsorbed antigens are required to detect the proteins. This type of 
quantification also requires a high degree of operating skill and the expensive 
instrument, or cell detachment method (Anselme, Noel, et al. 1999; Ellingsen 1991). 
 
1.5.2.3 Principle of Electrophoresis 
 
To date the only method for true competitive analysis is electrophoresis (Matsuura , 
Hosokawa, et al. 2000; Takami, Yamane, et al. 1998), often used in conjunction with 
staining reagents (i.e. coomassie or silver) to image proteins (Ellingsen 1991) for 
microscopic work, however, quantification by this route requires a high degree of 
operating skill. 
Electrophoresis is a simple and highly sensitive tool. The separation by electrophoresis 
is based on the fact that biological molecules carry an electric charge, the magnitude of 
which depends on the molecule under investigation, and the pH and composition of the 
supporting medium (Plummer 1987).There are several supporting media such as paper 
or agar gel, but the most frequently used is polyacrylamide gel, often referred to as 
PAGE, (Plummer 1987; Walker "Electrophoresis techniques" 2000) used in conjunction 
with sodium dodecyl sulfate (SDS) an anionic detergent. SDS-PAGE is extensively 
used as a method to analyse protein mixtures, depending on the percentage of PAGE 
used separating proteins ranges depending on the molecular size of the proteins. This 
process, however, requires the denaturation of proteins to be fully analysed. 
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1.5.2.4 Principle of Radiolabelling 
 
It is a method, also known as radioimmunoassay (RIA) (Kao 1999; Kao, Hubbell, et al. 
1999), that involves labelling cells or proteins with radioactive elements such as iodine 
isotopes (
125
I- and 
131
I-labels) bound to proteins (Fabrizius-Homan and Cooper "A 
comparison of the adsorption of three adhesive proteins to biomaterial sufaces" 1991; 
Fabrizius-Homan and Cooper "Competitive adsorption of vitronectin with albumin, 
fibrinogen, and fibronectin on polymeric biomaterials" 1991). This kind of labelling is 
most commonly used for antigens used as tracers in the radioimmunoassay applications, 
quite precise, accurate and economical. However, the iodination solution conditions are 
considered harsh, and only available for proteins containing tyrosine residues. (Bolton 
and Hunter 1973)  Also it is difficult to automate, takes relatively long time and dose-
response curve covers only a relatively narrow range of the analyte concentration. 
(Thorpe and Thorpe 2000) This shows that only a few selected proteins can be used and 
there is also a danger that protein damage may occur, which may lead to loss of 
sensitivity of the assay system.  
 
1.5.2.5 Assaying Kits 
 
Another method is using kits prepared by manufacturers such as Invitrogen (Quant-IT 
kit), R&D Systems (Quantikine: a BMP-2 specific kit) and others, which have detection 
limits and set procedures. Kits fall broadly into two categories, enzyme-linked 
immunosorbent assay (ELISA) or total protein type assays, where both colourimetric 
and fluorometric tools are employed.  The latter assays all proteins present irrespective 
of species or conformations.  ELISA, on the other hand, is limited to measurement of 
specific protein and can be conformation dependent.  Therefore in order to carry out a 
competitive study multiple analyses must be performed.  In addition the two-step nature 
of the ELISA methodology makes it susceptible to human errors such as pipetting 
stages and aspiration steps. 
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1.6 Thesis Hypotheses 
 
The hypothesis of this thesis is that physiochemical differences in SA and HA modulate 
competitive protein adsorption in a manner which contributes to the enhanced 
osteogenic activity of the SA material. In order to test this hypothesis a series of 
sequential studies were planned and are presented in this thesis as chapters 2 to 6. 
 
Chapter 2: Materials Production. 
 
The total characterisation of the biomaterials in all the morphological forms, powders, 
dense discs and porous granules is to be determined. The aim is to show that 
hydroxyapatite (HA) and silicate-substituted hydroxyapatite (SA) have similar densities 
when in the dense discs and porous granules forms. They both have the chemistry that is 
expected of them to be confirmed by powder composition characteristics with the 
correct position of the phosphate or silicate group, surface analysis and the surface 
topography of the specimens. Samples produced here closely represent those of pre-
existing specimen used for clinical procedures (i.e. Apatech), and thus represent real 
samples that would gave rise to analysis and trend that could be related to real 
situations. 
 
Chapter 3: Probe Manufacture. 
 
The synthetic route for the fluorescent labels is to be decided using compounds that are 
non-toxic to proteins or cells, strongly fluorescent and able to covalently attach to 
proteins. 
The synthetic route needs to be simplistic and reproducible for each of the fluorescent 
labels. The fluorescent labels need to show strong fluorescence in different media, and a 
similar fluorescence once covalently attached to proteins. 
 
Chapter 4: Single species probe validation. 
 
This work is to be done using bovine serum albumin (BSA), as it is an inexpensive 
protein, present in abundance in the body at a physiological level in the working range 
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of most commercial kits such like the Quant-IT kit and involved in many bone 
processes.  Experiments are to be set up against the probe labelled BSA at various 
conditions. Also, having the protein directly attached to the probe will allow for the 
qualitative analysis to be undertaken. The protein morphology on the dense discs 
surface, at several immersion time points, can be discerned and help show the possible 
differences that may occur on the two different biomaterials in the different media. 
 
Chapter 5: Methodology refinement. 
 
Bone morphogenetic protein-2 (BMP-2) is to be set up in 2 experiments using a growth 
factor specific kit (Quantikine, R&D systems) and the probe, and determine the binding 
affinity on the biomaterials‟ porous granular form. Here the kit works on the basis of 
colourimetry compared to the Quant-IT kit in Chapter 4, which works on the basis of 
fluorescence, the same as the probe. This study is to be undertaken to determine the 
influences and preferences of BMP-2 adsorption and desorption processes on the 
different biomaterials; and the media used; to establish what the important or 
pronounced factors to the behaviour are? 
 
Chapter 6: Competitive Binding Studies. 
 
In this chapter, all proteins are to be evaluated at their respective physiological amounts 
in various media at 37 
o
C.  
The initial set up involved two independently labelled proteins in solution. However, 
unexpected results obtained when performing competitive studies with dual labelled 
probes lead to additional studies into the protein conformation and necessitated 
modification of the methodology for the studies. 
 
 
All research findings and conclusions can then be found in Chapter 7 for a summary of 
the behaviour of the physiochemical differences observed in SA and HA modulated to 
competitive protein adsorption. 
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2.1 Background 
 
Hydroxyapatite (HA) and its other ion-substituted products such as silicate-substituted 
hydroxyapatite (SA) are already commercially available (Apatech ltd, Biomet or 
Ceramisys) and have been shown to be efficient and successful as bone grafts 
substitutes (BGS) towards bone repair (Hing, Revell, et al. 2006). The material‟s 
bioactivity and biocompatibility are linked to environmental factors such as proteins and 
other cells present and structural factors, but also the physiochemical properties of the 
materials itself (Hing, Annaz, et al. 2005). 
 
The work of several researchers has shown that the surface physiochemical properties 
such as surface roughness (Thomas, McFarland, et al. 1997), surface area (Harding, 
Rashid, et al. 2005), surface charge (Yin, Liu, et al. 2002), porosity (Hing, Best, et al. 
1999) and chemistry (Gibson, Best, et al. 2002; Hing 2005; Thomas, McFarland, et al. 
1997), of the implant (BGS) to be of great importance as well as their interactions with 
the composition of the surrounding environment. These studies have generated observed 
differences in cell adhesion as each factor affected the bioactivity and thus 
biocompatibility of the material in vivo and in vitro in different ways (Ducheyne and 
Qui 1999). For example, a Ca/P ratio of 1.67 is the optimum ratio to which 
stoichiometric HA forms as a one phase product, which was also found to be true when 
forming SA (Gibson, Best, et al. 1999; Hing, Gibson, et al. 1998) where enhanced 
bioactivity was achieved (Patel, Best, et al. 2002). Lower or higher ratios resulted in 
impurities, which often lead to poorly calcined or sintered samples (Gibson, Ke, et al. 
2001; Patel, Gibson, et al. 2001), that changed the biomaterials‟ surface area and 
charge, the packing of the crystallites, the roughness, and density, which subsequently 
have an effect on the adsorption property of the proteins to that surface (Barralet, Best, 
et al. 2000). 
 
Thus, it will be of great importance to characterise HA and SA so that microstructure is 
similar. 
  
Chapter 2. SYNTHESIS & CHARACTERISATION OF THE BIOMATERIALS 
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2.2 Experimental Methodology 
 
Silicate-substituted hydroxyapatite (SA) and stoichiometric hydroxyapatite (HA) 
powders were synthesised at Apatech ltd. The powders were characterised as received 
and calcined. The powders were then processed in the form of dense discs and porous 
granules with matched densities and surface morphologies between the SA and HA 
specimens.  
 
2.2.1 Materials Synthesis 
 
HA and SA Powder production 
 
Deionised water (DIW, 100 L) was added to the precipitation vessel with a 300 rpm 
overhead stirrer. 
For the preparation of SA powder; Si(OAc)4 was weighed, added to DIW vessel, left to 
stir completely before the addition of Ca(OH)2 (see Table 2.1) to the reaction vessel and 
left stirring (see Figure 2.1) at room temperature (RT). Ensuring all Ca(OH)2 was 
transferred, the equipment was washed down. Both 25 L mixing vessels were filled with 
DIW (20 L) with a 150 rpm mechanical stirrer. The ammonia was added before the 
phosphoric acid (H3PO4) addition, the mass added was recorded and the volume of 
ammonia added calculated, using the density value of 0.89 g/ml.   
 
Table 2.1 – Amount required of reactants to synthesise HA and SA powder 
Biomaterials Reactants Mass required (g) 
HA 
Calcium hydroxide, Ca(OH)2 3,927 
Orthophosphoric acid, H3PO4 3,709 
SA 
Calcium hydroxide, Ca(OH)2 3,928 
Orthophosphoric acid, H3PO4 3,441 
Silicon acetate, Si (OAc)4 395.0 
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For the preparation of the HA powder; Ca(OH)2 was added to the reaction vessel, again, 
ensuring all Ca(OH)2 was transferred, the equipment was washed down. Both 25 L 
mixing vessels were filled with DIW (20 L) with a 150 rpm mechanical stirrer. 
After 15 minutes, the stirrers were turned off and tubing was run from the 25 L vessels 
through a peristaltic pump (5001-5004 type, Heidolph) into the precipitation vessel with 
the pump rate set at 20 arbitrary units and the acid addition was begun. A bottle of 
ammonium hydroxide (2.5 L) was placed on a balance and the tubing was inserted into 
the bottle and fed through the peristaltic pump head to the precipitation vessel, then the 
balance was tarred. Using the calibrated time switch, the ammonia was set to be added 
at an arbitrary rate of 200, for a period of 4 minutes, starting 10 hours and 40 minutes 
after the start of the phosphoric acid addition 
 
 
Figure 2.1 – Experimental set up for the manufacture of HA/SA Powder (Pilot plant in 
Apatech
 
ltd) 
 
After the phosphoric acid solution addition was completed (next day for HA), the 
mixing vessels were rinsed with DIW (250 ml), and the tubing was flushed.  
The precipitation vessel was then left to stir for a further 2 hours, followed by the 
ageing process for a minimum of 10 hours. 
 
Filtering, Drying, Disc Milling and Calcining Powder 
 
The process is depicted in Figure 2.2 top left image shows the precipitate being filtered, 
using a horizontal filter with a compression system and pump at a pressure of 600 MPa. 
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The cakes were then retrieved and chopped into 2 cm cubes to be placed in separate 
trays of equal weigh compared to the bulk sample. Once all trays were filled, they were 
placed in the drying oven for over 4 days set at 80 
o
C (see Figure 2.2, top right image). 
 
The chunks of dried HA/SA from the oven were crushed into smaller pieces, using a 
pestle and mortar and passed through a sieve. The small pieces were then fed to the disc 
mill machine 1 kg at a time to be crushed to HA/SA powder of a particle size of 300 
µm. The HA powder was then collected into a plastic container (10 L), labelled with a 
batch number and dated (see Figure 2.2, bottom images). 
 
 
Figure 2.2 – Visual scheme of the filtering, drying, disc milling process of the powder 
 
For the calcination, 200 g of material (SA/HA) were transferred into a ceramic dish, 
which was then placed in a Carbolite Muffle RHF furnace (Carbolite, UK) set at 700 
o
C. 
The powder was then left to calcine for up to 4 hours. Once cooled, the powder was 
transferred to glass-sealed containers, labelled and dated.  
 
Porous granules (PG) Samples Preparation 
 
To a mill pot, the calcined (500 
o
C) powdered HA or SA (509-511 g) was transferred 
into a plastic container (2.5 kg) along with DIW (798-802 g) and mixed into a paste. To 
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this mixture milling media (4363-4437 g) were added. The container was sealed shut 
using nuts and bolts to avoid leaking, and the whole container was transferred onto a 
ball mill machine and spun at a rate of 270 rpm for 30 minutes. After the 30 minutes, 
the mill pot was opened in order to add the PVA (90-92 g) and sealed shut again. (see 
Figure 2.3, top images).The container was once again placed on the ball mill machine 
and spun at a rate of 270 rpm for 3 hours. After 3 hours, the spinning was stopped. The 
foam was sieved to remove all milling media. Once removed, the foam, porous material 
was transferred to moulds and dried for over 48 hours. Once dried, the foams were 
removed from the mould and transferred into ceramic deep trays to be sintered at 1260 
o
C for HA and 1300 
o
C for SA in a eurotherm furnace (Lenton, UK) for a dwell time of 
4 hours (see Figure 2.3, bottom left image). 
 
 
Figure 2.3 – Visual scheme for the foaming process for the production of PG 
 
Granulation of HA foams was achieved using 3 sets of sieves (5 mm, 2 mm and 1 mm). 
Each batch was weighed and transferred into the top of the sieve column, vigorously 
shaken until no further granules went anywhere (see Figure 2.3, bottom right image). 
The larger chunks, which did not sieve through, are then transferred into a bowl. A little 
at a time, they were crushed to smaller pieces and passed through sieve again. This 
process was then repeated until no further large chunks of HA or SA were left in the top 
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sieve tray. When completed, each layer (2-5 mm; 1-2 mm; <1 mm) was weighed and 
volume recorded of the final porous granules (PG). 
 
Dense Disc (DD) Samples Preparation 
 
Dense discs (DD) were prepared by pressing 1.00 g or 1.60 g of SA/HA powder in a 16 
mm or 20 mm steel die, respectively (as illustrated in Figure 2.4). The force used ranged 
from 1.50, 1.75 and 2.00-tonne pressure, corresponding to powders pressed at loads of 
15KN, 18 KN and 20 KN. Using  Equation 2.1, these loads can be expressed in terms of 
MPa for both steel die systems as shown in Table 2.2, where r is the radius of the die 
system. 
 
         
               
   
 
 
Equation 2.1 
 
Table 2.2 –Pressures used on the pressed discs for each steel die system 
Load / KN Pressure / MPa 
 16 mm steel die 20 mm steel die 
15 75.8 48.5 
18 90.9 58.2 
20 101.1 64.7 
 
The discs were then sintered in Carbolite Furnaces (RHF1600 or RHF1400, Carbolite, 
UK) at temperatures ranging from 1200-1375 
o
C for the SA and 1150-1300 
o
C for the 
HA samples with a ramp rate of 2.5 
o
C per minute, dwell time of 120 minutes and a 
cooling rate of 10 
o
C per minute to ambient temperature. 
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Figure 2.4 – Visual scheme of the compressing of biomaterial powder into DD 
 
 
2.2.2 Materials Characterisation 
 
X-ray Diffractometry (XRD) 
 
XRD patterns were obtained using a XPERT-PRO PW3064/60 (Philips, UK) with 
CuKα1 (λ = 1.5406 nm) and CuKα2 (λ = 1.5444 nm) radiation operating at 45 kV and 40 
mA. Data were collected over a 2θ range of 5o to 120o, with a step size of 0.03o and a 
dwell time of 200 s. 
Crystallography Parameters were obtained using the XRD patterns in conjunction with 
3 programs. Xpert HighScore Plus software along with the ICDD database was used to 
obtain the unit cell volume, and the values for the a, b and c axes using the peak list 
with the Miller indices of known stoichiometric HA. Pickpx2 software (developed in-
house, UK) enabled xrdml and uxd files of the XRD data to be converted into 
corresponding 2-theta values and their d-spacing along with peak intensities. And the 
UnitCellWin software (developed by T.J.B. Holland (Holland and Redfern 1997), UK) 
evaluated all information (Miller indices and 2-theta data) and calculated the unit cell 
parameters ( cba   and cell volume).  
In order to quantify the unit cell parameters, two methods were used, where one 
involved using the best fit values to that of stoichiometric HA and its Miller indices 
(method 1), and the other involved using the first 50 values from the XRD patterns of 
the samples and the HA Miller indices, as template (method 2). 
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Fourier Transform Infrared Spectroscopy (FTIR) 
 
FTIR-Photoacoustic spectroscopy (PAS) spectra were obtained using a Thermo Nicolet 
8700 spectrometer in conjunction with a PA Cell-MTEC Model 200 with KRS-5 
sample chamber window. Spectra were obtained at a resolution of 4 cm−
1
, averaging 
128 scans, operating from 4000 to 400 cm
-1
. The sample chamber of the PAS cell was 
purged with helium gas prior to analysis.  
 
Reference samples for HA and SA sintered at 1250 and 1300 
o
C were analysed using a 
Spectrum GX (Perkin Elmer, UK) with the spectrum v5.3 software and a SpecAc 
attachment. These spectra were obtained at a resolution of 4 cm
-1
, averaging 10 scans, 
operating from 2000 to 450 cm
-1
 in transmittance (% T) at an interval of 1 cm
-1
.  
 
 
X-ray Fluorescence (XRF) Spectroscopy 
 
For the XRF analysis, samples were sent to CERAM Research (Stoke-on-Trent, UK), as 
sintered granular samples. Samples were analysed using the XRF Panalytical (Axios). 
 
 
Surface Area Analysis & Porosimetry 
 
A micromeritrics FlowPrep060 degaser, multipoint analyser was used to measure the 
surface area (S.A.) of both powdered and granular samples of the biomaterials, as 
shown in Figure 2.5. Surface area values were obtained using helium (He) at 15 psi with 
an evacuation rate of 300 mmHg/min. Prior to the analysis samples were dried at 200 
o
C 
overnight with nitrogen (N2) at 15 psi. 
 
 Chapter 2 
59 
 
Figure 2.5 – BET instrument set up in the IRC at QMUL 
 
Strut porosity of the porous granules was confirmed by embedding porous specimens in 
resin mixture; 15 parts resin (EpoFix Resin, Struers, UK) for 2 parts hardener (EpoFix 
Hardener, Struers, UK) and left to slowly set for 8 hours. The specimens were then 
polished on diamond paper from P80 to P220, and then imaged using SEM. The strut 
porosity was then determined using ImageJ 1.44i (National Institute of Health, USA). 
 
 
Scanning Electron Microscopy (SEM)  
and Energy Dispersive Spectroscopy (EDS) 
 
An INSPECT F (FEI, UK) field emission gun scanning electron microscope (FE-SEM) 
equipped with an energy dispersive X-ray spectrometer (EDS) was used to observe 
morphology and determine elemental distribution of silicon (Si) at a high resolution and 
accelerating voltage of 10 kV with samples coated with gold for SEM imaging only, 
while carbon was used for the analysis of samples for EDS. 
 
Density Measurements 
 
Two methods were used for the density measurements, in order to obtain precise and 
accurate data from both biomaterials. Method-One involved using a micrometer; and 
method -Two involved using Archimedes‟ principle. 
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Method-One: The dense discs were measured using a micrometer (RS, Mitutoyo, 
Japan), along the diameter and height in triplicates, followed by weighing on an 
analytical balance.  
 
Method-Two: The specimens were weighed in a dry condition (Wdry) in triplicate using 
an analytical plus electronic balance (Ohaus, Leicester, UK). The specimens were then 
placed in boiling deionised water for 30 minutes (60 minutes for porous samples) to 
ensure all open pores were filled with water and left to cool, still submerged in water. 
The specimens were weighed using the density AP solids kit (Ohaus, Leicester, UK), 
three times submerged in deionised water (Wsub) of known temperature, and then three 
times in the wet state (Wsat). The apparent and real densities of specimens were 
calculated using Equation 2.2 and Equation 2.3, respectively. The former takes into 
account both the open and closed porosity of the material, while the latter only 
considers closed pores.  
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Equation 2.3 
 
 Equation 2.4 and Equation 2.5 were used to determine the closed and total porosity, 
respectively.  
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Equation 2.4 
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Equation 2.5 
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An accepted value of 3.156 g/cm
3
 (Akao, Aoki, et al. 1981) was used for the theoretical 
apatite density (ρHA); although in silicate substitution a slight shift in the density of SA 
may be expected, equal values were used for both. For all equations described above: D 
is density, W is weight, ρH2O is the density of deionised water at a given temperature, 
CSµ is the closed strut porosity and ρHA is the theoretical density of the apatite. For 
dense specimens, Wdry should equal Wsat (as there should not be significant amounts of 
open porosity) thus measuring Wdry  
and Wsat  only is needed to calculate the real density 
(Dreal) to determine the percentage of closed porosity. 
 
 
Atomic Force Microscopy (AFM) 
 
Atomic force microscopy (AFM, NTegra with NT-MDT set up, Russia) of the samples 
was performed using a silicon, N-type cantilever with a working range of 0.01-0.025 
ohm/cm, a frequency range of 145-230 kHz and a spring constant range of 20-95 N/m.  
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2.3 Results  
2.3.1 Chemical Analysis 
 
The biomaterials‟ phase purity and crystallinity, the presence of silicate and phosphate 
groups and the design level of silicate incorporation were confirmed using XRD, FTIR 
and XRF, respectively.  
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Figure 2.6 - Comparative XRD Patterns of SA & HA samples (a) as-received and (b) 
calcined in the range of 25 to 40 degrees 
 
XRD (Figure 2.6 A and B) confirmed the phase purity of both the HA and SA (A) as-
received and (B) calcined samples. There was no presence of either β-TCP or CaO 
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impurities, as they should be observed at around 31.2 
o
 and 37.8 
o
, respectively. (Hing, 
Gibson, et al. 1998; Mostafa 2005)  
A 
B 
Figure 2.7 – XRD spectra of the (a) A80XXD1091A and (b) A80XXD1500A 
hydroxyapatite sample with and without impurities present, respectively. 
 
Figure 2.7 A and B show the XRD patterns obtained of the HA synthesised at Apatech 
ltd, where the first batch (A) resulted in a HA product with a 5% CaO impurity, and the 
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latter (B) with the use of a corrected protocol resulting in the optimum stoichiometric 
HA produced. (Appendix 1for all raw data from CERAM)  
The phase purity was further confirmed by the XRF analysis, as shown in Table 2.3, 
where for HA #1 sample (A) the Ca/P was higher at 1.75 than the expected value of 
1.68 for HA #2 sample (B).  
 
Table 2.3 – XRF data obtained for HA and SA powders  
 wt % Molar ratio 
Sample CaO P2O5 SiO2 Ca/P ratio Ca/(P+Si) 
HA #1 57.36 41.47 - 1.75 - 
HA #2 53.70 40.57 - 1.68 - 
SA 56.37 40.47 1.73 1.76 1.68 
 
XRF of the powders further confirms that the substitution occurred due to the presence 
of 0.8 wt% silicon for the SA sample as it allowed for the Ca/P ratio to be determined 
(see Table 2.3), which is very important when the powder undergoes further heat-
treatments for the formation of the two morphological forms of the biomaterials. 
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Figure 2.8 - XRD pattern of HA and SA over the range of 20 to 50 2θ 
 
Figure 2.8 shows the XRD patterns of HA and SA sintered at their optimum sintering 
temperatures of 1250 and 1300 
o
C, respectively. No second phases could be identified 
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in both materials, where position, intensity and peak widths were not noticeably 
different, suggesting similarity in the level of crystallinity in the biomaterials. 
 
Further XRD patterns were obtained at different sintering temperatures and all depicted 
in Figure 2.9 and Figure 2.10, both for SA and HA powdered samples.  
 
2000
4000
6000
8000
1 10
4
1.2 10
4
1.4 10
4
1.6 10
4
20 25 30 35 40 45 50
1200
1225
1250
1275
X
R
D
 I
n
te
n
s
it
y
 (
a
.u
.)
2 Theta (degrees)
A
0
200
400
600
800
1000
1200
20 25 30 35 40 45 50
1300
1325
1350
1375
X
R
D
 I
n
te
n
s
it
y
 (
a
.u
.)
2 Theta (degrees)
B
 
Figure 2.9 – XRD spectra of SA in the range of 20 to 50 2θ at all sintered temperatures (a) 
1200-1275 
o
C and (b) 1300-1375 
o
C  
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Figure 2.10 – XRD spectra of HA between 20-50 degrees at all sintered temperatures 
(1150-1300 
o
C) 
 
The XRD spectra obtained show little differences in peak pattern as sintering 
temperature was increased to produce a more crystalline material. The differences were 
more evident, when the crystallographic parameters were determined. 
 
For the crystallographic parameters, two methods were used, where method-1 involved 
using the first 30 to 50 values from the XRD patterns of the samples against the HA 
Miller indices, while method-2 involved using the best fit data against the HA Miller 
indices as template. 
 
SA crystallographic parameters at all sintered temperatures ranging from 1200 to 1375 
o
C are tabulated in Table 2.4 and Table 2.5 for method 1 and 2, respectively.  
And for the HA crystallographic parameters at all sintered temperatures ranging from 
1150 to 1300 
o
C are tabulated in Table 2.6 and Table 2.7, for method 1 and 2, 
respectively. 
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Table 2.4 – Unit Cell parameters for all sintered samples of SA using method-1 
Sintered 
Temperature / 
o
C 
a/ Å c / Å Unit Cell Volume / Å3 
1200 9.29 6.79 507.63 
1225 9.41 6.89 528.18 
1250 9.40 6.83 522.39 
1275 9.30 6.77 507.52 
1300 9.41 6.88 527.89 
1325 9.36 6.91 524.90 
1350 9.41 6.87 527.00 
1375 9.41 6.89 528.38 
 
Table 2.5 – Unit Cell parameters for all sintered samples of SA using method-2 
Sintered Temperature / 
o
C a / Å c / Å Unit Cell Volume / Å 3 
1200 10.11 7.33 648.50 
1225 10.50 7.56 721.51 
1250 9.79 7.09 588.69 
1275 9.80 7.08 588.36 
1300 11.39 8.02 901.40 
1325 11.82 8.45 1023.11 
1350 11.25 8.02 879.64 
1375 11.81 8.49 1025.90 
 
Method 1 for SA specimen was the better method to use (see Table 2.4 and Table 2.5), 
as it gave rise to values comparable to the literature (Balas, Perez-Pariente, et al. 2003; 
Gibson, Best, et al. 1999; Hing, Revell, et al. 2006; Thian, Huang, et al. 2006). At 1300 
o
C, the appropriate unit cell volume and the axes were calculated; the optimum 
characteristic of the sample was reached by comparison the values found in literature.  
 
Again method 1 for HA specimen (see Table 2.6 and Table 2.7), was the better method, 
as it allowed a trend to be observed as temperature increased for the sintering process of 
the HA material. The crystallographic parameters confirmed that at 1250 
o
C the 
appropriate unit cell volume and the axes were determined; the optimum characteristic 
of the sample was reached.  
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Table 2.6 - Unit Cell parameters for all sintered sample of Stoichiometric HA using 
method-1 
Sintered Temperature / 
o
C 
a / Å c / Å Unit Cell Volume / Å 3 
1150 9.42 6.86 527.66 
1175 9.41 6.86 526.10 
1200 9.42 6.87 527.49 
1225 9.41 6.87 527.22 
1250 9.41 6.88 527.09 
1275 9.41 6.85 525.48 
1300 9.41 6.86 526.44 
 
Table 2.7 – Unit Cell parameters for all sintered samples of Stoichiometric HA using 
method-2 
Sintered Temperature 
/ 
o
C 
a / Å c / Å Unit Cell Volume / Å 3 
1150 10.28 7.39 676.91 
1175 10.56 7.49 723.59 
1200 10.79 7.70 775.62 
1225 10.37 7.42 690.43 
1250 10.61 7.55 736.29 
1275 10.58 7.53 730.57 
1300 10.52 7.53 722.70 
 
Following the XRD and XRF analysis, the FTIR was undertaken to show the peak 
position of the phosphate and silicate groups in the biomaterial samples. 
 
Figure 2.11 shows the FT-IR PAS of HA and SA sintered at their optimum 
temperatures, across the range of 4000 to 400 cm
-1
. The spectra depict the characteristic 
hydroxyl group (OH
-
) at 3570 cm
-1
 on both materials, and a band of adsorbed water on 
the SA spectra at 3417 cm
-1
, expected from the substitution within the HA lattice and 
release of hydroxyl group from the system. Figure 2.12 shows the spectra across the 
1400 to 400 cm
-1
, which is the characteristic region for both the phosphate and silicate 
ions to be present in. Both are depicted here in red dots for the phosphate and blue dots 
for the silicate groups. 
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Figure 2.11 – FT-IR spectra of HA and SA between 4000 and 400 cm-1 
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Figure 2.12 – FT-IR spectra of HA and SA between 1400 and 400 cm-1 (red and blue dots 
are associated with phosphate groups in HA and SA, respectively) 
 
Peak assignments can be clearly seen in Table 2.8, in terms of groups, bands and 
remarks, which are further confirmed through the reference samples analysis, as shown 
here in Figure 2.13. 
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Table 2.8 – FTIR peak assignments for silicate-substituted hydroxyapatite, with associated 
peaks for hydroxyapatite 
Groups Band (cm-1) Notes 
Phosphate 507,682 υ4 PO4
3-
  
 962 υ1 PO4
3-
  
 1032, 1046, 1080 υ3 PO4
3-
  
Phosphate 474 υ1 PO4
3-
  
Associated with HA 632, 600, 578 υ3 PO4
3-
  
Silicate 510 SiO4
4-
  
 970, 915, 850 SiO4
4-
  
Carbonate 1250-1500 CO2
3-
 
Surface adsorbed 
phosphate 
2000-2250 HPO4
3-
 
Adsorbed water 3300-3500 H2O 
Hydroxyl 3575 υ1 
-
OH notes 
 
20
30
40
50
60
70
80
90
100
600800100012001400
CaP ref
HA
T
ra
n
s
m
it
ta
n
c
e
 (
%
 T
)
Wavenumber (cm
-1
)
A
1
2
3
4
5
6
20
30
40
50
60
70
80
90
100
600800100012001400
CaP ref
ZrSi Ref
SA
Wavenumber (cm
-1
)
T
ra
n
s
m
it
ta
n
c
e
 (
%
 T
)
1'
2'
3'
6'
4'
5
7
8
9
B
 
Figure 2.13 – FTIR spectra of reference samples in the range 1400 and 500 cm-1 for (a) 
calcium phosphate with HA and (b) zirconium silicate and calcium phosphate with SA   
 
Figure 2.13A clearly shows where the phosphate group in the calcium phosphate 
(Ca3(PO4)2) sample overlapped with HA at peak positions of 1, 3, 4, 5 and 6 with a 
broader peak at position 2. While for SA (see Figure 2.13B) there were similarities in 
phosphate groups at peak positions 1, 2, 3 and 6, but with some ambiguities in peak 
positions 4 and 5, may be due to the presence of the silicate group. The zirconium 
silicate (ZrSiO4) reference sample showed a broad peak between 800 and 1000 cm
-1
, 
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which may result in the presence of the silicate groups at peak positions 7 and 8; the 
smaller size may be due to the relatively small amount of silicon present at 0.8 wt%. 
Peak positions 5 and 9 may also result from the presence of the silicate. Overall, the 
phosphate and silicate group positions shown in Figure 2.12 seemed to correspond to 
those observed in the reference samples.  
 
FTIR at all sintering temperatures, including as-received and calcined, were performed 
and shown here in Figure 2.14 for the SA and Figure 2.15 for the HA samples, 
respectively. 
The calcined and as-received SA samples, show broad spectra compared to the samples 
sintered at higher temperatures, clearly showing the change in the samples‟ 
morphology, which was expected as the samples crystallinity increased with increasing 
temperature. Once the samples were sintered beyond 1200 
o
C, it was hard to distinguish 
a peak position differences between samples. 
A similar observation was seen for the HA samples with the calcined and as-received 
samples also having a broad spectra as shown in Figure 2.15, but overall higher 
photoacoustic intensities were observed compared to SA samples. 
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Figure 2.14 – FT-IR spectra of SA between 4000 and 400 cm-1 at all sintered temperatures 
(1200-1375 
o
C) 
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Figure 2.15 – FT-IR spectra of HA between 4000 and 400 cm-1 at all sintered temperatures 
(1150-1300 
o
C) 
 
2.3.2 Powder Morphology 
 
The powder morphology was characterised in terms of surface area analysis, particle 
size and topography via SEM. Particle analysis of HA and SA were obtained and 
tabulated below in Table 2.9 and Table 2.10, as-received and calcined biomaterials, 
respectively. HA and SA particle sizes were very similar between samples for both 
treatments, which range agrees with values found in the literature(Gibson, Best, et al. 
2002; Gibson, Ke, et al. 2001). 
 
Table 2.9 – Particle size obtained for the as-received samples  
Sample 
Particle size (µm) 
d10 d50 d90 
HA 3.97 12.22 108.5 
SA 3.82 12.89 114.3 
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Table 2.10 – Particle size obtained for the calcined samples  
Sample 
Particle size (µm) 
d10 d50 d90 
HA 3.95 13.10 112.6 
SA 3.75 11.93 107.4 
 
The surface area was measured via BET and tabulated above (see Table 2.11) for the as-
received and calcined samples.  
 
Table 2.11 – BET Surface Area values for the powder apatites 
Sample name Surface Area / m
2
g
-1
 
HA as-received 51 
SA as-received 68 
HA calcined 31 
SA calcined 37 
 
The values obtained were lower to the HA values found in the literature (Gibson, Ke, et 
al. 2001) for the precipitate (as-received) samples, but with a similar pattern where SA 
had a larger surface area than HA. Once calcined, the surface area of the powders was 
dramatically reduced for both samples with the SA still having the higher value possibly 
due to the presence of silicon compared to HA. The as-received samples have larger 
surface area compared to the calcined (700 
o
C) samples. 
 
To further characterise the powdered samples, SEM images were obtained to show 
powders‟ morphology, as heat-treatment increased as shown in Figure 2.16. 
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Figure 2.16 – SEM of as-received powders of (a) HA and (c) SA, and calcined (b) HA and 
(d) SA 
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2.3.3 Dense Discs (DD) Morphology 
 
The density of the materials was investigated via two methods. The first method 
involved using a micrometer, while the second method, the Archimedes‟ principle. All 
measurements made using the micrometer gave rise to inconsistent data, this may reflect 
the fact that this method assumed that each disc were perfect cylinders (all raw data 
available in Appendix 2 to Appendix 10). Therefore, the values showed here are all 
from the Archimedes‟ principle method, see Table 2.12, and illustrated in Figure 2.17 ; 
and a summary at the optimum sintering temperature of 1300 
o
C shown in Table 2.13 
including values for the total porosity of the samples. 
 
Table 2.12 – SAD density at all sintering temperatures, using the Archimedes’ principle 
Sintering 
Temperature / 
o
C 
Density at 75.8 
MPa (±ζ) / gcm-3 
Density at 90.9 MPa 
(±ζ) / gcm-3 
Density at 101.1 
MPa (±ζ) / gcm-3 
1200 3.049 (±0.01) 3.057 (±0.01) 3.092 (±0.06) 
1225 3.064 (±0.01) 3.085 (±0.03) 3.086 (±0.01) 
1250 3.070 (±0.03) 3.085 (±0.01) 3.092 (±0.01) 
1275 3.086 (±0.01) 3.090 (±0.01) 3.106 (±0.01) 
1300 3.065 (±0.01) 3.089 (±0.01) 3.100 (±0.01) 
1325 3.068 (±0.01) 3.100 (±0.02) 3.098 (±0.01) 
1350 3.067 (±0.01) 3.097 (±0.01) 3.121 (±0.01) 
1375 3.073 (±0.02) 3.098 (±0.02) 3.109 (±0.01) 
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Figure 2.17 – Density of sintered SA at different pressures 75.8 (1.50), 90.9 (1.75) and 
101.1 (2.00) MPa, calculated using the Archimedes’ principle  
 
Table 2.13 – Average SA-D density sintered at 1300 oC, using the Archimedes’ principle 
Pressure / MPa Density (±ζ) / gcm-3 Total porosity / % 
75.8 3.065 (±0.01) 3.2 
90.9 3.089 (±0.01) 2.6 
101.1 3.100 (±0.01) 2.9 
 
The density of the HAD produced at 101.1 MPa were not included as the discs 
produced were brittle and broke up either on removal from the die or during sintering. 
Therefore only the data of the discs pressed at 75.8 and 90.9 MPa are included, as 
shown in Table 2.14 and Figure 2.18, with a summary shown in Table 2.15 with values 
for the total porosity of the samples at the two different pressures. 
 
Dense discs made at the applied pressure of 90.9 MPa resulted in the formation of the 
best discs with appropriate densities, showing no sign of breakage prior and after the 
sintering process. As a result, all required discs for all experiments in the following 
chapters were pressed at 90.9 MPa.  
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Table 2.14 – HAD density at all sintering temperatures, using the Archimedes’ principle 
Sintering 
Temperature / 
o
C 
Density at 75.8 
MPa (±ζ) / gcm-3 
Density at 90.9 MPa 
(±ζ) / gcm-3 
1150 3.083 (±0.01) 3.102 (±0.01) 
1175 3.110 (±0.01) 3.118 (±0.02) 
1200 3.116 (±0.01) 3.135 (±0.01) 
1225 3.126 (±0.01) 3.125 (±0.02) 
1250 3.120 (±0.01) 3.136 (±0.01) 
1275 3.126 (±0.02) 3.131 (±0.01) 
1300 3.117 (±0.01) 3.128 (±0.01) 
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Figure 2.18 – Density of sintered HA at different pressures 75.8 (1.50) and 90.9 (1.75) 
MPa, calculated using the Archimedes’ principle 
 
Table 2.15 – Average HA-D density sintered at 1250 oC, using the Archimedes’ principle 
Pressure / MPa Density (±ζ) / gcm-3 Total porosity / % 
75.8 3.120 (±0.01) 2.0 
90.9 3.136 (±0.01) 1.5 
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Grain size of the specimens was investigated using SEM in conjunction with EDS to 
confirm elemental distribution on the surface of the biomaterials. The figures below 
correspond to the SEM imaging of the biomaterials, followed by the EDS analysis.  
 
 
Figure 2.19- SEM imaging of (a) SA and (b) HA dense disc sintered at 1300 and 1250 
o
C, 
gold coated 
 
Figure 2.19A shows SA samples at its optimum sintering temperature showing no sign 
of degradation. Figure 2.19B depicts the crystal morphology of HA sintered at 1250 
o
C. 
The images showed a very crystalline structure with clear grain boundaries of an 
average grain size of 1-2 μm. 
The EDS analysis showed the content of element present on the surface of the samples 
under investigation in terms of percentages.  
 
Table 2.16 – EDS Analysis of HA & SA in terms of weight and atomic percentage of 
element present 
Elements 
HA SA 
Weight % Atomic % Weight % Atomic % 
Ca 37.6 22.0 34.4 19.4 
P 19.1 14.5 17.6 12.9 
O 43.3 63.5 47.2 67.0 
Si - - 0.8 0.7 
 
Table 2.16 shows the elemental distribution as a percentage on the surfaces of the two 
biomaterials. SA has 0.8 % silicon and HA has none. Figure 2.20A and B are the EDS 
A B 
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spectra, clearly showing the absence and presence of the silicon as an element in the 
biomaterials‟ surface of the dense discs. 
 
 
Figure 2.20 – EDS spectrum of the (a) SA and (b) HA sintered at 1300 and 1250 oC, 
respectively 
 
AFM was used to measure surface roughness (see Table 2.17) and confirm dense disc‟s 
material morphology and phase homogeneity.  
 
Table 2.17 – Average Surface Roughness of biomaterials calculated using AFM statistical 
analysis 
Materials Surface Roughness (±ζ) / nm 
SA 360 (± 80) 
HA 330 (± 40) 
 
 
Figure 2.21 – AFM images of (a) HA and (b) SA dense disc sintered at 1250 oC 
 
The AFM images in Figure 2.21 show different colours from light to dark, these 
represent how shallow or deep the surface is, taking this into account, it can be said that 
A B 
A B 
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HA has deeper surfaces than SA. These images also show that SA surface is more 
homogeneous that HA. And finally, some of the grain sizes observed may be 
comparable to the ones observed via SEM. 
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2.3.4 Porous Granules (PG) Morphology 
 
Porous samples of the biomaterials were investigated using the Archimedes‟ principle 
for the density and total porosity (see Table 2.18). The surface area of the samples was 
confirmed via BET (see Table 2.19) and the strut porosity, also known as the pore 
interconnectivity was calculated and values tabulated below (see Table 2.20) via 
samples embedded in resin, imaged by SEM (see Figure 2.22). 
 
Table 2.18 –Archimedes’ principle data for the porous materials 
Material Density (±ζ) / gcm-3 Total porosity / % 
SAG 2.874 (± 0.08) 80.8  
HAG 2.567 (± 0.04) 81.0 
 
Table 2.19 –Surface area data for the porous materials using BET 
Sample name Sample Weight / g Surface Area / m
2
g
-1
 
SAG 1.1162 0.169 
HAG 1.1566 0.134 
 
Table 2.20 –Strut porosity in the biomaterials  
Sample name Strut Porosity (±ζ) / % 
SAG 19.8 (± 0.52) 
HAG 19.6 (± 3.5) 
 
The porous samples were imaged further to show grain boundaries and sizes to be 
similar to those found on the dense discs surface in section 2.3.3. 
SA porous sample (see Figure 2.23) sieved through particle size of 2 < PG < 5 mm 
show clear and clean grain boundaries with a average grain size of 1 -2 µm, while the 
HA porous sample (see Figure 2.24) shows a similar pattern. Images on the SA showed 
smaller grains than HA, but overall they look similar. 
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Figure 2.22 – SEM images of (a) porous SA and (b) porous HA embedded in resin and 
polished used to determine the strut porosity via (c) SA and (d) HA thresholds 
 
 
Figure 2.23- Porous SA granules (sieve size of 2-5 mm) sample at a high and low kV, gold 
coated 
 
 
Figure 2.24 – SEM imaging of Porous HA (granular size sieve through 2-5 mm) gold 
coated  
A B 
C D 
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2.4 Discussions 
 
Chemical Analysis 
 
XRD pattern of the powdered HA samples, as shown in Figure 2.6, had larger intensity 
values than that of SA pattern on both patterns. For both biomaterials, the calcined 
patterns were more intense than those observed for the as-received patterns (see Figure 
2.6A and B). The XRD patterns overall were very similar between the biomaterial 
powders. The unit cell volume and axes (a and c) for the as-received and calcined 
samples were determined and showed inconsistency, which was found to agree with the 
findings in Gibson et al. (2001). Samples heated at and below 500 
o
C were found to be 
difficult to assess any effect of chemical changes on the phase composition and 
structure of HA, especially when prepared via the aqueous precipitation route was 
difficult (Gibson, Rehman, et al. 2000; Osaka, Miura, et al. 1991). The XRD pattern of 
the powders show that phase pure products were made as no impurities were found 
compared to the HA sample #1 formed as shown in Figure 2.25A. 
The differences in the intensity of the XRD pattern from HA to SA were known to be 
due to the presence of silicon (Si), as silicon is known to act as a sintering aid, which 
results in SA samples having lower crystallinity at the same calcination temperature 
than HA. Hence, lower intensity was observed. (Gibson, Best, et al. 2002; Kim, Lee, et 
al. 2003) This agreed with the findings and supported by the SEM images obtained, as 
shown in Figure 2.16 that showed a change in structure of the samples‟ edges with more 
change observed on SA than HA.  
 
The XRD patterns of the SA and HA samples with increasing sintering temperature 
illustrated in Figure 2.9 and Figure 2.10, showed very little difference in peak position 
in both samples. The effect of increasing temperature on the biomaterials was more 
apparent when looking at the crystallographic parameters in Table 2.4 and Table 2.6 
generated through the XRD patterns in Figure 2.9 and Figure 2.10, for SA and HA 
respectively. Using the patterns and a refinement software, the structural parameters of 
the HA and SA have been determined and found in the literature to show a certain 
tendency, where for all SA samples, the unit cell parameters were slightly greater than 
those obtained for HA. Thus, showing a trend in which the incorporation of Si in the 
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HA lattice increases the  a- and c- axes , as well as the unit cell volume, this possibly 
due to silicon‟s larger atomic size and the change on the surface charge of the 
biomaterial, as the phosphate ions are replaced. Before and beyond the optimum 
sintering temperature for SA and HA was reached, the crystallographic parameters in 
Table 2.5 and Table 2.7, analysed using method-2, did not correspond to expected data 
found in the literature, and method 1 was found to be more reliable in generating the 
expected data. The differences in crystallographic parameters can also be due to the way 
the hydroxyapatite: stoichiometric and substituted, have been synthesized (Balas, Perez-
Pariente, et al. 2003; Gibson, Best, et al. 1999; Thian, Huang, et al. 2006). 
In this investigation, the unit cell parameters obtained from the samples made, should be 
ideally within the data obtained from Gibson, as the samples would be quite similar in 
nature due to the process used to manufacture them, with an emphasis on SA unit cell 
parameters being larger than those obtained from HA. Therefore, this would be an 
expected observation when characterising samples for this investigation, which was 
observed in this study. 
 
Following the XRD, XRF of the powders further confirmed the difference in the 
biomaterial‟s composition due to the presence of silicon, but also established that the 
substitution had occurred with no changes to the Ca/P ratio, suggesting that upon 
sintering a single phase product was formed, as described by the work of Hing and 
Gibson et al. It is important to have the correct Ca/P ratio in order to have the optimum 
specimen (see Figure 2.25 , CaP2 sample) (Hing, Gibson, et al. 1998). 
 
 
Figure 2.25 – XRD pattern indicating the position of impurities in hydroxyapatite, where 
calcium oxide is present in CaP1, tricalcium phosphate in CaP3, and the optimum sample 
composition in CaP2. (Hing, Gibson, et al. 1998) 
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Higher than the expected ratios result in the formation of calcium oxide (CaO) 
impurities within the samples, as shown on the initial HA produced (see Figure 2.7A) 
which agreed with Hing et al. (see Figure 2.25 sample CaP1) (Hing, Gibson, et al. 
1998), while a lower ratio gives rise to the beta-tricalcium phosphate to form upon 
sintering above 1200 ºC as in the CaP3 sample, as shown in Figure 2.25. This 
observation was further confirmed by others as well as the importance of the Ca/P ratio 
(Mostafa 2005). 
XRD and XRF analyses, together, confirmed the biomaterial powders to be phase pure 
and silicate substituted.  
 
Analysing the powders via FTIR showed a broader spectrum for the SA material, 
probably due to the loss of the hydroxyl through the substitution compared to HA, as 
shown in Figure 2.11 at the full range of 4000 to 400 cm
-1
, which was expected and 
agreed with by others.(Balas, Perez-Pariente, et al. 2003; Gibson, Best, et al. 1999; 
Hing, Revell, et al. 2006; Thian, Huang, et al. 2006). For the characteristic phosphate 
and silicate group peak position, a more specific range was used at 1400-400 cm
-1
, as 
shown in Figure 2.12, in order to identify the individual groups. The assignments made 
in , agreed with those found in the work of Gibson, Best et al. (Gibson, Best, et al. 
1999), where the peak positions observed showed phosphate peaks at 950, 890 and 840 
cm
-1
 in SA compared to HA between 960 and 1100 cm
-1
, which have moved due to the 
presence of silicate. Further confirmed by peak assignment found in the work of Hing et 
al. (Hing, Revell, et al. 2006) and Thian et al. (Thian, Huang, et al. 2006).  
The peak positions were then compared to crystalline sample references obtained in 
Figure 2.13, calcium phosphate (Ca3(PO4)2) and zirconium silicate (ZrSiO4), clearly 
showing corresponding positions to those observed in the SA or HA samples, which 
was in agreement with assignments found in the work of Rashid et al. (Rashid, Harding, 
et al. 2008) 
 
Increasing sintering temperature of the powders during the FTIR, just like the XRD 
analysis, showed little differences between samples sintered above 1150 
o
C.  
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Powder Morphology 
 
The particle size distribution of the as-received (precipitate) and calcined powder 
samples were within the normal range reported in the literature for HA synthesised 
using the same general production route. HA and SA particle sizes were fairly similar, 
especially once calcined at 700 
o
C, with slightly higher particle sizes observed from the 
HA samples, which was described by Gibson et al. (Gibson, Best, et al. 2002; Gibson, 
Ke, et al. 2001) 
 
Table 2.11 clearly showed SA to have the higher surface area values measured via BET 
compared to HA, as the temperature increased. SA surface area of the as-received 
material was found to be lower in values compared to that found in the literature, but 
still higher than HA. The higher surface area in SA has been known to be indicative of 
the presence of silicon (Si) as a substituted element, which inhibits the crystal growth 
where smaller but a larger amount of crystallites are formed, in the SA precipitate 
compared to HA precipitate (Gibson, Best, et al. 2002). 
The work of Raynaud and his co-workers showed that with increasing Ca/P ratio from 
1.50 to 1.71 on HA powder sintered at 1000 
o
C, there was a decrease of the specific 
surface area from 88± 2 to 55 ± 1 m
2
/g. This observation demonstrated the importance 
of acquiring the appropriate Ca/P to achieve the corresponding surface area from the 
biomaterials. This suggests a possible trend that with increasing temperature, a decrease 
of surface area will also be evident, which would make temperature an important factor 
in obtaining a biomaterial specimen with an appropriate surface area, which agreed with 
findings in this study. This was further exhibited when working with the dense disc 
morphological form of the biomaterial. When the Ca/P reached the optimum ratio at 
1.667 for HA, the specific surface area obtained was 58± 1.5 m
2
/g, close to the value 
obtained in this work (Raynaud, Champion, et al. "Calicum phosphate apatites with 
variable Ca/P atomic ratio I. Synthesis, characterisation and thermal stability of 
powders" 2002). 
The surface area and particle size of HA biomaterials are strongly affected by the Ca/P 
ratio and sintering temperatures of the starting materials, thus it was very important to 
get the chemical analysis right. 
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Figure 2.16A and C showed the SEM of the as-received samples of HA (A) and SA (C) 
respectively, at the micron level. The samples depicted are an agglomeration of the 
needle-like crystalline structure of hydroxyapatite, which is usually found in the 
literature as T.E.M. images at the nano-level (Weiner and Wagner 1998). Thus, samples 
showed less sharp the edges for both HA and SA, compared to clear crystal needles, and 
once calcined this effect was lessened, as shown in Figure 2.16B and D. This effect was 
more apparent on the SA biomaterial, reflecting the smaller crystallite formation in the 
precipitate powder possibly due to its higher surface area. 
 
Dense Discs (DD) Morphology 
 
SA sintering temperatures can be as high as 1400 
o
C to reach optimum density of the 
material, depending on the weight percent amount of silicon substituted. At low 
temperature (1000-1150 
o
C) low densities of the samples were observed as compared to 
that of stoichiometric HA (Gibson, Best, et al. 2002). This observation agreed with 
observation found in this work also. Beyond 1400 
o
C, the SA samples are prone to 
undergo a second phase change to calcium silicate as its melting point is within this 
temperature region. Thus, the sintering experiment for the SA samples was investigated 
from above 1150 
o
C to below 1400
 o
C, to optimise the production of a highly dense 
biomaterial, and avoid the low densities sample production and second phase formation 
of the biomaterial. 
In the case of hydroxyapatite (HA; calcium phosphate ceramics), the sintering 
temperature has been established in the range between 1000 
 o
C to 1500 
o
C, following 
compaction of the powder into the desired shape (Hench 1991). However, it was also 
found that beyond 1250 
o
C, HA has a tendency to degrade into its derivative (β-TCP) 
and decompose, or have calcium oxide impurities, depending on the Ca/P ratio of the 
powder produced. Also, the influence of heat on HA has been investigated extensively 
to demonstrate that calcination of HA powder at temperatures between 400 and 1000 
o
C 
influenced its properties towards a material more crystalline (Patel, Gibson, et al. 2001). 
Thus, the sintering experiment was undertaken above 1000 
o
C up to 1400 
o
C to achieve 
a more crystalline product, no impurities and highly dense material. 
 
Observed densities were comparable to values found in the literature with HA 
exhibiting higher densities than those observed for SA, which corresponded to an 
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average 98 % density for SA compared to 99 % for HA dense discs pressed at 90.9 
MPa. Dense apatite can also be described as microporous, where the materials have a 
total porosity of less than 5 % by volume, as shown for SA in Table 2.13 and HA in 
Table 2.15, to be true. (LeGeros and LeGeros 1993) Table 2.13 and Table 2.15 show the 
average densities determined using the Archimedes‟ principle, at the optimum sintering 
temperature for the biomaterials.  
The low microporosity observed during the analysis for samples pressed at 90.9 MPa 
was another advantage in using this applied pressure for the formation of the dense 
discs. According to previous work (LeGeros and LeGeros 1993), the applied pressure 
used was within the range found in that work, which was also dependent on the 
sintering temperature used and heating duration. In other work, an applied pressure of 
200 MPa was used to compress 2 g of sample, however, the size and silicon content 
differed from that under investigation compared to Gibson‟s samples, which contained 
only 0.4 wt% Si in HA to form 12 mm diameter and 6 mm thickness discs (Gibson, 
Best, et al. 1999). This may suggests that with reduced silicon content a higher applied 
pressure may be required to achieve a similarly microporosity. 
 
SEM images of SA (A) and HA (B) shown in Figure 2.19 indicated that the biomaterial 
produced was not decomposing, showed clear grain and grain boundaries. Clean grain 
boundaries were observed with relatively similar grain sizes on both surfaces, but SA 
having on average smaller ones than HA. This was further confirmed by the AFM and 
agreed with findings in previous studies, where the incorporation of the silicate group in 
the HA lattice showed to produce smaller grain size in the biomaterials.(Balas, Perez-
Pariente, et al. 2003; Gibson, Ke, et al. 2001) 
The differences seen in the EDS shown in Figure 2.20 further confirm the XRF and thus 
the presence of silicon in the biomaterials and its composition, as a substituted 
biomaterial. 
 
AFM confirmed the differences in grain size of the two biomaterials‟ surfaces, where 
SA shows smaller grain size (see Figure 2.21B) compared to HA (see Figure 2.21A), 
thus leading to more boundaries forming that may have resulted in the increase in 
surface roughness of the SA biomaterial, as shown in Table 2.17, but also the increased 
presence of triple junctions at the grain boundaries. For the purpose of this study and 
using proteins instead of cells, i.e. larger molecular weights, and concentration 
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increased roughness on the biomaterials may lead to increased protein adsorbed. This 
will be further discussed in the following chapters. 
 
 
Porous Granules (PG) Morphology 
 
The density of the porous samples was lower than the calculated density of the dense 
discs, however, the overall trend of SAG having the higher value compared to HAG 
was still observed, as shown in Table 2.18. This observed lower density was also found 
by others (Hing, Best, et al. 1999) for the porous specimens, which were cylindrical in 
shape with a length of 8.8 mm and a diameter of 4.6 mm.  
Using the Archimedes‟ principle also allowed for the total porosity of the samples to be 
determined at an average 80 % for both samples, which was as expected. This would 
represent the macroporosity of the samples via density and SEM (in mm), while the 
microporosity (the strut) can be visualised using SEM (in µm), but sometimes also 
measured using intrusion porosimetry. (Rosengren, Pavlovic, et al. 2002) 
 
The surface area for the porous granules has been determined using BET as shown in 
Table 2.19. SAG had a higher surface area compared to HAG, which was expected as 
for the chemical and powder analyses, confirming the influence of Si in the biomaterial. 
The introduction to porosity should not affect the surface chemistry of the samples 
compared to the powder or dense disc specimens, as in principle only the 
interconnectivity would have increased  (Shors and Holmes 1993) which was observed 
here also.  
 
Strut porosity of the porous samples was observed in Figure 2.22 to be the same for 
both biomaterial, and valued at around 19.6 %, shown in Table 2.20, which was about 
0.4 % lower than expected but similar in both samples. Figure 2.22 clearly showed 
samples to have very similar topographies when visualised at the 100 µm range. 
Other SEM images of the porous samples (not embedded in resin) in Figure 2.23 and 
Figure 2.24 for SAG and HAG, respectively, confirmed specimen similarity in the grain 
structure and boundaries.  
 
  
 Chapter 2 
90 
2.5 Summary & Conclusions 
 
The biomaterials SA and HA were characterised and found to correspond to 
characteristics found in the literature, with densities of 98 % and 99 %, respectively. 
The photo-acoustic spectra confirmed the peak positions of key functional groups of the 
samples; the XRD confirmed the formation of a one phase pure biomaterial with a high 
degree of crystallinity, in addition it gave rise to corresponding crystallographic patterns 
and parameters. The XRF in conjunction with EDS confirmed the composition and 
silicon substitution, while the SEM and AFM confirmed surface topography.  
 
Further characterisation of the porosity of the samples, both dense and porous, revealed 
the expected trends of the samples where the dense samples had 100 % closed porosity, 
while the porous samples showed an average of 80 % total porosity with a closed strut 
porosity of 19.8 and 19.6 % for SA and HA, respectively. 
 
BET confirmed higher surface area values observed for SA compared to HA due to the 
presence of the silicon.  
 
Differences in samples are now accounted for, and hence differences seen in the 
adsorption/desorption profiles can be explained due the presence or not of the silicate 
ions substituted which replace the phosphate ions. 
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3.1 Background 
 
The use of fluorescent tags (or labels) has been previously mentioned and researched 
specifically for staining antigens since the 1950s (Coons and Kaplan 1950; McKinsey, 
Spillane, et al. 1962). They are also commonly used for microscopy or as clinical 
immunoassays to monitor or quantify several biological processes. The fluorophores are 
usually labelled to antigens, which would then be used to detect fluorescent signals 
when bound, for example to proteins, cells and other biological samples. Several steps 
are required, highly skilled (or trained) operators are needed as well as expensive 
reagents or kits; therefore the process is complex which limits the possibility of 
automating this system of analysis, (Wei, Blumenthal, et al. 1994) but also could hinder 
the possibility of detection in a competitive environment. 
 
The most common fluorophores used are the fluorescein and rhodamine derivatives, 
such as fluorescein isothiocyanate (FITC) or the sulforhodamine 101 (SR101) or Texas 
red (TXR). (Abuelyaman, Hudig, et al. 1994; Little, Paquette, et al. 1997) These 
fluorophores have excitation and emission spectra at different characteristic 
wavelengths, which can permit simultaneous detection.  
 
The aim in this chapter was to develop a method to facilitate the competitive evaluation 
of protein adsorption on silicate-substituted hydroxyapatite (SA) and stoichiometric 
hydroxyapatite (HA).  Thus we set out to establish a method based on the use of 
proteins individually covalently modified with fluorescent tags emitting at different 
wavelengths. This required selection of suitable labels and methods for their covalent 
attachment to the proteins. 
  
Chapter 3. SYNTHESIS AND CHARACTERISATION OF FLUORESCENTLY 
LABELLED PROTEINS 
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3.2 Experimental Methodology 
3.2.1 General Procedures 
 
Glassware was cleaned with soapy lukewarm water, and rinsed with enough water, 
acetone and followed by dichloromethane (DCM). The glassware was then dried in an 
oven at 110 
o
C overnight. Syringes, syringe needles and stainless steel transfer tubes 
(also known as cannulae) were all cleaned by passing concentrated nitric acid and 
distilled water through them. Some of the reagents used in the synthesis were 
considered to be air and moisture sensitive, in such cases, all manipulations were carried 
out under inert atmosphere of nitrogen using standard cannula techniques. 
 
All solvents were dried over the appropriate drying agent, for example, magnesium 
sulphate (Abuelyaman, Hudig, et al. 1994). All solvents were stored in reservoirs 
equipped with Young‟s taps over the appropriate molecular sieves under nitrogen 
atmosphere and degassed prior to use. 
Dichloromethane (DCM), dimethylformamide (DMF) and chloroform (CHCl3) were 
purified by refluxing for 4 hours over calcium hydride (CaH2). Methanol (MeOH) was 
distilled in the presence of a small quantity of magnesium. The solvents were then 
transferred under N2 into flasks and stored over activated 4 Ǻ molecular sieves. 
Hydrochloric acid (HCl) of a concentrated form of 11.1 M was used. Deuterated 
solvents (DMSO-d6 and CDCl3) were purchased from Cambridge Isotopes, UK and 
used as received. Solvents used for fluorometric analysis, ethanol, were of spectroscopic 
grade purchased from HP, and used as received. 
 
Fluorescein isothiocyanate isomer I (FITC), methyl-6-Aminocaproate hydrogenchloride 
(ACA-OMe.HCl), bovine serum albumin (BSA), N, N‟-Dicyclohexylcarbodiimide 
(DCC), phosphorus oxychloride (POCl3) and 4-methylmorpholine (NMM) were 
purchased from Sigma-Aldrich, UK and used as received. Sulforhodamine 101 (SR101) 
(free acid) was purchased from ACROS Organics, prior to use the sample was vacuum 
dried at 100 
o
C, overnight. 
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3.2.2 Instrumentation parameters 
 
Nuclear Magnetic Resonance (NMR)  
 
NMR spectra were obtained using a JEOL 270 (
1
H, 270 MHz; 
13
C-(Dowd, Rosen, et 
al.), 67.88 MHz) and Bruker AMX400 (
1
H, 400 MHz; 
13
C-{
1
H}, 100.61 MHz). Spectra 
were obtained operating from δ 0-10 ppm chemical shift (δ) reported relative to the 
position of the solvent signal.  For 
1H NMR, chloroform δ 7.26, DMSO δ 7.25, 
methanol δ 3.34 and water δ 4.31 were used as internal references, while for 13C NMR, 
chloroform δ 77.36, DMSO δ 40.45 and methanol δ 49.86 were used. 
 
Fourier Transform Infrared (FITR) - Attenuated Total Reflectance (ATR) 
 
ATR spectra were obtained using an ATR (Bruker) and Hitachi IR spectrometer. 
Spectra were obtained at a resolution of 4 cm
−1
, averaging 16 scans, operating from 
4000 to 400 cm
-1
. All samples were analysed neat. 
 
 Ultraviolet-Visible Spectroscopy 
 
UV-visible spectra were obtained using a Hewlett Packard Spectrophotometer (Hewett 
Packard, UK) operating from 200 to 1100 nm. 
Fluorescence spectra were obtained using the Fluoro-Max-3 Spectrometer (Yvon-Jobin 
Horiba, UK) with a xenon lamp. The spectra were obtained at an excitation wavelength 
of 494 nm for the FITC and its derivative, and 586 nm for the SR101 fluorophores 
under investigation, operating from 250 to 750 nm with slit widths of 1.5 were 
employed.  
 
Mass Spectroscopy 
 
Mass Spectra were obtained from the EPSRC National Service at Swansea. The spectra 
were measured using LTQ Orbital XL (Thermofisher Scientific, UK) high resolution 
instrument across the full range in electrospray.   
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3.2.3 Synthesis of the fluorophores 
 
In the following sub-sections, the synthetic route to producing the fluorophore 
will be explained from their precursor reagent to the final product via a two-step 
manufacturing process; (1) a coupling with a spacer and (2) a conversion from an ester 
to a carboxylic acid. Using, the extended fluorophore, individual protein species were 
coupled via the lysine residue through the carbolic acid reactive group of the 
fluorophore. 
 
3.2.3.1 Preparation of Fluoresceinthiureidocaproic acid (FTCA) 
 
(i) Coupling the Aminocaproic acid Ester to the Fluorophore Fluorescein 
isothiocyanate 
 
The synthesis followed the work of Abuelyaman et al. (1994) FITC (197.9 mg, 0.508 
mmol) was dissolved in DMF (5 ml), a solution of ACA-OMe (153.2 mg, 0.843 mmol) 
in DMF (1 ml) was added at RT to the FITC mixture and stirred for 30 minutes. 
(Abuelyaman, Hudig, et al. 1994) The solvent was removed in vacuo. The collected 
residue was purified on a silica gel column eluted with chloroform: methanol (4:1), the 
fractions were collected and combined with Rf values of 0.33-0.51 measured on TLC 
chromatographic paper, depending on the height of the column made, then concentrated 
to give a dark orange oily residue. This residue was then vigorously stirred (or 
triturated) with distilled water (5-10 mL) to give the crude fluoresceinthioureidocaproic 
methyl ester (FTCE) solid (155.6 mg, 0.291 mmol, 57.3 % yield).  
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Figure 3.1 – Structure of the FTCE compound 
 
NMR assignments corresponding to proton position shown in Figure 3.1 δH (270MHz, 
DMSO-d6) 10.17 (2H, br s, OH), 8.32, (1H. bs, H12), 6.70-6.58 (6H, m, xanthene 
moiety, H2 to H9), 3.59 (3H, s, COOMe), 3.43 (2H, bs, H13), 2.31 (2H, t, H17), 1.54-
1.51 (4H, m, H14 and H16) and 1.33-1.24 (2H, m, H15).  
 
(ii) Converting the FTCE to its Acid Derivative FTCA 
 
The water was decanted away from the FTCE orange sheet-like compound from part (i); 
once the water was removed, sodium hydroxide (NaOH, 3 ml, 1.0 M) was added, 
followed by a minimum volume of methanol (a few drops) to give a clear solution. The 
mixture was stirred at RT for 1 hour. The solvent was concentrated in vacuo and the 
remaining aqueous solution was placed in an ice bath. Hydrochloric acid (concentrated 
HCl, 11 M) was added dropwise with stirring to the solution until it became acidic 
(pH~3-4). The orange suspension formed was then cooled for an additional 3 hours; the 
solid was isolated by filtration using a Buchner funnel and flask, and dried to give crude 
FTCA (155.0 mg, 0.2978 mmol, 58.6 % yield).  
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Figure 3.2 - Structure of the FTCA compound 
 
NMR assignments corresponding to proton position shown in Figure 3.2 δH (400MHz, 
DMSO-d6) 11.56 (1H, bs, OH), 10.15 (2H, s, OH), 7.78-7.92 (1H, d, H11), 7.24 (1H, d, 
H10), 6.70-6.52 (6H, m, xanthene moiety, H2 to H9), 3.72-3.58 (2H,br  s, H13), 2.30 
(2H, t, H17), 1.62-1.50 (4H, m, H14 and H16) and 1.38-1.24 (2H, bs, H15) 
IR assignments: maxv /cm
-1
 (KBr) 3735.9 (O-H), 2945.1 (C-H), 2478.4 9 (N-H), 1701.1 
(C=C) and 1596.9 (C=O). 
UV-Vis (2.845x 10
-6
 M in water and ethanol): 493 λ/nm, Absorbance of 0.8, equivalent 
to  a extinction coefficient (ε) value of  281,000 Lmol-1cm-1. 
Fluorescence (2.845x 10
-6
 M in water and ethanol): Excitation 494 λ/nm and Emission  
521.6 λ/nm with an intensity of approximately 2.7 x 106 (AU) 
Mass Spec: The spectrum clearly shows that FTCA with its corresponding molecular 
ion found  m/z  521.1364 (20) M
+
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3.2.3.2 Preparation of the Texas red sulfonylamidocaproic acid (TSCA) via Texas 
RED (TXR) 
 
(i) Synthesising the TXR fluorophore 
 
Sulforhodamine 101 (SR101, 259.9 mg, 0.4283 mmol) was treated with phosphorus 
oxychloride (POCl3, 3 ml, 4.935 g, 32.19 mmol) according to work of Titus et al. 
(Titus, Haugland, et al. 1982) After standing for 12 hours under nitrogen, the dark 
solution was poured onto a minimal amount of crushed ice. After 15 minutes, the 
product was extracted into chloroform, washed several times with cold water and dried 
with magnesium sulfate (Mg2SO4). The material was then dried by evaporation in 
vacuo. The material was re-dissolved in chloroform (25 ml), and precipitated with an 
excess of hexanes (PET 40-60 
o
C). The dark blue-green product (410.7 mg) was then 
filtered, vacuum dried under nitrogen, and stored in a container in the fridge freezer.  
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Figure 3.3 – Structure of the Texas red (TXR) compound 
 
NMR of this product was inconclusive, and other characterisation including mass 
specrometry and IR of the material also showed inconsistencies with the expected 
product. Due to the colour of the product indicating presence of the target, the next 
synthetic step was undertaken, assuming that further processing would allow for a better 
separation of the by-products during analysis. 
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(ii) Adding an Aminocaproic acid methyl ester spacer to the TXR fluorophore 
 
Dry product from part (i) (410.7 mg, 0.6573 mmol) was dissolved in chloroform (15 ml) 
and to this solution 6-aminocaproic acid methyl ester (120.4 mg, 0.6627 mmol) was 
added in the presence of NMM (72.4 l, 66.6 mg, 0.6585 mmol). The final solution was 
stirred at 0 
o
C for 30 minutes, followed by further stirring at RT overnight. The reaction 
mixture was then concentrated in vacuo to give a dark red solid (241.4 mg).  The NMR 
showed this to be a mixture including the capote ester and possibly the TCSE 
compound, see Figure 3.4A. This particular mixture was further purified by 
recrystallisation and taken to the next step.  
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Figure 3.4 - Structure of the (a) TSCE and (b) TSCA compounds 
 
(iii) Conversion of the Ester TSCE to the Acid TSCA 
 
NaOH (10 ml, 1M) was pipetted into a round bottom flask (25 ml) containing the TSCE 
reaction mixture, followed by a few drops of methanol. The mixture was stirred for 2 
hours at RT and then cooled in an ice bath. Concentrated HCl (11 M) was added 
dropwise carefully until the dark solid completely precipitated. The product, pale pink 
crystals when isolated, was collected and dried by vacuum filtration (59.2 mg). The 
mother liquor remained deeply purple but no solid TSCA (see Figure 3.4B) product 
could be obtained from this.  The whole process was repeated again with the same 
result.  
 
  
A B 
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3.2.4 Coupling Fluorophore labels to Proteins 
 
(i) FTCA, the GREEN emitting Fluorophore 
 
Fluorophore (FTCA, 13.5 mg, 0.0259 mmol) was diluted in water (1 ml); DCC (130.0 
mg, 0.6304 mmol) was added in water (1 ml). The fluorophore mixture was then 
incubated for 5 minutes at RT with the DCC solution, where NaOH (3-5 drops, 1 M) 
was added to maintain reaction solution at pH 5. BSA (48.0 mg) was added to yield a 
final molar ratio of approximately 1 mole of fluorophore to each available 50 amino 
acids of the protein for coupling. The reaction was left to incubate for 4 hours in the 
dark, for the conjugation to occur, with continuous stirring (460 rpm). The reaction was 
then stopped by adding sodium acetate (NaOAc; 29.6 mg, 0.3608 mmol) to achieve a 
final concentration of 100 mM and incubated for a further 1 hour. The FTCA-BSA 
conjugate was separated from free fluorophore by direct dialysis against PBS (pH 7.4, 
0.01 M), where two changes overnight had been sufficient (Harlow and Lane 1988).  
The freeze dried solution gave a bright orange filamentous material (15.8 mg) that was 
stored in the fridge and readily redispersed when required. 
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Figure 3.5 – Structure of the FTCA coupled to BSA via the lysine residue 
 
UV-Vis (8.131 x 10
-6
 M in PBS): 494 λ/nm, Absorbance of 0.3, equivalent to a 
extinction coefficient (ε) value of  37,000 Lmol-1cm-1. 
Fluorescence (8 .131 x 10
-6
 M in PBS): Excitation 494 λ/nm and Emission 518  λ/nm 
with an intensity of 3.10 x 10
6
 (AU) 
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(ii) Identification and coupling of a RED emitting Fluorophore 
 
Given that we were unable to isolate any solid red emitting TSCA (see experimental), 
direct labelling with the precursor (SR101) alone was attempted, although sulfonic acid 
coupling analogous to the carboxylic acid coupling used for FTCA is rare. Given that 
SR101 is a strong acid, it was assumed that no coupling reagent would be necessary for 
it to attach to protein covalently; hence, two methods were explored. Method one (M1) 
was carried out without coupling reagent, while method two (M2) employed a coupling 
reagent following the same protocol as for the FTCA coupling process. 
 
Method One (M1): Fluorophore (SR101, 15.6 mg, 0.0257 mmol) was diluted in water 
(2 ml), where NaOH (5 drops, 1 M) was added to maintain the mixture at pH 5. BSA 
(47.4 mg) in water (1 ml) was added, and then the reaction mixture was left to incubate 
for 4 hours in the dark with continuous stirring (460 rpm). In an attempt to separate the 
target SR101-BSA (M1) conjugate (Figure 3.6) from free fluorophore by direct dialysis 
against PBS, none of the fluorophore remained in the dialysis tube. 
 
Method Two (M2): Fluorophore (SR101, 14.5 mg, and 0.0239 mmol) was diluted in 
water (1 ml) and mixed with a solution of DCC (124.4 mg, 0.6033mmol) in water 
(1ml). The fluorophore mixture was then incubated for 5 minutes at RT, where NaOH 
(3-5 drops, 1M) was added to maintain the solution at pH 5. BSA (51.3 mg) and the 
reaction solution were left to incubate for 4 hours with continuous stirring (460 rpm). 
The reaction was stopped by adding sodium acetate (NaOAc; 29.2 mg) to achieve a 
final concentration of 100 mM and incubated for 1 hour. The SR101-BSA (M2) 
conjugate was separated from free fluorophore by direct dialysis against PBS. The 
freeze dried dialysed solution afforded a dark red solid (14.9 mg). This was stored in the 
fridge and redispersed as required. 
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Figure 3.6 – Structure of SR101 coupled to BSA via the lysine residue 
 
UV-Vis (8.008 x 10
-6
 M in PBS): 587 λ/nm, Absorbance of 0.5, equivalent to an 
extinction coefficient (ε) value of  62,000 Lmol-1cm-1. 
Fluorescence (8 .008 x 10
-6
 M in PBS): Excitation 586 λ/nm and Emission 608 λ/nm 
with an intensity of 3.75 x 10
6
 (A.U.) 
 
Other attempted syntheses of target labels for coupling to proteins are tabulated in 68 to 
70 in Appendix 11. 
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3.3 Results and Discussions 
 
The aim of the work in this chapter was to establish protocols whereby fluorescent 
probes with different colours could be covalently attached to a model protein BSA 
without significant quenching of fluorescence intensity. The fluorescence from proteins 
having the different labels attached could subsequently be used to monitor competitive 
adsorption events on biomaterial surfaces. Thus the covalent attachment should ensure 
that mixtures of proteins or batches of proteins having different labels attached should 
be stable to under the conditions of experiments.  
 
Fluorescein Derivative (FITC) 
 
Fluorescein isothiocyanate is the original fluorescein molecule functionalized with an 
isothiocyanate group (-N=C=S-), replacing a hydrogen atom on the benzene ring of the 
fused ring structure. It has similar and improved properties to its precursor, fluorescein, 
which can exist in the form of various species (see Figure 3.7) in solution due to its 
sensitivity to pH. 
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Figure 3.7 – pH dependent species of Fluorescein 
 
This reactive group can then react with amine groups on proteins, the sulfur group is 
known to be responsible for modulating fluorescence properties of the chromophore 
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through a dynamic quenching mechanism (Klonis and Sawyer 2003), therefore the 
FITC further requires a spacer to avoid this phenomenon.  
The synthetic approach used for the coupling of BSA labelled with the fluorophore 
fluoresceinthiureidocaproic acid, FTCA, is shown in Scheme 3.1. 
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Scheme 3.1– Synthetic approach to BSA coupled to FTCA 
 
This approach was previously published (Abuelyaman, Hudig, et al. 1994). The 
synthesis of FTCA is shown in step 1, while the coupling to BSA is shown in step 2. 
The coupling reaction was prepared as described and slightly modified by Harlow et al. 
in 1988 (Harlow and Lane 1988) in order to allow for a physiological amount of BSA 
saturated with fluorophore. During the synthesis of FTCA (Figure 3.2) pH 5 was 
maintained for the formation of the fluoresceinthiureidocaproic acid.  
Isothiocyanate groups are very reactive groups, but are stable at low pH and they do not 
easily hydrolyse. They form upon coupling with amine groups a thiourea link via a 
nucleophilic addition due to their electrophilic character, and the thiourea link is very 
stable both in aqueous neutral solution, but also in alkaline media (Valentine, Amarnath, 
et al. 1992). This reaction was aided by the fact that amine groups in proteins are 
reactive nucleophiles.  
This affects the distribution of mono and dianion in the product. The FTCA compound 
was isolated in a crude form. This was observed from the 
1
H NMR spectrum, where 
there were a number of resonances (solvent and water) in addition to those reported in 
the literature (Abuelyaman, Hudig, et al. 1994). The IR obtained for both the ester and 
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carboxylic acid of FTCA showed characteristic peaks such as hydroxyl vibration at 
3350 cm
-1 
and carboxylic acid vibration at 1590 cm
-1
, but this method did not give 
conclusive structural information.  
 
Mass spectroscopic analysis of the FTCA fluorophore was undertaken and of its 
precursor, fluorescein isothiocyanate (FITC) and showed the expected molecular ions 
for the parent compounds (see Table 3.1).  
 
Table 3.1 – Mass Spectrum fragmentation patterns of the FCTA and FITC 
m/z 
Corresponding ion 
of FTCA 
m/z 
Corresponding ion 
of FITC 
348.09 Fluorescein.NH4
+
 388.02 [C21H11NO5SH]
+
 
422.07  [C21H15N2O5NH4]
+
  777.06  [C21H11NO5SH]2
+
 
521.14  [C27H24N2O7SH]
+
   
 
The appearance of some higher molecular weight fragments suggested occurrence of 
dimer formation in the case of FITC but this may have also occurred during ionisation. 
The fragmentation patterns of the FTCA showed the presence of the caproic acid spacer, 
which confirmed  derivitisation of the FITC.  
 
The crude FTCA isolated was used without further purification and used to label BSA. 
It was  conjugated via the lysine residue as it is the amino acid most frequently used for 
this purpose to lead to a successful covalent attachment to macromolecules. (Klonis and 
Sawyer 2003). It was reasoned that any uncoupled fluorophore would be removed in the 
dialysis step of the coupling protocol. This was proved to be successful as a limited 
amount of free fluorophore was observed in the dialysis fluid after the process. Also, a 
very intense orange coloured protein solution was isolated for the adsorption and 
desorption studies. 
 
The average fluorescence emission wavelength observed with the labelled-protein is 
very similar to that of the free FTCA at an average of 516.67 nm (Table 2 and Figure 
10). This value closely corresponds to value found in the literature at 517 nm (Titus, 
Haugland, et al. 1982).  
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A shift might have been expected after conjugation to BSA but the spacer group would 
hinder interaction between the label and the protein surface as expected and possibly 
minimize effects of the protein on the fluorophore.  
 
Table 3.2 - Excitation & Emission of the FTCA-BSA in phosphate buffered saline (PBS) 
Sample Concentration / M Excitation / nm Emission / nm 
FTCA-BSA 8.131 x 10
-6
 494 519 
FTCA 8.131 x 10
-7
 494 518 
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Figure 3.8 – Emission Spectra at 2 distinct concentrations of the (a) FTCA and (b) FTCA-
BSA in PBS 
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Figure 3.9 – Fluorescence Spectra of FTCA-BSA at different time intervals 
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A fluorescence stability study of FTCA-BSA confirmed that fluorescence intensity was 
stable over several days (Figure 3.9).   
 
Fluorescein isothiocyanate and its precursor, fluorescein, are known to couple 
specifically to N-terminal of a peptide or amino acids of proteins. (Wei, Blumenthal, et 
al. 1994) They are also known to form dimers readily in aqueous solution, which would 
explain the inconsistencies observed during IR and NMR analysis, but also the extra 
fragments in the mass spectrum analysis. High concentration or close proximity of the 
dyes induces this phenomenon, which can result in fluorescence quenching; as a result a 
spacer is used to minimize this effect.  
 
 
Rhodamine Derivative (SR101) 
 
The rhodamine derivaties, which emit in the red region of the visible spectrum, are 
another commonly used type of fluorophore for fluorescence based analytical 
applications. Sulforhodamine 101 (SR101), specifically Texas red (TXR), has been the 
label of choice for this purpose. Texas red is known to form covalent links with amino 
groups on proteins when the appropriate reagent and protein are mixed. (Titus, 
Haugland, et al. 1982) The following synthetic approach describes the process towards 
the synthesis of the red emitting fluorescent label called Texas red (TXR) as shown in 
step 1 of Scheme 3.2. 
 
Step 1 of this scheme turned out to be somewhat challenging and no evidence of 
conversion could be observed as indicated by NMR, IR and mass spectroscopy on the 
isolated material. Part of the challenge was related to the moisture sensitivity of the 
reagents; according to Titus et al., the free sulfonic acid renders the TXR more 
hydrophilic and more soluble (Titus, Haugland, et al. 1982). It must be kept as dry as 
possible prior to addition to the protein solution, but also the protein solution is to be 
kept quite cold on ice to enhance coupling relative to the hydrolysis process with rapid 
mixing.  
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Scheme 3.2 – Synthetic route to the formation of TXR 
 
The mass spectrum showed that the TXR compound was not isolated although it may 
have been produced judging by the colour of the product solutions; it may have been 
subsequently hydrolysed during attempted isolation. According to Lefevre and his co-
workers, it has been reported that Texas Red sulfonyl chloride (TR-SC) which is a very 
popular red emitting dye, is also unstable to moisture during storage and prone to 
hydrolysis in the conjugation reaction (Lefevre, Kang, et al. 1996), due to the presence 
of the sulfonyl chloride. Apparently, a higher pH of 9-9.5 is also required for the 
conjugation to occur successfully compared to pH 5 used for the conjugation of FTCA. 
However pH 9-9.5 is much too high for proteins, which often leads to the denaturation 
of the protein in solution.  
The TXR was needed to introduce the caproate spacer but in view of the difficulty in 
synthesising this it was decided to use the precursor SR101 as shown in Scheme 3.3 
without a spacer for further studies in this investigation rather than pursuing the target 
TSCA in Scheme 3.2. 
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Scheme 3.3 – Synthetic route for the coupling of SR101 to BSA 
 
Coupling to BSA using SR101 allowed lower pH to be used, at room temperature and 
with good reproducibility. The sulfonic acid group (SO3H) present in SR101 facilitated 
and improved the conjugation of this red emitting dye to the protein. Thus, this process 
was favoured and  the compound was stable in an aqueous solution (Ishizaka, Habuchi, 
et al. 1999) as shown in the life-time study in Figure 3.10, and also in a serum and 
serum-free media shown in Chapter 6. 
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Figure 3.10 – Fluorescence Spectra of SR101-BSA at different time intervals 
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It was originally thought, that as a strong acid, SR101 may not need the use of a 
coupling reagent such as DCC to couple to the lysine residue present on the protein, as 
shown in method (1) of Scheme 3.3. However, when the SR101-BSA solution was 
dialysed in PBS to separate the unbound/free SR101, all of the coloured (deep purple) 
SR101 leached out of the tube to leave behind the uncoupled BSA.  
 
Further characterisation through fluorescence (Table 3.3 and Figure 3.11) and life-time 
study (Figure 3.10) confirmed SR101 to have formed a covalent attachment to BSA. 
 
Table 3.3 - Excitation & Emission of the labelled-protein SR101-BSA in phosphate 
buffered saline (PBS) 
Sample 
Concentration 
/ M 
Excitation / 
nm 
Emission / 
nm 
SR101-BSA 8.008 x 10
-6
 586 608 
SR101 8.008 x 10
-7
 586 605 
 
This confirmed that the strong acid alone may have only formed some kind of weak 
interactions rather than a covalent amide link with BSA.  
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Figure 3.11 – Emission Spectra at 2 distinct concentrations of the (a) SR101 and (b) the 
SR101-BSA in PBS 
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As a result, the experiment was repeated with the use of DCC (as described in method 
two) and when the SR101-BSA solution was dialysed, very little unbound SR101 
leached out, confirming the presence of a covalent attachment.  
 
SR101-BSA fluorescence emission wavelength at 606 nm showed little difference to 
that of the free SR101 fluorophore, which was as expected (see Figure 3.12). 
 
 
Figure 3.12 – Expected Fluorescence for the (b) SR101 and (c) TXR compared to (a) 
Fluorescein spectra (Lefevre, Kang, et al. 1996) 
 
In this case, the sulfonamide group attached to the xanthenes moiety may act as a space 
between the fluorophore and the protein. As shown in Scheme 3.3, the xanthene moiety 
is more sterically demanding than the fluorescein isothiocyanate shown in Scheme 3.1 
and as such interactions with the protein leading to fluorescence quenching might be 
less of an issue in this case rendering the presence of a spacer less critical.  
 
Sulfonamide groups have quite an importance in medicinal chemistry applications 
(Caddick, Wilden, et al. 2004), constituting the largest class of anti-microbial agents. 
According to the work of Caddick and Wilden et al. the formation of sulfonamides 
mostly relied on the presence of the sulfonyl chlorides (SO2Cl), however due to their 
disadvantages, the route through the sulfonic acids (SO3H) has been investigated. So 
far, there is no current procedure that transforms sulfonic acid to sulfonamide in one 
synthetic step. In the work of Caddick et al., however, activation of the sulfonic acid is 
required by triphenylphosphine ditriflate (Ph3P
+
-O-
+
PPh32OTf
-
) to create an 
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intermediate (e.g. compound 7 in Scheme 3.4) that would be suitable towards the 
following nucleophilic reaction with the amines to form the sulfonamide (see Scheme 
3.5). 
 
 
Scheme 3.4 – Activation of sulfonic acid by Triphenylphosphine Ditriflate (Caddick, 
Wilden, et al. 2004) 
 
 
Scheme 3.5 – Sulfonamides and Sulfonate esters from Activated sulfonic acid. (Caddick, 
Wilden, et al. 2004) 
 
Triphenylphosphine oxides are known to be troublesome to remove at the end of the 
reaction, thus may cause concern, but again the Caddick‟s group worked on replacing 
the need for this by using solid-supporter variant, which can be removed by washing. 
 
This is not too different to the synthetic route used in this study, where DCC was also 
used to activate the sulfonic acid towards the addition of the amine group form the 
BSA, as shown in Scheme 3.3. The only difference would be the ease at which DCC 
was removed at the end of the reaction, as it drives the reaction forward to form an 
oxide complex, leaving behind the sulfonamide link to the protein.  
 
The novelty, here, could be in the reagent used for the intermediate formation before the 
coupling reaction to the amine, as this was successful with minimum loss of 
fluorophore, and thus fluorescence intensity. 
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3.3.1 The Labelling Protocol  
 
The final labelling route could then be described. The relationship between the moles of 
the fluorophore and protein was calculated with the assumption according to Harlow 
(Harlow and Lane 1988) that for every 1 mg of fluorophore, 50 peptides would be 
labelled per mole of proteins expressed as follows, where 10 is an integer factor for the 
coupling reaction to saturate all lysine residue present; 
 
                      
                                                  
Equation 3.1 
 
It was very important to take into account the amount of lysine residues available for 
coupling, value found in the literature. Using Equation 3.1 the mass of fluorophore for 
the protein under investigation can then be determined, and made up into the protein 
solution in water, usually made as a stock solution three times larger than the original. 
 
Fluorophore (FTCA or SR101) was diluted in water (1 ml); DCC was added in water (1 
ml). The fluorophore mixture was then incubated for 5 minutes at RT with the DCC 
solution, where NaOH (3-5 drops, 1 M) was added to maintain reaction solution at pH 
5. BSA, FN, BMP-2 or OPN was added. The reaction was left to incubate for 4 hours 
in the dark, for the conjugation to occur, with continuous stirring (460 rpm). The 
reaction was then stopped by adding sodium acetate (NaOAc) to achieve a final 
concentration of 100 mM and incubated for a further 1 hour. The labelled protein 
conjugate was separated from free fluorophore by direct dialysis against PBS or water, 
where two changes overnight had been sufficient (Harlow and Lane 1988). 
 
Figure 3.13 summarises the schematic route to labelling BSA or rhBMP-2 with FTCA, 
while Figure 3.14 shows the route to labelling FN or rmOPN to SR101. Amounts of 
fluorophore would vary according to the molecular weight and final protein 
concentration required for the investigation. 
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Figure 3.13 – Coupling reaction scheme of the BSA or rhBMP-2 with FTCA 
 
 
 
Figure 3.14 – Coupling reaction scheme of the FN or rmOPN with SR101 
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3.4 Summary & Conclusions 
 
FTCA was prepared and coupled to BSA. There were difficulties in making the TXR 
and thus TSCA with finally no conclusive chemical analysis to indicate the compound 
was present among the product mixture. As a result, its precursor (SR101) was used.  
 
Initially, the SR101 compound (used as received) was reacted with BSA without 
coupling reagent (DCC). When this method (one) proved to be unsuccessful, the 
process was repeated using method (two) including the DCC. Subsequent dialysis 
clearly indicated that a covalent amide link to BSA was introduced. This suggests that 
the role of DCC in this reaction was crucial to achieve covalent bonding. 
The simplicity of this direct coupling route from the relatively cheap SR101 by-passing 
the need for tortuous synthesis of TSCA was a very useful discovery, however 
sulfonamide formation from sulfonic acid has already been demonstrated by Caddick et 
al (Caddick, Wilden, et al. 2004). 
Further chemistry on simple lysine containing model compounds could confirm the role 
of DCC in effecting the covalent coupling of SR101 but this is beyond the scope of this 
work. 
 
Therefore, in this study the use of SR101 as the red emitting fluorophore will be 
favoured over the TXR, and used along with the green emitting FTCA to label proteins 
for the competitive binding studies to be undertaken. 
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4.1 Background 
 
Protein adsorption to a biomaterial surface is one of the earliest events that occurs post 
implantation (Anselme 2000; Baxter, Frauchiger, et al. 2002; Green, Davies, et al. 
1999), occurring within seconds of introduction into the body. The adsorbed protein 
layer subsequently influences host response by acting as an intermediary between the 
implant surface and the surrounding tissue through its ability to facilitate cell motility, 
attachment and development. In the case of bone graft substitute materials, modulation 
of the species and conformation of proteins that adsorb to the surface have been 
demonstrated to be critical in promoting osteogenic cell attachment (Bumgardner, 
Wiser, et al. 2003; McFarland, Thomas, et al. 2000; Thomas, McFarland, et al. 1997; 
Yang, Cavin, et al. 2003), spreading (Sawyer, Hennessy, et al. 2005; Yang, Roach, et 
al. 2001), proliferation (Rouahi, Champion, et al. 2006; van Wachem, Vreriks, et al. 
2006), morphology (Allen, Tosetto, et al. 2006; Gugala and Gogolewski 2004; Kilpadi, 
Chang, et al. 2001) and development (Kilpadi, Sawyer, et al. 2004; Rouahi, Gallet, et 
al. 2006; Wilson, Clegg, et al. 2005) 
In the quest to develop bone graft substitutes with enhanced bioactivity or 
osteoinductivity monitoring protein adsorption and desorption behaviour on surfaces 
has increasingly been recognised as vital to understanding the mechanisms and 
processes that occur between a material‟s surface and the host environment. (Anselme, 
Noel, et al. 1999; Ducheyne and Qui 1999; Ellingsen 1991; Guth, Campion, et al. 
"Effect of Silicate-Substitution on Attachment and Early Development of Human 
Osteoblast-Like Cells Seeded on Microporous Hydroxyapatite Discs" 2010)  
 
In many studies, protein adsorption or depletion is quantified indirectly using enzyme-
linked immunosorbent assays (ELISAs) or total protein type assays, where radioactive, 
colourimetric or fluorimetric probes are employed. (Fabrizius-Homan and Cooper 
"Competitive adsorption of vitronectin with albumin, fibrinogen, and fibronectin on 
polymeric biomaterials" 1991; Rosengren, Pavlovic, et al. 2002; Wilson, Clegg, et al. 
2005) Total protein assays quantify all proteins present irrespective of species or 
conformation, ELISAs on the other hand are limited to measurement of a specific 
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protein and as a result of the reliance on antibodies can also be conformation dependent.  
Therefore, in order to carry out a competitive study multiple analyses must be 
performed.  To date the truly competitive analysis are restricted to sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) methodologies, ellipsometry, 
for analysis of real-time adsorption kinetics, (Elwing 1998), or matrix-assisted laser 
desorption ionisation mass spectrometry (MALDI-MS) adapted for surface analysis 
determination (Griessera, Kingshottb, et al. 2004). All of these methodologies require a 
high degree of operator expertise and skill to obtain truly quantitative data in addition to 
specialised equipment. 
 
The aim of this chapter was to validate the use of the fluorophore probes as protein 
labels for tracking protein adsorption and desorption in a competitive environment. In 
order to validate the use of direct protein labelling with the fluorophore probes in 
quantitative monitoring of adsorption and desorption two sets of experiments were 
performed. In addition, adsorption isotherms for BSA to HA and SA were constructed 
in order to observe BSA behaviour and calculate the BSA surface coverage to the two 
materials. 
 
(1) In the first set of experiments BSA adsorption and desorption was monitored 
using an established commercially available total protein assay kit.  
 
(2) In the second set of experiments BSA adsorption and desorption was monitored 
directly through analysis of fluorescence intensity of the fluorophore labelled 
BSA. 
 
Details of the fluorescent labelling can be found in Chapter 3, section 3.3.1. Both 
protocols utilise the phenomenon of fluorescence spectroscopy to monitor sample 
concentration. 
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4.2 Experimental Methodology 
 
Bovine serum albumin (BSA) was used as a model protein, due to its relative cost 
effectiveness and abundance in blood plasma making it a useful comparator when 
studying the competitive environment. Protein adsorption and desorption on both 
hydroxyapatite (HA) and silicate-substituted apatite (SA) materials were investigated. 
Two morphological forms of the specimen were used making four groups of test 
specimen: silicate-substituted dense discs (SAD), silicate-substituted porous granules 
(SAG), hydroxyapatite dense discs (HAD) and hydroxyapatite porous granules (HAG). 
Details of the materials synthesis and characterisation can be found in Chapter 2.  
 
All chemicals were supplied by Sigma-Aldrich unless otherwise specified. The 
commercial total protein assay kit used was a Quant-IT kit (Invitrogen, UK). 
 
4.2.1 Specimens and Test solutions 
 
Tabulated below are the type of specimens in Table 4.1 and test solutions in Table 4.2 
used for the experiments undertaken in Table 4.3 and Table 4.4. 
 
Table 4.1 – Specimen description and acronyms used throughout study 
Specimen description  Acronyms 
Silicate-substituted apatite dense discs SAD 
Silicate-substituted apatite porous granules SAG 
Hydroxyapatite dense discs HAD 
Hydroxyapatite porous granules HAG 
 
Test solutions of unlabelled (BSA) were generated from a stock solution of 50 mg/mL, 
and then diluted to the appropriate concentration with PBS or MEM to the required 
volume. A similar protocol was followed for the labelled (FTCA-BSA) from a stock 
solution of 15.8 mg/mL, as previously prepared and described in Chapter 3 section 
3.3.1. 
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Table 4.2 – Test solutions: buffer, medium and protein solutions 
Test solutions Details Concentrations 
Phosphate Buffered 
Saline 
PBS: dissolve one tablet in 
200mL deionised water pH 7.4 
(product code: P4417) 
0.01 M 
Minimum essential 
Eagles‟ medium 
MEM: containing inorganic 
components, amino acids and 
vitamins (product code:M3024) 
9.3 g/L 
Bovine Serum 
Albumin (BSA) 
BSA: lyophilised powder 
dissolved in PBS or MEM to 
produce stock solution of 50 
mg/mL  (product code:A9647) 
Several from 
0.002 to 20 
mg/mL 
 
Table 4.3 – Specimen and experiments undertaken in PBS 
Specimens SAD SAG HAD HAG 
Temperature (
o
C) RT 37 RT 37 RT 37 RT 37 
20 mg/mL BSA √ √ √  √ √   
4 mg/mL BSA √ √   √ √   
0.004 mg/mL BSA √ √ √  √ √ √  
20-0.002 mg/mL BSA √ √   √ √   
4 mg/mL FTCA-BSA √ √  √ √ √  √ 
 
Table 4.4 – Specimen and experiments undertaken in MEM (at 37 oC only) 
Specimen SAD SAG HAD HAG 
8 mg/mL BSA √  √  
4 mg/mL BSA √  √  
2 mg/mL BSA √  √  
1 mg/mL BSA √  √  
0.5 mg/mL BSA √  √  
4 mg/mL FTCA-BSA √ √ √ √ 
 
RT is room temperature, which was 19 (± 2.0) 
o
C. Dilutions were chosen in order to 
mimic BSA physiological concentration at 4 mg/mL, the pharmacological amounts 
Chapter 4 
119 
often used towards osteoinduction study of 4 µg/mL; and finally the other to represent 
BSA saturation levels above 4 mg/mL. 
 
4.2.2 Adsorption and Desorption Protocol 
 
For the quantitative data, BSA or FTCA-BSA solutions of different concentrations were 
prepared, and each of the protein solutions (1.5 mL) was then placed in a clean glass 
vial. A biomaterial, dense or porous, HA or SA was added to analyse adsorption, 
where 100 μL of protein solution was removed at the following intervals (1, 5, 10 and 
15 minutes). After 15 minutes, the samples were removed and the original soaking 
solution stored. The samples were placed in PBS (1.5 mL), shaken for 5 minutes, then 
removed and the washing solution stored. The samples were then placed in fresh PBS or 
MEM (1.5 mL) to analyse desorption, where 100 μL of the solution was removed at the 
following intervals (5, 60, 240, 1440 minutes). The samples were kept in clear glass 
vials.  
 
 A B 
Figure 4.1 – (a) Picture of the FluoStar Instrument used for the analysis of adsorption and 
desorption and (b) plate layout 
 
For the qualitative data, adsorbed FTCA-BSA from PBS at RT and MEM at 37 
o
C were 
imaged (see section 4.2.5) on dense discs of the biomaterials after samples were 
incubated for  time intervals of 1, 5, 10, 15, 30 and 60 minutes in solutions containing 4 
mg/mL FTCA-BSA. 
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Instrument parameters: FluoStar Galaxy Microplate Reader: 96 –well plate reader 
(BMG laboratories, UK) with fluorescence intensity and time resolved settings with 
excitation and emission set at 485 and 520 nm, respectively. A cycle time of 120 
seconds with 10 flashes, 0.5 seconds delay with orbital shaking set for 10 seconds 
before each cycle was used. 
 
4.2.3 Analysis using the Quant-IT kit 
 
The manufactures‟ standard protocol was followed, according to the leaflet provided. 
The components of the Quant-IT™ Protein Assay Kit were equilibrated at room 
temperature or 37 
o
C for a few hours. A working solution was prepared by diluting 
Quant-IT™ protein reagent (1:200) in Quant-IT™ protein buffer in a plastic container, 
where for example, for 100 assays, 100 µL of Quant-it protein reagent (Component A) 
was diluted in 20 mL of Quant-it protein buffer (Component B) and mixed well. Glass 
containers were not used, as the protein reagent is known to adsorb to glass. Once 
mixed, the working solution is stable for up to 3 hours, if protected from light. 200 µL 
of the working solution was then loaded into each microplate well with a kit detection 
limit of 0.25-5.00 µg of protein. Despite this detection limit, calibrations were run at 
lower levels to accommodate the comparison with the novel FTCA-BSA probe 
developed in this work. Thus, using the standards provided by the Quant-IT protein 
assay kit, and the methodology as described by the manufacturer, two low calibration 
curves were prepared, one for the generation of the 0-5 µg standard curve, which 
required 10 µL of each BSA standards added in triplicate to wells containing the 200 µL 
of the working solution, and the second, for the generation of the 0-1 µg standard curve, 
where 2 µL of each BSA standards was added in triplicate to wells. 
 
Two high calibration curves were also prepared to cover the higher concentration range 
of the adsorption study, in which the protein was found to crash out of solution unless 
vigorous stirring was applied immediately before the data was collected. For the 
generation of the 0-500 µg standard curve, 10 µL of each BSA standard was added in 
triplicate to wells containing the 200 µL of the working solution, and for the generation 
of the 0-100 µg standard curve, 2 µL of each BSA standard was added in triplicate to 
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wells. Table 4.5 shows the expected BSA amount observed per well for all 4 calibration 
curves, two low and two high, which were prepared in PBS and MEM. 
 
Table 4.5 – Amounts of the BSA in serial dilutions used for the Calibration curves 
Amount of BSA per well in µg 
5-0 1-0 500-0 100-0 
5.0 1.0 500.0 100.0 
4.0 0.8 250.0 50 
3.0 0.6 125.0 25 
2.0 0.4 62.50 12.5 
1.0 0.2 31.30 6.25 
0.5 0.1 15.60 3.13 
0.25 0.05 7.810 1.56 
0 0 0 0 
 
Protocol for the determination of the BSA surface coverage 
 
Adsorption isotherms of unlabelled-protein (BSA) on SAD and HAD both at 19 (± 2.0) 
o
C (room temperature: RT) and at 37 
o
C were investigated in order to determine the 
average monolayer coverage of BSA on the dense biomaterials. Assumptions were 
made in order to determine the surface area of both the albumin and the discs. Albumin 
was calculated using the assumptions that it has a molecular weight of 66,320 Daltons 
(Harlow and Lane 1988) and is a globular protein (prolate ellipsoid) with dimensions of 
140 x 40 x 40 Å (Hirayama, Akashi, et al. 1990), resulting in a cross-sectional surface 
area of 5.03 x10
-17
 m
2
. It was also assumed that only the top side and side of the dense 
disc would be available for protein adsorption, tabulated below. 
 
Table 4.6 – Calculated Surface Area for the dense biomaterials using micrometer 
measurements 
Biomaterials Surface area (±ζ) / m2 
SA 2.24 x10
-4
 (±0.001) 
HA 2.22 x10
-4
 (±0.001) 
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The surface area of the dense discs was determined by taking the average disc 
dimensions and calculating the area by assuming each disc to be a smooth perfect 
cylinder with top and side most exposed to protein under investigation.  Previous work 
(in Chapter 2) had demonstrated that these assumptions were not strictly true as the 
discs are known to have a surface roughness of 0.3-0.4 µm and were not perfect 
cylinders, however this proved to be the most practical method available, as surface area 
was found to be below the detection limits of both the BET porosimeter and He 
pycnometer.  
Using these surface area values, the theoretical number of binding sites for both 
biomaterials can thus be calculated with Equation 4.1 and tabulated in Table 4.7. 
 
                                                    
                 
                
 
Equation 4.1 
 
Table 4.7 – Theoretical Number of Binding Sites; a ratio of the surface area values 
Biomaterials 
Theoretical Number of 
Binding Sites 
SA 4.46 x 10
12
 
HA 4.41 x 10
12
 
 
The surface area values were then used to calculate the adsorption surface coverage in 
terms of molecules per dense disc, while using the Quant-it kit protein assay allowed for 
the amount of BSA adsorbed to be obtained. 
 
                 
Equation 4.2 – Adsorbed (Γ) amount equation (D'Andrea and Fadeev 2003) 
 
The adsorbed amounts were calculated using Equation 4.2, where Γ is the adsorbed 
amount in mol per g, Co is the original protein concentration in mol dm
-3
,Ceq is the 
equilibrium concentration after adsorption in mol dm
-3
, V is the total protein volume of 
the solution in L and m is the mass of the sample in g. Using this equation, a 
relationship in the adsorption isotherm can thus be determined quantitatively, in terms 
of BSA surface coverage in percentages adsorbed on the surface of the biomaterials. 
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4.2.4 Analysis using the Fluorophore 
 
All FTCA-BSA buffer and medium solutions were equilibrated at RT (19 (± 2.0) 
o
C) on 
the bench top or at 37 
o
C in an incubator for a few hours. 200 µL of the freshly made 
PBS or MEM was then loaded into each microplate well. For the analysis: 5 µL of 
original and adsorbed samples were placed in the wells according to the layout (see 
Figure 4.1B) followed by 20 µL of the wash and desorbed samples, and the standards 
for each method where 10 µL and 2 µL were added to separate wells. 
 
FTCA-BSA (15.8 mg/mL) in PBS or MEM was used to construct calibration curves. 
Serial dilutions (1 mL) were prepared, from which, high and low standards were 
generated following a similar protocol to that of BSA only protein solution.  
 
Table 4.8 – Amounts of the BSA in the FTCA-BSA serial dilutions used for the 
Calibration curves 
BSA Concentrations / µg 
Original/ µg/mL  10 µL 2 µL 
15800 158 31.6 
7900 79.0 15.8 
3950 39.5 7.90 
1975 19.6 3.95 
988 9.88 1.96 
494 4.94 0.988 
247 2.47 0.494 
0 0 0 
 
The two calibration curves generated were 0-158 µg high standard curve, which 
required 10 µL of FTCA-BSA standard added in triplicates to wells containing fresh 
PBS or MEM (200 µL). The low 0-32 µg standard curve was generated using 2 µL of 
the FTCA-BSA. To make the calibration curves, the protein concentration was plotted 
against fluorescence intensity; a line of best fit was generated to obtain an equation of 
the linear line along with the R
2
 value. Using the equation of the line in the form of y = 
Chapter 4 
124 
mx + C with the intercept set at 0 when the data was best fitted, the actual protein 
amount per well can be calculated, and thus the amount in the total volume deduced.  
 
To test the calibration curves a series of FTCA-BSA solutions were prepared and fitted. 
For this test analysis FTCA-BSA (15.3 mg/mL) in MEM stock solution was used to 
make eight different concentrations including stock, 12, 10, 8, 4, 2, 1 and 0.5 mg/mL. 5 
µL of each solution were then placed in wells, containing 200 µL of MEM, according to 
the layout as shown in Figure 4.1B, done in triplicate at 37 
o
C. 
 
4.2.5 Fluorescence Microscopy 
 
Fluorescence microscopy was performed using a Zeiss Axioskop microscope, 
employing a mercury lamp UV source, and three filters with excitation/emission 
wavelengths of 450-490/515 nm, 365/395 nm and 546-512/598 nm which enable 
imaging of dyes that fluoresce in the green, blue or red, respectively. The images 
(micrographs) were taken at magnifications of 50, 100 or 200 and used for qualitative 
analysis of the protein adsorption on dense discs of the biomaterials with a working 
fixed exposure of 695 milliseconds.  
 
  
Figure 4.2 – FM background images of HAD emitting (a) green, (b) red and (c) blue fixed 
at an exposure of 695 ms, scale shown to represent 10 µm. 
 
Initially, the HA and SA dense discs were imaged blank for the background 
fluorescence (Figure 4.2 and Figure 4.3) at a fixed exposure of 695 and 3930 ms, 
respectively, with a 50X magnification through three distinct filters. The main interest 
to these FM images was the green and red emission observed, so the following images 
were focused on these and compared between biomaterials in terms of adsorption time 
at 200X magnification with a scale shown to represent 10 µm. 
A B C 
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Figure 4.3 – FM background images of SAD emitting (a) green, (b) red and (c) blue fixed 
at an exposure of 3930 ms, scale shown to represent 10 µm. 
 
The BSA coated samples were prepared as follows: 1 mL aliquots of FTCA-BSA at 4 
mg/mL in PBS or MEM at 37 
o
C was transferred in to 24-well plate containing dense 
disc of the biomaterials, and left submerged for 1, 5, 10, 15, 30 and 60 minutes. After 
immersion time, the discs were rinsed in PBS or MEM then imaged, and transferred 
into a clean 24-well plate containing formaldehyde. 
 
  
A B C 
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4.3 Results 
4.3.1 Quant-IT analysis 
 
Calibration curves for the unlabelled BSA study at room temperature (RT, 19 (± 2.0) 
o
C) and 37 
o
C in PBS and MEM were generated using both the Quant-IT kit supplied 
BSA standards for the low ranges and in house prepared protein solutions for high 
ranges. This resulted in the generation of two low protein range calibrations at levels of 
0-1 and 0-5 µg BSA per well, and two high protein range calibrations at levels of 0-100 
and 0-500 µg BSA per well. 
 
Table 4.9 – R2 values of the BSA calibrations in PBS at RT 
Range BSA / µg R
2
 values obtained 
Low 
0-5 0.996 
0-1 0.948 
High 
0-500 0.904 
0-100 0.882 
 
Table 4.10 – R2 values of the BSA calibrations in PBS at 37 oC 
Range BSA / µg R
2
 values obtained 
Low 
0-5 0.995 
0-1 0.987 
High 
0-500 0.967 
0-100 0.922 
 
The calibration values obtained, using the Quant-IT Kit at RT and 37ºC, are shown in 
Table 4.9 and Table 4.10 respectively. For the low range the R
2
 values were lower at 37 
o
C compared to RT, while for the high range the opposite behaviour was observed. 
Overall, the correlation was good, more polynomial than linear for any of the ranges  
(Appendix 19 to Appendix 22 in Figure 129 to Figure 132) from the point of origin and 
thus the kit had inherent detection limits set by the calibration range selected, to a 
minimum of 0.2 µg per well. 
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A change in medium (MEM) improved correlation moderately for the low and high 
ranges, as shown in Table 4.11, however, relationships remained non-linear (Appendix 
19 to Appendix 22 in Figure 129 to Figure 132). 
 
Table 4.11 – R2 values of the BSA calibrations in MEM at 37 degrees 
BSA Range µg R
2
 values obtained 
Low 
0-5 0.995 
0-1 0.933 
High 
0-500 0.922 
0-100 0.907 
 
Using the Quant-IT kit, the analysis of the low concentration at 0.004 mg/mL BSA was 
not possible as expected. Protein amounts in 5 and 20 µL corresponded to 2 and 8 ng 
per well, respectively, which are lower than that of the manufacturers recommended low 
range of 0.25 µg per well, which agreed with our findings.  
 
Analysis of the median concentration at 4 mg/mL, which is also the physiological 
concentration of BSA, was successful, see Figure 4.4. The time-dependent adsorption 
profiles showed porous granules adsorbed less BSA than dense discs in an overall trend 
as follows SAD > HAD > SAG > HAG with more affinity towards the silicate samples. 
Dense disc (DD) samples showed a faster rate of adsorption compared to the porous 
granular (PG) samples, which showed a slower rate which could be due to the diffusion 
in the pores of the protein in solution, followed by a plateau of BSA adsorption. 
Desorption, in contrast, was instantaneous from porous granules (PG) with extensive 
desorption from HAG and very little desorption occurred from HAD, giving rise to a 
desorption trend as follows: HAG > SAG >> HAD = SAD. 
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Figure 4.4 –BSA (a) adsorption and (b) desorption profiles on biomaterials at RT analysed 
using the Quant-it kit at an initial concentration of 4 mg/mL in PBS (n= 3 ±s.d.) 
 
At high concentration (40 and 20 mg/mL), the analysis was unreliable as the Quant-IT 
kit reagent instigated precipitation of the protein from solution at this high 
concentration.   
Adsorption profiles on silicate-substituted hydroxyapatite showed a similar behaviour 
between dense discs and porous granules to the physiological concentration, where DD 
adsorbed more than PG with larger adsorbed amounts. The desorption also showed a 
similar pattern to that observed at physiological concentration, in the following trend 
HAG >> SAG >> HAD > SAD. 
 
 
Determination of BSA surface coverage on dense discs (DD) 
 
As there appeared to be some temperature effect, adsorption isotherms were 
investigated on dense discs of the biomaterials, at RT (19 (± 2.0) 
o
C) and 37 ºC.  
Figure 4.5 and Figure 4.6 depict the raw time-dependent data observed on SAD and 
HAD, respectively, at RT and 37 
o
C at around the physiological BSA concentration. 
 
Adsorption on SAD showed BSA adsorbing more with increasing initial concentrations 
at RT with the exception of the 5 mg/mL solution, Figure 4.5A. At the 15 minutes time 
point more BSA was adsorbed from the 4 mg/mL protein solution compared to the 
others, followed by the 2, 5 and finally 1 mg/mL solutions. Past this time point for all 
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concentrations except the 5 mg/mL solution, a slow decrease or plateau of the adsorbed 
amounts was observed.   
At 37 
o
C, there was more BSA adsorbed from the smaller protein concentrations 
compared to the larger ones, where at the 15 minute time point, more BSA was 
adsorbed from the 2mg/mL solution compared to the 1, 5 and 4 mg/mL solutions, 
Figure 4.5B. However, beyond that for all concentrations except the 5 mg/mL solution, 
a slow increase or plateau of the adsorbed amounts was observed. 
 
SAD      SAD 
0
400
800
1200
1600
0 10 20 30 40 50 60
Adsorption Time (minutes)
A
m
o
u
n
t 
o
f 
B
S
A
 a
d
s
o
rb
e
d
 o
n
to
 S
A
D
 a
t 
R
T
 (

g
/m
l)
A
4 mg/mL
5 mg/mL
2 mg/mL
1 mg/mL
RT
0
400
800
1200
1600
0 10 20 30 40 50 60
Adsorption Time (minutes)
A
m
o
u
n
t 
o
f 
B
S
A
 a
d
s
o
rb
e
d
 o
n
to
 S
A
D
 a
t 
3
7
 o
C
 (

g
/m
l) B
4 mg/mL
5 mg/mL
2 mg/mL
1 mg/mL
37
 o
C
 
Figure 4.5 - Adsorption profiles of BSA protein at around physiological concentrations on 
SAD at (a) RT and (b) 37 
o
C using the Quant-it kit in PBS (n= 3 ±s.d.) 
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Figure 4.6 - Adsorption profiles of BSA protein at around physiological concentrations on 
HAD at (a) RT and (b) 37 
o
C using the Quant-it kit in PBS (n= 3 ±s.d.) 
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Adsorption on HAD showed BSA adsorbing more from the higher concentrations 
compared to the lower ones, where more BSA was adsorbed from the 4 mg/mL solution 
(the physiological level). At the 15 minute time point compared to the others, see Figure 
4.6A. Beyond the 15 minutes, less BSA was adsorbed, decreasing with time, from the 
higher concentrations, while for the lowers one the amount adsorbed seemed to have 
reached a plateau.  
At 37 
o
C, the initial BSA adsorption seemed fast with a dynamic behaviour, see Figure 
4.6B. At the 15 minute time point, significantly more BSA was adsorbed from the 
physiological level (4 mg/mL) protein solution compared to the other protein solutions 
with an observed dip at the 5 minute point. 
The other concentrations adsorbed less than the 4 mg/mL protein solution, they also go 
through a dip at 5 minutes with the exception of the 2 mg/mL solution, but not as drastic 
as the physiological concentration solution. Overall more BSA was adsorbed at 37 
o
C, 
compared to at RT for the 5 and 4 mg/mL solution, and less for the 2 mg/mL protein 
solution, and no significant difference for the 1 mg/mL solution. 
 
Figure 4.7 and Figure 4.8 depict the raw data on SAD and HAD, respectively, at higher 
BSA concentrations. 
 
Adsorption on SAD show more BSA adsorbed with increasing concentrations at RT 
(Figure 4.7A). However, the adsorption was not significantly different from the two 
concentrations for the first two time points. Beyond the 5 minutes time point, there was 
a further increase in BSA adsorbed from the 20 mg/mL solution compared to an 
observed decrease from the 10 mg/mL solution. Beyond the 15 minutes time point, both 
protein solutions show a slow and steady decrease of BSA adsorbed on the 
biomaterial‟s surface.  
At 37 
o
C in Figure 4.7B, different adsorption patterns were observed from both BSA 
concentrations. For the first two time points, more protein was adsorbed from the 20 
mg/mL solution, however past that point there was a sharp decrease from that protein 
solution, which was then adsorbing less than the 10 mg/mL BSA solution for the 
remainder of the adsorption period. 
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Figure 4.7 - Adsorption profiles of BSA protein at high concentrations on SAD at (a) RT 
and (b) 37 
o
C using the Quant-it kit in PBS (n= 3 ±s.d.) 
 
Adsorption on HAD show at both temperatures more BSA adsorbed with increasing 
BSA concentrations, see Figure 4.8A. At RT, the patterns for 20 and 15 mg/mL 
concentrations show a dip at the 15 minutes time point compared to a dip seen at the 5 
minutes time point for the 10 mg/mL concentration. 
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Figure 4.8 - Adsorption profiles of BSA protein at high concentrations on HAD at (a) RT 
and (b) 37 
o
C using the Quant-it kit in PBS (n= 3 ±s.d.) 
 
Beyond the 15 minutes, all concentrations showed increased BSA adsorption. At 37 
o
C, 
there was no significant adsorption difference between the 15 and 10 mg/mL 
concentrations at the 1 minute time point. An observed dip was also seen at these 
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concentrations at the 5 minutes time point. For the 20 mg/mL concentration, an 
increasing BSA adsorption pattern was seen up until the 15 minutes time point was 
reached, then beyond that, the rate of adsorption was reduced but still increasing. A 
similar observation was depicted here for the 15 and 10 mg/mL BSA concentrations. 
 
Using the raw time-dependent data in Figure 4.5, Figure 4.6, Figure 4.7 and Figure 4.8, 
and the methodology in conjunction with Equation 4.1 and Equation 4.2 copied here 
below (1) and (2), respectively, the concentration-dependent adsorption isotherms for 
HAD and SAD were calculated at RT and 37 
o
C, see Figure 4.9. 
 
(1)                                                     
                 
                
 
(2)  Γ                 
 
Adsorption isotherms on HAD both at RT and 37 
o
C clearly showed three different 
patterns in the three regions (A, B and C), as shown in Figure 4.9A and B, compared to 
only 2 patterns of behaviour on SAD across the three regions. 
On HAD at RT, Region A occurred over the lower concentrations with no significant 
change in BSA adsorbed with time and increasing equilibrium concentration. In region 
B, as the equilibrium concentration increased more BSA was adsorbed, the highest 
levels being achieved between the 5 and 60 minute time points. And finally in Region 
C, the physiological BSA level of 4 mg/mL, which is the equivalent of an equilibrium 
concentration of 6.03 x 10
-8
 mol/L, the highest adsorbed amount was observed at the 15 
minute time point, following a dipped trend for all other time points. At 37 
o
C, the three 
regions of behaviour were similarly identified in Figure 4.9B, again region A was 
consistent with the behaviour of a monolayer, as seen at RT, with an increased adsorbed 
amount of BSA observed. Region B remained the highest of the regions, but slightly 
less adsorbed amounts compared to RT; however, more BSA was adsorbed at 15 and 60 
minute time points. In Region C, higher levels of BSA were adsorbed at all time points 
except at 5 minutes.  
 
On SAD only 2 adsorption patterns were observed across the three regions both at RT 
and 37 
o
C, as shown in Figure 4.9C and D, respectively, compared to HAD. At RT, the 
monolayer formation (Region A) was reached faster, rapidly forms into the next step in 
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Region C, then closely followed by Region B, the highest region of adsorbed amount of 
BSA. While at 37 
o
C, Region A showed an increased amount of BSA adsorbed on the 
surface at all time points, little change in Region C except at the 15 minute time point 
was observed, and a decreased amount of BSA was adsorbed in Region B. Figure 4.9D 
BSA adsorption did not rise with increasing equilibrium concentration.  
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Figure 4.9 - Adsorption Isotherms of BSA in PBS on HAD at (a) RT and (b) 37 
o
C and 
SAD (c) RT and (d) 37 
o
C using the Quant-it kit (n= 3 ±s.d.) 
 
The BSA surface coverage at 6030 x 10
-11
 mol/L, which is equivalent to the 
physiological concentration of BSA at 4 mg/mL, was then calculated.  
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At RT, HAD had a BSA surface coverage of more than 100 % from the first time point 
of immersion at its highest and decreasing with time, suggesting the rapid formation of 
multi-layer BSA sheets on the surface of the biomaterials. A similar observation was 
seen on SAD, where the BSA surface coverage was also more than 100 % starting from 
its lowest and increasing with time until the 15 minute time point, then slowly 
decreasing with time. 
 
At 37 
o
C, higher BSA surface coverage was observed from HAD, except at the 5 minute 
time point where only 91.4 % was calculated, this was lower than 100 %, suggesting 
that at that time point a BSA monolayer might be present.  Again on SAD, the BSA 
surface coverage started low at 63.6 %, then increased with time up until the 1440 time 
point, with a similar magnitude to RT values found. This may suggest that at 37 
o
C, the 
BSA coverage on the SAD surface was accumulative, starting with the monolayer, 
saturating just before the 5 minute time point (169 %), and increasingly forming the 
multi-layer with time. 
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4.3.2 Analysis using the Fluorophore (FTCA)  
 
Calibration graphs were generated over two ranges using FTCA directly labelled on the 
BSA at RT (19 (± 2.0) 
o
C) and 37 ºC, in PBS and MEM demonstrated a linear 
relationship between the fluorescence intensity and the amount of protein present per 
well (Appendix 23 and Appendix 24 in Figure 133 and Figure 134) and correlation 
coefficients were much improved compared to the Quant-IT kit calibrations. 
 
Table 4.12 – R2 values of the FTCA- BSA calibration curves in PBS at RT 
Range BSA µg R
2
 values obtained 
Low 0-31 0.997 
High 0-158 0.968 
 
Table 4.13 – R2 values of the FTCA-BSA calibration curves in PBS at 37 oC 
Concentration Curves generated µg R
2
 values obtained 
Low 0-31 0.962 
High 0-158 0.927 
 
Table 4.14 – R2 values of the FTCA-BSA calibration curves in MEM at 37 oC 
Concentration Curves generated µg R
2
 values obtained 
Low 0-32 0.926 
High 0-159 0.942 
 
In order to test the use of the fluorescent label as a quantitative monitoring tool known 
samples were prepared and analysed in MEM at 37 ºC. The results of this analysis 
demonstrated the technique to have an average error level of 6.7 % which was assumed 
to be acceptable as average error observed using the Quant-IT kit was 5.6 %.  
 
Having identified that the technique was suitable for quantitative analysis the 
adsorption/desorption experiments performed with the Quant-it kit were duplicated with 
FTCA-BSA in PBS at RT at an initial BSA concentration corresponding to the 
physiological level of 4 mg/mL to ensure that addition of FTCA-BSA did not 
significantly affect the adsorption/desorption behaviour of BSA.  
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Table 4.15 – Values of the FTCA- BSA calibration curves in MEM at 37 oC 
Known Sample 
Concentration 
(mg/mL) 
Intensity 
Obtained 
Calculated 
Concentration 
(mg/mL) 
Percentage 
Error 
15.3 35950 14.6 4.6% 
12.0 32527 12.8 -6.6% 
10.0 29316 11.2 -12% 
8.0 26657 7.6 5% 
4.0 19859 4.2 -5% 
 
Figure 4.10 shows the amount of BSA adsorbed from HAD (A) and SAD (B) at RT as 
analysed using the Quant-it kit and FTCA-BSA, clearly showing similar quantities  
adsorbed at the end of the adsorption period, with very different adsorption trends 
obtained on both materials.  
 
Desorption data (Figure 4.11), while indicating similar ultimate magnitudes of 
desorption from HAD and SAD, there was no significant difference, varied in that use 
of the FTCA-BSA enabled more accurate analysis of the pattern of release, reflecting 
the fact that these levels were approaching the detection limits of the Quant-it assay.  
 
FTCA-BSA was then used to study the effect of test conditions on protein adsorption 
and desorption. Experiments were performed in PBS at 37 ºC and in MEM at 37 ºC to 
deconvolute the effect of changing both test environment and temperature. 
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Figure 4.10 – Adsorption profiles of (a) HAD and (b) SAD at RT in PBS at an initial 4 
mg/mL concentration, using Quant-IT kit and FTCA-BSA (n= 3 ±s.d.) 
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Figure 4.11 – Desorption profiles of (a) HAD and (b) SAD at RT in PBS at an initial 4 
mg/mL concentration, using Quant-IT kit and FTCA-BSA (n= 3 ±s.d.) 
 
FTCA-BSA was then used to study the effect of test conditions on protein adsorption 
and desorption. Experiments were performed in PBS at 37 ºC and in MEM at 37 ºC to 
deconvolute the effect of changing both test environment and temperature. 
 
Figure 4.12 shows the effect of temperature on the adsorption and desorption of FTCA-
BSA in PBS on the dense discs. More BSA was adsorbed at RT than at 37 
o
C for both 
biomaterials at the end of the adsorption period.  
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Figure 4.12 – FTCA-BSA (4 mg/mL) Adsorption at (a) RT and (b) 37 oC and desorption at 
(c) RT and (d) 37 
o
C profiles of the dense biomaterials in PBS (n= 3 ±s.d.) 
 
In Figure 4.12A, the adsorption rate of HAD was much faster than that observed for 
SAD, and at the end of the adsorption time SAD and HAD adsorption were not 
significantly different. In Figure 4.12B, at 37 
o
C, the adsorption rate for both HAD and 
SAD was much faster with SAD significantly adsorbing more than HAD. 
More BSA was desorbed at RT compared to 37 
o
C, however at RT the desorption was 
not significantly different between HAD and SAD (see Figure 4.12C). The increase in 
temperature on the desorption allowed for a distinctive behaviour to be observed, see 
Figure 4.12D, where HAD desorbed more than SAD, as seen previously by the Quant-
IT data. 
 
Figure 4.13 shows the effect of changing test environment at the same temperature (37 
o
C) from PBS to MEM on the dense discs. 
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Figure 4.13 – FTCA-BSA (4 mg/mL) Adsorption in (a) PBS and (b) MEM and desorption 
in (c) PBS and (d) MEM profiles of the dense biomaterials in at 37 
o
C (n= 3 ±s.d.) 
 
Figure 4.13A and B show that more FTCA-BSA adsorbed on the biomaterials in PBS 
than MEM with SAD adsorbing more than HAD. In both media the initial adsorption 
rate was fast with not significantly different between the biomaterials for the first 
minute of adsorption. Beyond that point, FTCA-BSA adsorbed more on the SAD 
specimen with some dynamism in PBS (Figure 4.13A), and a decreased behaviour in 
MEM, see Figure 4.13B. 
 
Figure 4.13C and D show the effect of media on the desorption behaviour from the 
dense discs. The difference in media seemed to have induced a change in desorption 
pattern and amount of FTCA-BSA desorbed from the biomaterials. It appeared that 
more FTCA-BSA was desorbed in MEM to PBS with no significant difference at the 
end of the desorption period. Figure 4.13C shows a similar pattern in PBS to that 
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observed by the Quant-IT analysis. A slow and steady desorption rate for both 
biomaterials with a further increase seen from HAD, however, not so significant. 
Figure 4.13D shows a different behaviour for both, where the rate was much faster in 
MEM than PBS and still increasing past the 240 minutes time point. HAD desorbed 
more than SAD, but the converged trend with desorbed amounts for both biomaterials 
being similar at the end of the desorption period. 
 
The following graphs will show the effect of changing the biomaterial‟s morphological 
form from dense disc (DD) to porous granules (PG) in PBS and MEM at 37 
o
C. This 
would be comparable to the data found in Figure 4.13 for DD. 
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Figure 4.14 – FTCA-BSA (4 mg/mL) Adsorption in (a) PBS and (b) MEM at 37 oC and 
desorption in (c) PBS and (d) MEM at 37 
o
C profiles of the porous biomaterials (n= 3 
±s.d.) 
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Figure 4.14 shows more BSA was adsorbed in PBS than MEM with SAG adsorbing 
more than HAG at the end of the adsorption period. In MEM, SAG adsorbed less after 5 
minutes, and then caught up in adsorption amount with HAG with no significant 
difference between the samples. Overall more FTCA-BSA was adsorbed on PG 
compared to DD as shown in Figure 4.13 with SA adsorbing more than HA with 
different patterns in MEM, but not in PBS. 
 
Figure 4.14A shows a fast rate of adsorption from SAG than HAG in PBS with amounts 
of FTCA-BSA increasing with time, significantly more on SAG compared to HAG. In 
MEM, there was also a fast rate (see Figure 4.14B), but amount of adsorbed FTCA-
BSA beyond the 1 minute adsorption period decreased in a dynamic manner.  
 
Figure 4.14C and D show the effect of porosity on the desorption of FTCA-BSA from 
the biomaterials. More FTCA-BSA was desorbed in MEM than PBS from PG compared 
to DD(see  Figure 4.13C and D) with the expected trend of HA desorbing more than 
SA, similarly seen throughout the study. 
 
In conclusion, the study FTCA-BSA study showed both decreased adsorbed and 
desorbed FTCA-BSA amounts on DD in PBS with increasing temperature, a change in 
media also decreased the amount of FTCA-BSA adsorbed, but showed an increase in 
the desorption process. The introduction of porosity increased both the amount of 
FTCA-BSA adsorbed and desorbed, especially in MEM, where the small components 
may have helped in the protein diffusion into the porous biomaterials. Overall, more 
FTCA-BSA was adsorbed on SA compared to HA, and less desorbed on SA compared 
to HA.  
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4.3.3 Fluorescence Microscopy (FM) 
 
A significant advantage of using FTCA-BSA (4 mg/mL) for analysis of protein 
adsorption/desorption behaviour was the ability to study the bulk morphology of BSA 
in contact with HA and SA, which was found to be very different on the biomaterials, 
yet similar in the different media.  
 
The work was set up in two experiments. Initially in PBS at RT (19 (± 2.0) 
o
C) on HAD 
and SAD to help interpret the data obtained from the isotherms and the fluctuating 
adsorption pattern observed. And the other experiment at 37 
o
C in MEM to assess the 
BSA morphology in a different media.  
 
Experiment One 
 
Figure 4.15, Column A showed a fluctuating fluorescent intensity with increasing time 
that may suggest a dynamic FTCA-BSA adsorption on the surface at RT. Globular 
FTCA-BSA clusters were present heterogeneously spread across the surface. There was 
a change in morphology resulting in regions, where dual morphology was observed, up 
until the 60 minute time point was reached, where the protein clusters were again 
predominantly globular on the surface. 
 
In contrast, the BSA morphology on SAD, as shown in Figure 4.15, Column C, showed 
more clusters from the first minute, more fluorescent with smaller globules.  The protein 
was spread out more homogeneously across the surface, especially on the ten minute 
specimen, creating a mesh like effect. The protein still retained a globular shape as more 
time elapsed on the surface of the SA biomaterial in PBS. 
 
Figure 4.15, Columns B and D showed the images when excited within the red emitting 
region, to observe if any autofluorescence has occurred, where HAD showed to have 
more autofluorescence than SAD. 
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Columns:   A.           B.               C.   D. 
  HAD      SAD 
 
  
  
  
  
   
Figure 4.15 – FM images of FTCA-BSA demonstrating the protein morphology on (a) 
HAD and (c) SAD; and the black images which should show minimum amount of red 
emitting protein (b) on HAD and (d) on SAD at all time intervals in PBS at RT 
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 Experiment Two 
 
The second experiment set up involved looking at the morphology of the BSA in MEM 
at 37 
o
C on both biomaterials, HAD (see Figure 4.16, Column A) and SAD (see Figure 
4.16, Column C). In MEM, no protein „fingers‟ like morphology was observed. The 
adsorption was slower and the globules were smaller than those observed in PBS. 
 
On HAD, smaller clusters were formed across the surface, which eventually 
accumulated to form larger clusters as time elapsed, heterogeneously spread on the 
surface. Thus, the fluorescence also increased with time.  
While on SAD, the protein morphology was very similar to that observed in PBS. 
Smaller globules of protein were present on the surface compared to HAD surfaces. The 
globules began to cluster only after the fifteen minute time point, which then further 
continued after an hour. 
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Columns:        A    B        C   D 
     HAD        SAD 
   
  
  
  
  
  
Figure 4.16 – FM images of FTCA-BSA demonstrating the protein morphology on (a) 
HAD and (c) SAD; and the black images which should show minimum amount of red 
emitting protein (b) on HAD and (d) on SAD at all time intervals in MEM at 37 
o
C 
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4.4 Discussions 
 
Quant-IT kit calibrations showed a more polynomial rather than linear pattern both in 
PBS and MEM at RT (19 (± 2.0) 
o
C) and 37 
o
C (see Appendices 19 to 22). The graphs 
of the provided BSA standards and the two generated curves at 0 to 5 and 0 to 1 µg 
BSA per well were non-linear below 1.0 and 0.6 µg, respectively. Similar observation 
patterns were seen for the in-house BSA standards for the higher curves of 0 to 500 and 
0 to 100 µg BSA per well, where the data was non-linear below 50 and 20 µg, 
respectively, even though the standards were repeated at different time in triplicate. 
Thus, in contrast, with the calibrations observed from the FTCA-BSA that gave rise to 
linear plot across the complete concentration range, throughout the repeats, suggesting 
reliability of the curves for the analysis of adsorption and desorption. (Appendices 23 
and 24) This was a surprising observation as the commercial assay kits are expected to 
be more reliable than that; this may suggest that only a short range is used, as these 
would definitely show a more linear trend. 
 
The FTCA-BSA was validated in two experimental set ups. Set up one consisted of 
making known concentrations of the FTCA-BSA, measuring their fluorescence 
intensity and fitting them to the calibration curves to calculate the actual concentrations. 
The results shown in Table 4.15 confirmed the validity of the method with an average 
error of 6.7 %, which could in part be due to operator handling. The second set up 
involved duplicate analyses of the adsorption and desorption behaviour on dense discs 
at RT using both the Quant-IT kit and FTCA. The results for this were depicted in 
Figure 4.10 for the adsorption and Figure 4.11 for the desorption, clearly showing 
similarities in amounts adsorbed and desorbed at the end of the designated period with 
distinct behavioural patterns. 
 
4.4.1 Quant-IT kit Study 
 
During the initial analysis, the Quant-IT kit proved to be only useful at RT (19 (± 2.0) 
o
C) and the physiological levels compared to the higher and lower concentrations, 
shown in Figure 4.4 with an adsorption trend was observed where SAD > HAD > SAG 
> HAG in PBS with a desorption trend of HAG > SAG >> HAD = SAD. Clearly 
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showing that silicate-substituted hydroxyapatite (SA) has a stronger binding affinity 
than stoichiometric hydroxyapatite (HA) measured by the commercial kit and further 
confirmed by previous studies, where in the work of Patel et al., Hing and Guth et al. 
showed SA to enhance bioactivity and biocompatibility towards improved bone repair. 
(Guth, Campion, et al. "Effect of Silicate-Substitution on Attachment and Early 
Development of Human Osteoblast-Like Cells Seeded on Microporous Hydroxyapatite 
Discs" 2010; Hing 2004; Patel, Best, et al. 2002) 
At low BSA levels, it was assumed, then verified via the calibrations non-linearity, that 
the detection limit of the kit was reached. Therefore, another kit would have been 
necessary to quantitatively measure protein at this level, which would mean adding on a 
further expense and probably another time-consuming manufacturer‟s procedure.  
At high BSA levels, the working reagent solution made the protein crash out of 
solution, during plate-reading. It often required additional vigorous agitation to 
determine the protein concentration. Dilution of the samples could have been 
undertaken, so that protein was within the kit working range, however it would not have 
mimicked the desired adsorption-desorption environment. Also, the kit, being a total 
protein kit, means that the analysis would involve all proteins in any given sample and 
the specific discernment of proteins would therefore not be possible in a competitive 
environment. 
 
Determination of the BSA coverage through the adsorption isotherms using 
the Quant-IT kit 
 
At around the physiological level, the effect of temperature on SAD showed BSA 
adsorbing in the following trend 4 >  5 > 2 > 1 mg/mL protein solutions at RT (19 (± 
2.0) 
o
C) compared to the patterns seen at 37 
o
C, 2 > 1 > 4 > 5 mg/mL (see Figure 4.5). 
On HAD, a different behaviour was seen where at both RT and 37 
o
C, the adsorption 
trend was the same 4 > 5 > 2 = 1 mg/mL protein solutions (see Figure 4.6). More BSA 
was adsorbed on SAD compared to HAD at RT, while curiously the effect was reversed 
at 37 
o
C. At the higher concentrations the adsorption trend showed that at RT, HAD 
adsorbed more BSA than SAD from the 20 mg/mL BSA concentration, while the 
opposite effect was seen when 10 mg/mL BSA concentration was analysed. The overall 
adsorption pattern on SAD suggested that significantly more BSA was adsorbed from 
the 20 mg/mL protein solution compared to the 10 mg/mL, while the trend on HAD 
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showed proportionality to the protein concentrations used, where from the 20 > 15 >> 
10 mg/mL more BSA was adsorbed with increasing protein concentrations measured at 
the end of the adsorption period. At 37 
o
C, HAD adsorbed more BSA than SAD for all 
concentrations, with an overall pattern of 20 > 15 > 10 mg/mL for HAD and 10 > 20 
mg/mL for SAD at the end of the adsorption period.  
The adsorption on the biomaterials was a dynamic process especially on SAD, often 
related with accelerated cell adhesion as well. This observation has been observed by 
others, especially in the work of Hing et al. (Hing, Annaz, et al. 2005), Rashid et al. 
(Rashid, Harding, et al. 2008) and Guth et al. (Guth, Campion, et al. "Effect of Silicate-
Substitution on Attachment and Early Development of Human Osteoblast-Like Cells 
Seeded on Microporous Hydroxyapatite Discs" 2010; Guth, Campion, et al. "Surface 
Physiochemistry Affects Protein Adsorption to Stoichiometric and Silicate-Substituted 
Microporous Hydroxyapatites" 2010), showing that cell adhesion was affected by 
protein adsorption. The dynamic behaviour of cell adhesion was observed on the 
biomaterials, possibly due to their sensitivity to the dynamic behaviour of adsorbed 
protein layer on the surface, which agreed with this work and the work of Allen et al. 
(Allen, Tosetto, et al. 2006)  
 
Using the methodology described in section 4.2.3, the adsorption isotherms were 
constructed with the raw data as shown in Figure 4.5, Figure 4.6, Figure 4.7 and Figure 
4.8 was converted into adsorbed amounts (Γ) in moles/g against the equilibrium 
concentrations in mol/L. 
 
Figure 4.9A showed three regions on the HAD surface. The pattern seen in Region A at 
RT suggested that the adsorption was limited by the formation of one layer, however 
values calculated for the BSA surface coverage were more than 100%, suggesting the 
formation of a multi-layer. In Region B, the pattern seen suggested a dynamic formation 
and rearrangement of a multilayer at the higher concentrations, as the values calculated 
fluctuated beyond the 100 % threshold. Region C, which occurred at the physiological 
concentration, also showed to have more than 100 % BSA surface coverage at all time 
points, but at a lower magnitude compared to the other concentrations, suggesting that 
the surface of the dense discs may be saturated with proteins, which would then explain 
the need for the formation of the multi-layer as equilibrium concentration increases. The 
work of Zeng et al. (Zeng, Chittur, et al. 1999) has shown that a higher BSA adsorption 
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rate was observed on HA compared to different surfaces. Although, the work was 
achieved using thin films of the materials, similar observations were obtained on 
different forms of the biomaterials. At the 5 and 10 minute time points, their work did 
suggest a change in the speed of the adsorption rate, which could explain the differences 
observed here. However, the pattern observed closely resembled that found in the work 
of Mavropoulos et al. (Mavropoulos, Costa, et al. 2011). Although they did not include 
higher concentrations beyond 2 mg/mL BSA solutions, it can be assumed that the 
possibility of a dynamic process on the surface may occur also. At 37 
o
C (Figure 4.9B) 
the three regions were still observed with Regions A and C being larger compared to 
values previously seen at RT. Region B showed an increased degree of dynamic 
behaviour with increasing levels of protein adsorption at lower magnitude, still 
suggesting a continual cycle of rearrangement and exchange on the surface.  
For SAD, (see Figure 4.9C and D) the adsorption isotherms showed different patterns to 
HAD with only two distinct patterns across the three regions both at RT and 37 
o
C. 
Lower adsorbed amounts were observed on SAD compared to HAD, but a more 
dynamic behaviour was obtained at the two temperatures, suggesting a faster formation 
of BSA multilayers.  
Previous studies have been performed using ELISA and have shown greater amounts of 
BSA, FN or VN adsorption on HA as compared to titanium or steel, which are less 
hydrophobic; this is in agreement with the observations here  for HA and SA, 
suggesting that the hydrophobic nature is not a limiting factor (Kilpadi, Chang, et al. 
2001). Due to the presence of the ions in the lattice of the ceramic, HA is more 
hydrophobic than SA in nature and both overall are less hydrophobic than metals, 
followed by polymers (hydrophilic). 
 
4.4.2 FTCA-BSA Studies 
 
Validation with Dense Discs in PBS at RT (19 (± 2.0) 
o
C) 
 
Initially, the FTCA-BSA study was undertaken in PBS at RT, where the adsorption 
trend was as follows: SAD > HAD after the 15 minutes adsorption time, the same as for 
the BSA only study, confirming that the label did not affect the adsorption behaviour of 
the protein on the biomaterials. The dynamics during that period of time may have been 
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slightly different, but overall, it seemed to suggest an accumulative protein adsorption 
process compared to the dynamic process seen when analysed using the kit. The 
desorption profiles also highlighted very little desorption from DD. The observed 
desorption trend HAD > SAD, again was similar to that of BSA with Quant-IT study.  
 
Having validated the use of the FTCA-BSA, further work was then centered on 
demonstrating the differences in adsorption and desorption profiles between the 
biomaterials, stoichiometric HA and SA, two morphological forms; dense disc (DD) 
and porous granules (PG), and the effect of temperature (Figure 4.12), media (Figure 
4.13) and porosity (Figure 4.14).  
 
Effect of Temperature; Room Temperature (RT: 19 (± 2.0) 
o
C) and 37 
o
C 
 
The effect of temperature on DD showed that more BSA was adsorbed at RT compared 
to 37 
o
C on the DD surfaces with SA adsorbing more than HA (see Figure 4.12). 
Historically temperature has not been standardised in protein adsorption experiments 
and ranged from 4 to 37 
o
C. (Grinnell and Feld 1982; Kilpadi, Chang, et al. 2001; 
Steele, Johnson, et al. 1992) The change in temperature seemed to affect the affinity of 
the protein depending on the chemistry of the biomaterials. For example, in the work of 
Guth et al. (Guth, Campion, et al. "Surface Physiochemistry Affects Protein Adsorption 
to Stoichiometric and Silicate-Substituted Microporous Hydroxyapatites" 2010) half the 
amount of fibronectin was adsorbed to the HA surface at 37 
o
C compared to RT, while 
for SA the amount tripled at 37 
o
C. This may suggest that a change in energy in the 
protein solution, may have affected the protein dynamic behaviour, and thus its 
interaction with the biomaterials. The fact that FN is a protein of 440,000 Daltons 
compared to the BSA (66,320 Daltons), and the energy (increased temperature) may 
dissipate differently in a smaller protein, and hence the behaviour would be different, as 
observed in this work. The overall pattern was found to be true, in the work of Guth et 
al. where SA adsorbed more than HA, which then further lead to more cell adhesion. 
(Guth, Campion, et al. "Effect of Silicate-Substitution on Attachment and Early 
Development of Human Osteoblast-Like Cells Seeded on Microporous Hydroxyapatite 
Discs" 2010) 
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Effect of media; PBS and MEM at 37 
o
C 
 
Changing media on DD at 37 
o
C (see Figure 4.13) showed that more BSA was adsorbed 
from PBS solutions compared to MEM on the DD surfaces, 15-20 % compared to 10-15 
% with SA adsorbing more than HA in MEM. However, this observation clearly 
showed that MEM, which has both inorganic and amino acid constituents affected the 
interactions of the BSA with the biomaterial surfaces similarly to results found in the 
work of Dong et al. (Dong, Wang, et al. 2007) with a growth factor. In this work, 
although the protein here investigated was rhBMP-2, they demonstrated that the 
presence of amino acids can influence the adsorption behaviour of the growth factor to 
HA. These amino acids, also termed fulcrum-adsorption residues, such as asparagine 
(Asn) or glutamic acid (Glu) are all present in the MEM at an average concentration of 
0.0134 g/L, and therefore could have influenced the BSA adsorption on the 
biomaterial‟s surface. However, in this instance, the trend was more towards inhibiting 
adsorption compared to enhancing it as observed in the rhBMP-2 study, and further 
confirmed in Chapter 5 of this thesis. The differences in behaviour could be due to the 
size of the proteins, where BSA is approximately three times larger than rhBMP-2, and 
additionally the physiological concentrations being larger (4 mg/mL compared to 300 
ng/mL). In the work of Green et al. albumin was shown to exhibit the Vroman effect 
over two other proteins on polymeric surfaces in the presence of other organic 
components. (Green, Davies, et al. 1999)  
 
Effect of Porosity Porous Granules (PG) at RT and 37 
o
C 
 
The introduction of porosity at RT showed a slower BSA rate of adsorption on PG 
compared to the DD surfaces with lower adsorbed amount, but increased desorbed 
amounts detected in PBS using the Quant-IT kit, as shown in Figure 4.4.   
At 37 
o
C, the behaviour was different when using the probe. Higher adsorbed amounts 
of FTCA-BSA were detected on PG compared to DD in both media. The rate of 
adsorption, however, induced a slower rate of adsorption due to the introduction of 
porosity. This could be due to the rate of diffusion of the protein, water and the other 
component of the medium interacting with the larger surface area and pores of the 
biomaterials, which agrees with the work of Rashid et al. (Rashid, Harding, et al. 2008) 
and Guth et al. (Guth, Campion, et al. "Effect of Silicate-Substitution on Attachment 
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and Early Development of Human Osteoblast-Like Cells Seeded on Microporous 
Hydroxyapatite Discs" 2010) There is a form of ion exchange that changes the surface 
charge of the material and with increased surface area, i.e. increased porosity, that 
process influences the speed at which a protein may adsorb on the biomaterial surface. 
This may further suggest the lower adsorbed amounts detected in MEM, 5 to 10 % 
lower as shown in Figure 4.13 and Figure 4.14, as there are more components of this 
media to interact with this process. Hence, less FTCA-BSA was adsorbed on SAG in 
MEM compared to PBS (26 % compared to 34 %), but overall more was adsorbed on 
SAG compared to SAD in a dynamic fashion (34 % and 26% in Figure 4.14A and B 
compared to 22% and 15% in Figure 4.13A and B in PBS and MEM, respectively), only 
the pattern and rate of adsorption differed in the different media. This observation was 
expected as shown from the work of Guth et al. (Guth, Campion, et al. "Effect of 
Silicate-Substitution on Attachment and Early Development of Human Osteoblast-Like 
Cells Seeded on Microporous Hydroxyapatite Discs" 2010; Guth, Campion, et al. 
"Surface Physiochemistry Affects Protein Adsorption to Stoichiometric and Silicate-
Substituted Microporous Hydroxyapatites" 2010) clearly suggested that the introduction 
of porosity in polymeric membranes and calcium phosphates enhances adsorption 
behaviours and cell attachment. 
In HA, the change in porosity in PBS showed similar adsorbed amounts detected but 
different rate and pattern of adsorption, as shown in Figure 4.13A and Figure 4.14A, 
respectively. Adsorption on DD showed lower adsorbed amounts from PBS to MEM 
(17 % to 11%), as seen with SA, but not from DD to PG in MEM (11 % to 25%), as 
shown in Figure 4.13B and Figure 4.14B. More FTCA-BSA was adsorbed on HAG in 
MEM in comparison to PBS, and overall pattern observed with SA. This may suggest 
that the effect of morphology enhanced FTCA-BSA adsorption on HA in MEM towards 
a similar reactivity to SA irrespective of biomaterial‟s chemistry. 
 
Overall, SA specimens adsorbed more than HA specimens, suggesting a stronger 
affinity between FTCA-BSA and silicate-substituted specimens compared to the 
stoichiometric apatite, further demonstrated when taking into account the desorption 
pattern HAG > SAG in both media, with more desorbing in MEM than PBS (see Figure 
4.14C and D) compared to values obtained from DD (Figure 4.13C and D). 
Desorption values obtained from dense disc (DD) in both media showed no significant 
difference between biomaterials, other than less than 1 % was desorbed in PBS 
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compared to less than 10 % in MEM. Introduction of porosity resulted in higher 
desorbed amounts in both media with a significant difference between biomaterials 
possibly due to their chemistry. Following on the previous observations, more FTCA-
BSA was desorbed from MEM compared to PBS. 45 % was desorbed from HAG 
compared to 33 % from SAG as shown in Figure 4.14D in MEM; compared to 19 % 
from HAG and 6 % from SAG in PBS. This further suggests that SA enhances BSA 
adsorption on its surface, dense discs or porous granules, as it retains more through the 
desorption process. 
 
Both morphological forms have been the subject of extensive research due to their 
different biological response to bone growth when incorporated as implants both in 
vitro and in vivo models. (Hing, Best, et al. 1997; Ripamonti 1996) Bone implants are 
more likely to be moulded or pressed (Rouahi, Gallet, et al. 2006) as dense or porous 
materials (Hing, Best, et al. 2004; Hing, Revell, et al. 2006), rather than left as fine 
powders, especially for bony defects, therefore trends that would be observed here, may 
differ slightly from previous studies in terms of the chemical composition and physical 
properties of hydroxyapatite powders (Best, Sim, et al. 1997) to initiate bone ingrowth. 
HA mimics very closely the composition of mineral bone, thus studies using its lattice 
as a base to enhance its bioactivity and biocompatibility, have been undertaken 
extensively and successfully by researchers. (Botelho, Lopes, et al. 2002; Gibson, Best, 
et al. 1999; Gibson, Best, et al. 2002) Gibson‟s team, in particular, have successfully 
incorporated silicate ions into the HA lattice, as a single phase material with a similar 
Ca/(P+Si) ratio of 1.67 and minimal changes in the crystallographic parameters. Since 
the introduction of silicon in the HA lattice (Gibson, Best, et al. 1999), silicate-
substituted hydroxyapatite (SA) has been shown to have a stronger affinity for BSA 
compared to stoichiometric HA (Balas, Perez-Pariente, et al. 2003; Patel, Best, et al. 
2002), which has been quantified in this study also. This was especially true when 
porosity of the samples was introduced, shown in the works of Hing and Patel (Hing, 
Best, et al. 2004; Patel, Brooks, et al. 2005) where SA adsorbed more and thus 
enhanced the possibilities of improved bone repair and remodelling. However, there are 
still uncertainties regarding the mechanism by which the silicon, as a silicate ion, 
increases the bioactivity.  
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Fluorescence Images Interpretation 
 
Having labelled the BSA directly, the qualitative data was also collected; see Figure 
4.15 and Figure 4.16. These studies were set up into two experiments.  
Amount of protein observed on the surface in MEM and PBS matched the Quant-IT kit 
analysis, especially the isotherm experiments in terms of demonstrating the fluctuations 
observed in the adsorption behaviour quantified previously and shown in Figure 4.9. 
They clearly show that protein was not uniform on the surfaces; this could also suggest 
that using equilibrium concentrations and shapes of isotherms to confirm monolayer 
formation (adsorption isotherms) on a biomaterial surface has its limitations. In the 
work of Zeng and Mavropoulos (Mavropoulos, Costa, et al. 2011; Zeng, Chittur, et al. 
1999), the isotherms were analysed through non-fluorometric methods on thin films and 
powders, respectively, and did not include images to confirm protein morphology or 
homogeneity on the surface of the biomaterials. In the work in this study, FTCA-BSA 
in PBS adsorption at RT at all time points was clearly adsorbing differently on the 
silicate-substituted hydroxyapatite (SAD) compared to the stoichiometric 
hydroxyapatite (HAD). The morphology of the protein was also totally different, more 
globular on the SAD and elongated on the HAD samples. Also, BSA seems to adsorb 
more evenly (homogeneously) on SAD surfaces than on HAD, but no monolayer was 
observed. This difference could be explained by the differences in the biomaterial‟s 
surface charge, packing and composition of the ions. The work of Porter et al. tried to 
answer this question using high-resolution transmission electron microscopy to observe 
and characterise defect structures in SA. They found that SA formed an increased 
number of triple junctions compared to HA, which may have a role in the increased 
bioactivity of the material. (Porter, Best et al. 2004; Porter, Buckland et al. 2005) Thus, 
it could also explain why more protein was adsorbed, when taking into account the 
SEM images obtained in Chapter 2 for both dense discs and the porous samples of SA. 
Moreover, often protein morphology on HA is modelled via computational methods like 
in the work of Chen et al. (Chen, Wu, et al. 2008) where the images produced were 
simulated to show SA has stronger interaction to the carboxylic group from the protein 
compared to HA, but over 25 % silicate group content was used, that may not be 
representative to actual phenomena observed in vitro or in vivo, as silicate contents are 
usually lower than 16 %. However, their findings agreed to findings in this chapter that 
SA has stronger affinity than HA.   
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4.5 Summary & Conclusions 
 
Quant-IT kit was only useful at physiological levels, compared to the FTCA-BSA tool 
that covered the complete concentration range. This was further confirmed when 
looking at the calibrations generated from both set ups. The Quant-IT kit detection 
pattern may suggest that a form of dynamic adsorption occurs on the biomaterials as 
time elapses, whereas using the FTCA-BSA fluorophore approach, the pattern suggests 
protein adsorption occurs cumulatively as time elapsed.  
Endpoint data from both set ups were very similar when looking at the validation at RT. 
FTCA-BSA allowed for several concentrations to be determined, and using the 
fluorescence, the protein was successfully imaged on the HA and SA surfaces in two 
different media. 
 
FTCA-BSA studies showed that more FTCA-BSA was adsorbed and desorbed at RT 
compared to 37 
o
C on the dense discs biomaterials with SAD adsorbing more and 
desorbing less than HAD. 
More FTCA-BSA was adsorbed in PBS compared to MEM on SAG, SAD and HAD, 
except on HAG, where more was adsorbed in MEM. It was suggested that the 
components present in solution were influences on the interactions between protein and 
components before and during the adsorption process of the protein on the biomaterials. 
Introducing porosity increased the amount of FTCA-BSA adsorbed and desorbed in 
both media, with more affinity with the silicate-substituted hydroxyapatite over the 
stoichiometric one. 
 
The use of FTCA covalently attached to BSA allowed for protein solutions to be 
measured at various concentrations in PBS and MEM with little limitation to the 
quantifiable aspect of the analysis.  
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5.1 Background 
 
Recombinant human Bone morphogenetic protein-2 (rhBMP-2) is one of the most 
important growth factors in bone repair and remodelling. It was discovered in 1965 by 
Urist to induce bone formation from decalcified bone in vivo (Urist 1965; Urist and 
Strates 1971) and then further investigated as a member of the transforming growth 
factor-β (TGF-β) superfamily (Sampath, J.E., et al. 1990) , which regulate new bone 
formation, showing BMP-2 to be an osteoinductive and osteogenic protein (Nickel, 
Dreyer, et al. 2001; Sampath, J.E., et al. 1990; Wang, Rosen, et al. 1990) when 
adsorbed on carriers and implanted in animal models. 
The clinical relevance of BMPs has been reviewed in the work of Schmitt et al. 
(Schmitt, Hwang, et al. 1999) and found to be a formidable tool to promote bone 
regeneration, which also plays a critical role in osteoblast function, (Zhao, Qiao, et al. 
2006) that lead to BMP-2 being recognised as an osteoconductive and both 
morphogenic and mitogenic growth factor. (Hirata, Nomura, et al. 2007; Hoshino, Egi, 
et al. 2006; Schliephake, Aref, et al. 2005) It is often studied with carriers such as 
collagen (Col) (Matsumoto, Yamaji, et al. 2001), or polymer or ceramic materials 
(Groeneveld and Burger 2000),  both in vitro and in vivo studies, at a particularly high 
concentration of 1.4 µg to 11 µg per mg of collagen compared to its physiological 
concentration of 300 ng/ml (Urist, DeLange, et al. 1983; Urist and Strates 1971). The 
high concentration is usually associated with the differences in species between rats 
(Yasko, Lane, et al. 1992), rabbit or baboon that required different concentration to 
result in a similar amount of bone formation via cell differentiation (Yamaguchi, 
Katagiri, et al. 1991). Thus differences in concentration were also seen in human 
clinical studies, especially in the area of bone defects. (Groeneveld and Burger 2000) 
Therefore, investigating the growth factor may aid in explaining these differences. 
Although, rhBMP-2 is assessed in vivo in terms of bone regeneration applications via 
implantation in animal models (Ripamonti 1996) through histomorphometry and 
histology to measure and visualise both new bone growth within carriers, actual work 
on the growth factor‟s morphology and behaviour itself is limited. The work mostly 
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centred on the growth factor influences and not on a better mechanistic view into the 
adsorption process of rhBMP-2 on hydroxyapatite or its morphology on the surface 
prior to implantation.  
 
In this chapter, the adsorption/desorption behaviour of the growth factor, bone 
morphogenetic protein-2 (rhBMP-2; Sera Laboratories, UK) was investigated on porous 
granules (PG) at 37 ºC to assess any variation in BMP-2 affinity to apatite scaffolds 
with silicate substitution at both physiological and pharmacological doses, and to 
validate the use of direct labelling towards producing quantitative and qualitative results 
compared to using the rhBMP-2 specific kit.   
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5.2 Experimental Methodology 
 
Studies were performed at both physiological (300 ng/mL) and pharmacological (4 
µg/mL) concentrations to assess graft performance under wound healing conditions and 
as a BMP-2 carrier respectively. Two methods of analysis were employed to quantify 
BMP-2 adsorption and release, a commercially available sandwich ELISA and the in-
house fluorophore labelling protocol previously described in Chapter 3 section 3.3.1. 
 
All glassware and containers were used as received sterile from the manufacturer 
(VWR). All reagents were brought to 37 
o
C in an incubator before use.  All chemicals 
were supplied by Sigma-Aldrich unless otherwise specified. The rhBMP-2 (RCYT-261) 
was purchased from Sera Laboratories, UK and the Human BMP-2 Quantikine ELISA 
kit (SBP200) purchased from R&D systems, UK.  
 
5.2.1 Specimens and Test solutions 
 
Tabulated below are the type of specimens in Table 5.1 and test solutions in Table 5.2 
used for the experiments undertaken in Table 5.3 and Table 5.4. 
 
Table 5.1 – Specimen description and acronyms used throughout study 
Specimen description  Acronyms 
Silicate-substituted apatite porous granules SAG 
Hydroxyapatite porous granules HAG 
 
Test solutions of unlabelled BMP-2 (rhBMP-2) were generated from a stock solution of 
100 µg/mL in acetic acid and then diluted to the design concentration levels with either 
PBS or MEM as required. Labelled BMP-2 (FTCA-rhBMP-2) was prepared using the 
rhBMP-2 at a concentration of 12 µg/mL in PBS or MEM, and then diluted to generate 
a stock solution of 4 µg/mL, which was stored at -70 
o
C in 1 mL aliquots. 
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Table 5.2 – Test solutions: buffer, medium and protein solutions 
Test solutions Details Concentrations 
Phosphate Buffered 
Saline 
PBS: dissolve one tablet in 
200mL deionised water pH 7.4 
(product code: P4417) 
0.01 M 
Minimum essential 
Eagles‟ medium 
MEM: containing inorganic 
components, amino acids and 
vitamins (product code: M3024) 
9.3 g/L 
Recombinant Human 
Bone Morphogenetic 
protein-2  
rhBMP-2: lyophilised powder 
reconstituted in acetic acid to 
make 100 µg/mL stock solution 
(product code: RCYT-261) 
4, 12 µg/mL 
and 300 ng/mL 
 
Table 5.3 – Specimen and experiments undertaken in PBS (at 37 oC) 
Specimen SAG HAG 
4 µg/mL rhBMP-2 √ √ 
300 ng/mL rhBMP-2 √ √ 
4 µg/mL FTCA-rhBMP-2 √ √ 
300 ng/mL FTCA-rhBMP-2 √ √ 
 
Table 5.4 – Specimen and experiments undertaken in MEM (at 37 oC) 
Specimen SAG HAG 
4 µg/mL rhBMP-2 √ √ 
300 ng/mL rhBMP-2 √ √ 
4 µg/mL FTCA-rhBMP-2 √ √ 
300 ng/mL FTCA-rhBMP-2 √ √ 
 
The concentration at 4 µg/mL is the pharmacological concentration, while the 300 
ng/mL concentration represents the physiological BMP-2 amount; and 12 µg/mL is the 
stock solution that was prepared for the growth factor dilutions. 
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5.2.2 Protocol for Growth Factor Adsorption/ Desorption Study  
 
rhBMP-2 or FTCA-rhBMP-2 solutions at physiological (300 ng/mL) and 
pharmacological (4 µg/mL) concentrations were prepared, and each of the protein 
solutions (1.5 mL) was then placed in a clean glass vial. Test biomaterial samples, 
porous granules of HA or SA (approx 0.50 g) were added to analyse adsorption, where 
100 μL of protein solution was removed at the following intervals (1, 5, 10 and 15 
minutes). After 15 minutes, the test sample was removed and the original soaking 
solution stored. The test sample was placed in PBS or MEM (1.5 mL), shaken for 5 
minutes, then removed and the washing solution stored.  
 
The biomaterial was then placed in fresh PBS or MEM (1.5 mL) to analyse desorption 
(or release), where 100 μL of the solution was removed at the following intervals (5, 
60, 240, 1440, 2880 minutes). The biomaterial was then removed to a further lidded 
vial. All experiments were performed in an incubator at 37 
o
C, and a water-bath at 37 
o
C 
used for storage of the aliquots. 
 
 
Figure 5.1 – Porous Granules of SA and HA submerged in physiological (300 ng/mL) and 
pharmacological (4 µg/mL) concentrations of FTCA-rhBMP-2 
 
For the qualitative data, adsorption of FTCA-rhBMP-2 in PBS and MEM at 37 
o
C was 
imaged using a Zeiss Axioscope microscope as described in Chapter 4 on dense discs 
(prepared as described in Chapter 2) after discs were incubated for periods of 1, 5, 10, 
15, 30 and 60 minutes. 
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5.2.3 Analysis using the Quantikine ELISA kit  
 
The manufactures‟ standard protocol was followed, according to the leaflet provided. 
The wash buffer concentrate (20 mL) was diluted into deionised water (DIW) to prepare 
the wash buffer (500 mL). If crystals formed in the concentrate, the buffer was warmed 
to room temperature and mixed gently until the crystals completely dissolved.  
 
Calibrator diluent RD5P concentrate (20 mL) was added into DIW to yield calibrator 
diluent RD5P (1X) (200 mL), and allowed to mix for 15 minutes prior to use. 
 
 
Figure 5.2 – Schematic of the Serial Dilution made of the rhBMP-2 Standards copied from 
the manufacturer procedure manual 
 
The rhBMP-2 standard was reconstituted with DIW (1 mL). This produced a stock 
solution of a concentration of 20, 000 pg/mL. Using the stock, dilution series were made 
(see Figure 5.2). Each tube was thoroughly mixed before the next transfer, where the 
4,000 pg/mL standard served as the high standard and the calibrator diluent RD5P (1X) 
served as the zero standard (0 pg/mL). 
The substrate solution; colour reagent A and colour reagent B were mixed together in 
equal volumes within 15 minutes of use and protected from light. The resultant mixture 
was then transferred to each well in 200 μL aliquots. 
 
All samples and standards were assayed in duplicates, following a plate layout (see 
Figure 5.3). The manufactures‟ protocol was followed, according to the booklet 
provided. 
For the first step, all reagents were prepared as described in the previous section. The 
microplate strips were removed from the plate frame returned them to the foil pouch 
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containing the desiccant pack and resealed. To each well Assay Diluent RD1-19 was 
added (100 μL). The standard, control and samples were added 50 l per well, covered 
with the adhesive strip provided, then felt to incubate for 2 hours at room temperature 
on a horizontal orbital microplate.  
 
 A  B 
Figure 5.3 – (a) Plate and (b) layout for the unlabelled rhBMP-2 analysis 
 
Each well was aspirated and washed, the process was repeated three times for a total 4 
washes. Each well was washed by filling them with wash buffer (400 l) using a multi-
stream pipette. Complete removal of liquid at each step was essential for accurate data. 
After the last wash, any remaining wash buffer was removed by aspirating or inverting 
the plate and blotting it against clean paper towels. BMP-2 conjugate (200 l) was 
added to each well, covered with a new adhesive strip and incubated for 2 hours at room 
temperature on the shaker.  The aspiration/wash was repeated, before the next step, the 
substrate solution addition. Substrate Solution (200 l) was added to each well and 
incubated for 30 minutes at room temperature on the benchtop, protected from light.  
Stop Solution (50 l) was added to each well. The colour in the wells should change 
from blue to yellow. If the colour in the wells was green or did not appear uniform, the 
plate was gently tapped to ensure thorough mixing. 
 
In order to generate the calibrations and use the optical density values, the data was 
initially corrected by subtracting the 544 nm values from the 450 nm values obtained 
from the GalaxyStar instrument. For the standards, only, a further subtraction of the 0 
pg/mL value from all other standards was undertaken to correct for the calibration 
curve. 
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Using the FluoStar Galaxy Microplate Reader, 96 –well plate reader (BMG laboratories, 
UK) the absorbance, also known as optical density, was measured and set at 450 nm, 
and the correction at 544 nm with cycle time of 60 seconds. 
 
5.2.4 Analysis using direct Fluorophore coupling  
 
RhBMP-2 was labelled as described in Chapter 3 section 3.3.1 with a fluorophore 
concentration of 8.84 x 10
-5
 M. The final concentration of FTCA-rhBMP-2 was verified 
by freeze drying of a 3 mL sample, and the remainder diluted with PBS or MEM to a 
stock solution of 4 µg/mL.  
Using the 4 µg/mL FTCA-rhBMP-2 stock solution, standards of known concentrations 
were made in fresh PBS or MEM, aliquots of 1 mL solutions, in order to determine 
protein amounts in unknown samples. Serial dilutions were produced including the 4 
µg/mL (4000 ng/mL) as the highest concentration and PBS or MEM only to generate 
the 0 ng/mL concentration.  
 
Table 5.5 – Concentrations of the rhBMP-2 in the FTCA-rhBMP-2 serial dilutions used 
for the Calibration curves 
rhBMP-2 Concentrations (ng/mL) 
Original  10 µL 2 µL 
4000 40.0 8.0 
2000 20.0 4.0 
1000 10.0 2.0 
500 5.0 1.0 
250 2.5 0.5 
125 1.25 0.25 
62.5 0.625 0.125 
0 0 0 
 
Calibration curves were thus generated, where for the high calibration 10 µL was used 
and 2 µL was used for the low calibration. Table 5.5 shows the standards used when 
constructing the calibration curves. All FTCA-rhBMP-2A and PBS or MEM solutions 
were equilibrated at 37 
o
C, where 200µL of the freshly made PBS or MEM was then 
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loaded into each microplate well. 5 µL of original and adsorbed samples were placed in 
the wells according to the layout made (see Figure 5.4), followed by 20 µL of the wash 
and desorbed samples. Standards were added as previous section described. 
 
   
Figure 5.4 - Plate layout for the FTCA-rhBMP2 analysis 
 
Fluorescence intensity and time resolved settings with excitation and emission were set 
at 485 and 520 nm, respectively. A cycle time of 120 seconds with 10 flashes, 0.5 
seconds delay with orbital shaking set for 10 seconds before each cycle was used. 
 
5.2.5 Fluorescence Microscopy 
 
1 mL aliquots of FTCA-rhBMP-2 at 300 ng/mL in PBS and MEM at 37 
o
C was 
transferred in to 24-well plate containing dense disc of the biomaterials, and left 
submerged for 1, 5, 10, 15, 30 and 60 minutes. After immersion time, the discs were 
rinsed in PBS or MEM then imaged, and transferred into a clean 24-well plate 
containing formaldehyde. 
 
Fluorescence microscopy was performed using a Zeiss Axioscope microscope, 
employing a mercury lamp UV source, and three filters with excitation/emission 
wavelengths of 450-490/515 nm, 365/395 nm and 546-512/598 nm which enable 
imaging of dyes that fluoresce in the green, blue or red, respectively. The images 
(micrographs) were taken at magnifications of 50, 100 or 200 and used for qualitative 
analysis of the protein adsorption on dense discs of the biomaterials with a working 
fixed exposure of 695 ms.   
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5.3 Results 
5.3.1 Quantikine analysis 
 
Calibration plots using the BMP-2 Quantikine kit were linear across the concentration 
range in both PBS and MEM, respectively (see Appendix 25, Figure 135), and showed 
good correlation, tabulated below. 
 
Table 5.6 – R2 values of the rhBMP-2 calibration curves in the various medium at 37 oC 
Media 
Curves generated 
/ pg/mL 
R
2
 values 
obtained 
PBS 0 - 4000 0.990 
MEM 0 - 4000 0.996 
 
The adsorption and desorption profiles of rhBMP-2 were determined for both 
physiological (300 ng/mL) and pharmacological (4 g/mL) concentrations at 37 oC for 
silicon-substituted porous granules (SAG) and hydroxyapatite (HAG) in PBS and 
MEM. 
The adsorption profiles at physiological concentration (300 ng/mL) for both 
biomaterials in PBS and MEM are depicted here in Figure 5.5A and B, along with the 
total adsorbed amount as a percentage (%) of the initial rhBMP-2 concentration used in 
this study. More rhBMP-2 was adsorbed in MEM compared to PBS. The behaviour in 
PBS was very similar to that of MEM, and approximately 7.5-fold lower with less than 
2.0 ng/mL of rhBMP-2 being adsorbed onto the porous biomaterials in PBS. 
The adsorption trend was similar to that observed for BSA and FTCA-BSA in Chapter 4 
where SAG adsorbs more than HAG in the porous form in PBS and MEM. 
 
The adsorption profile at the pharmacological concentration in PBS is shown in Figure 
5.5C, where SAG was found to adsorb more than HAG. The patterns were similar in 
shape to that observed for the physiological concentration experiment, but with more 
rhBMP-2 overall detected from the SAG samples at all time points compared to HAG.  
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In MEM (Figure 5.5D), adsorption values were found to be greater that those obtained 
from the physiological concentration in MEM (300 ng/mL), but looked similar to those 
obtained from PBS (4 µg/mL). However, a faster rate of rhBMP-2 adsorption was seen 
in MEM compared to PBS for HAG, with little or no change for the SAG specimen. 
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Figure 5.5 – Adsorption profiles of rhBMP-2 in (a) PBS and (b) MEM at physiological and 
in (c) PBS and (d) MEM at pharmacological concentrations at 37 
o
C biomaterials (n= 2 
±s.d.) 
 
The rate of rhBMP-2 release from the physiological level study in PBS, as shown in 
Figure 5.6A, seemed rapid to release either all the adsorbed amounts or more with no 
clear trend in the magnitude of rhBMP-2 released in PBS with regard to materials 
chemistry. On the graphs, release is also shown as a percentage (%) from the total 
adsorbed at the end of the adsorption period. This may suggest that in PBS, the ionic 
composition of the medium influenced the rhBMP-2 release towards a complete 
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desorption of the growth factor from the biomaterial‟s surface, or due to its influence 
during the rhBMP-2 adsorption process, the growth factor was only loosely binding to 
the surface, as shown in Figure 5.5A, low adsorption and rapid release was obtained. 
Another suggestion would be that in PBS and at the physiological concentration, 
rhBMP-2 may be subject to large conformational changes, which the antibodies in the 
kit would be sensitive to, and allow only for a particular conformation to be detected 
during the adsorption and release, which would also explain the low adsorbed amounts 
previously obtained in Figure 5.5A.  
In MEM, higher adsorbed (see Figure 5.5B) and released (see Figure 5.6B) amounts 
were obtained from HAG and SAG, with SAG adsorbing and releasing more at the 
physiological concentration. MEM is a medium with both inorganic and organic 
components, these components may have influenced both the interactions between the 
growth factor and the medium, but also the interactions between the growth factor and 
the biomaterial‟s surface, and thus enhanced the amount of rhBMP-2 adsorbed and 
released in solution. 
At the pharmacological concentration, the rate of release was fast but minimal in both 
PBS and MEM (see Figure 5.6C and D) compared to the physiological level. Moreover, 
the amounts released from HAG were larger than those obtained at physiological, yet 
comparable to those obtained in MEM. While the release from SAG also showed a 
larger amount compared to the physiological, but in MEM less was released compared 
to values obtained from the physiological environment. It may also suggest that a 
change in test environment has affected the release pattern from SAG, compared to 
HAG. This may further confirm the observation clearly shown at the physiological level 
that a stronger affinity occurs with the growth factor to the biomaterials‟ surfaces due to 
the interaction with MEM and its components to either the protein or biomaterials‟ 
surfaces.  
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Figure 5.6 – Desorption profiles of rhBMP-2 in (a) PBS and (b) MEM at physiological and 
in (c) PBS and (d) MEM at pharmacological concentrations at 37 
o
C biomaterials 
(n=2±s.d.) 
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5.3.2 Analysis using the Fluorophore 
 
Calibration curves were generated using the FTCA-rhBMP-2 in PBS and MEM show a 
linear relationship over high (0-40 ng/mL) and low (0-8 ng/mL) rhBMP-2 ranges per 
well (see Appendix 26 and Appendix 27, in Figure 55 and Figure 56, respectively). The 
calibration curves R
2
 values are shown in Table 5.7 for the PBS solutions and in Table 
5.8 for the MEM solutions. 
 
Table 5.7 – R2 values of the rhBMP-2 calibration curves in PBS at 37 oC 
Concentration 
Curves generated / 
ng/mL 
R
2
 values 
obtained 
Low 0-8 0.993 
High 0-40 0.942 
 
Table 5.8 – R2 values of the rhBMP-2 calibration curves in MEM at 37 oC 
Concentration 
Curves generated / 
ng/mL 
R
2
 values 
obtained 
Low 0-8 0.985 
High 0-40 0.982 
 
Using the fluorophore covalently labelled to rhBMP-2, the adsorption (as shown in 
Figure 5.7) and desorption profiles of FTCA-rhBMP-2 were determined for both 
physiological and pharmacological concentrations at 37 
o
C in PBS and in MEM, also 
depicted in terms of percentage adsorbed from initial concentration and percentage 
desorbed from total adsorbed amount. 
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Figure 5.7 – Pictures of FTCA-rhBMP-2 adsorption onto HAG (a) and (c), and SAG (b) 
and (d)  
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Figure 5.8 – Adsorption profiles of FTCA-rhBMP-2 in (a) PBS and (b) MEM at 
physiological (300 ng/mL) and in (c) PBS and (d) MEM at pharmacological (4 µg/mL) 
concentrations at 37 
o
C biomaterials (n= 3 ±s.d.) 
A C 
D B 
Chapter 5 
171 
The adsorption profiles at physiological concentration in PBS as shown in Figure 5.8A 
confirmed that SAG has a higher affinity for FTCA-rhBMP-2 than HAG, similarly 
observed when using the Quantikine kit, but only in pattern, values obtained here were 
hugely different. In MEM (see Figure 5.8B) the adsorption pattern for both SAG and 
HAG were higher than those obtained in PBS, with FTCA-rhBMP-2 having more 
affinity for the HAG for the first two time points, but at the end of the adsorption period 
SAG adsorbed slightly more than HAG.  
 
At the pharmacological concentration, the adsorption profiles observed shown in Figure 
5.8C and D, showed more FTCA-rhBMP-2 adsorbed by SAG compared to HAG with a 
relatively fast rate of adsorption in PBS compared to MEM. As seen previously, more 
FTCA-rhBMP-2 was adsorbed in MEM with an even faster rate of adsorption compared 
to the one seen in the PBS experiment. In both media, SAG adsorbed more FTCA-
rhBMP-2 than HAG. However, the detected level of adsorbed growth factor was again 
much higher as compared to using the ELISA, and the greater affinity shown for SAG 
was not observed with FTCA-rhBMP-2 in MEM at physiological concentration. 
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Figure 5.9 – Desorption profiles of FTCA-rhBMP-2 in (a) PBS and (b) MEM at 
physiological (300 ng/mL) and in (c) PBS and (d) MEM at pharmacological (4 µg/mL) 
concentrations at 37 
o
C biomaterials (n= 3 ±s.d.) 
 
The release in PBS showed HAG releasing more than SAG at all time points at the 
physiological level as shown in Figure 5.9A, whereas in MEM, SAG released more than 
HAG (see Figure 5.9B). More FTCA-rhBMP-2 was released in MEM compared to PBS 
from both biomaterials with a strong affinity for the SAG in PBS, and a different 
behaviour in MEM with HAG showing a stronger affinity to FTCA-rhBMP-2.  
 
At the pharmacological concentration, HAG and SAG released FTCA-rhBMP-2 in PBS 
at the same rate and pattern with little difference, other than HAG released slightly 
more. In MEM, however, HAG randomly released more FTCA-rhBMP-2 than SAG. 
HAG showed more desorption in MEM compared to in PBS, whereas SAG had a 
similar rate and pattern in both media.  
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5.3.3 Fluorescence Microscopy  
 
Using FTCA-rhBMP-2 allowed for qualitative data to be collected in the form of 
fluorescence images on the dense discs form of the biomaterials as depicted at all time 
points in Figure 5.10 and Figure 5.11 in PBS and MEM on HAD and SAD, 
respectively.  There was no protein auto fluorescence detected in the red or blue so only 
images with fluorescence in the green associated with the FTCA probe are presented. 
 
Figure 5.10, Column A shows the FM images obtained when HAD was immersed in 
FTCA-rhBMP-2 in PBS solutions at particular time intervals. After 1 minute protein 
was adsorbed to the surface in distinct clusters with a globular morphology, the clusters 
being heterogeneously distributed over the disc surfaces. The number of clusters present 
on the surface increased with time up to 10 minutes, however from 15 minutes further 
protein adsorption was accommodated through growth on the globule clusters. 
Figure 5.10, Column B shows the FM images from SAD samples of FTCA-rhBMP-2 in 
PBS. As on HAD samples, the adsorbed protein was observed to have a globular 
morphology; however these globules were initially adsorbed to the surface individually 
and homogeneously over the SAD surfaces. The formation of clusters was observed 
from 30 minutes. 
 
The change from PBS to MEM showed a change in the protein morphology on HAD 
surfaces, as shown in Figure 5.11, Column A, where little protein was adsorbed in 
smaller globules compared to PBS, and as time elapsed the globules became more flat. 
Beyond the 15 minutes, the morphology of the protein changed to more sheet-like, and 
spread out, followed by the formation of clusters with increasing fluorescent intensity 
and time of immersion (30 and 60 minutes). While, protein morphology on the SAD 
samples did not changed, as shown in Figure 5.11, Column B, where the rhBMP-2 was 
still globular in shape, small; and increasing in intensity and amount with time. Only 
after the sixty minute immersion did the protein slightly change shape to a rather flatter 
cluster of small globules. 
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Columns:    A. HAD        B. SAD 
  
  
  
  
  
  
Figure 5.10 – FM images of FTCA-rhBMP-2 on (a) HAD and (b) SAD at all time intervals 
in PBS at 37 
o
C  
1 min 
5 min 
10 min 
15 min 
30 min 
60 min 
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Columns:    A. HAD        B. SAD 
  
  
  
  
  
  
Figure 5.11 – FM images of FTCA-rhBMP-2 on (a) HAD and (b) SAD at all time intervals 
in MEM at 37
o
C  
60 min 
30 min 
15 min 
10 min 
5 min 
1 min 
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5.4 Discussions 
 
Calibrations from both methods generated good linear relationships both in PBS and 
MEM, with R
2
 values ranging from 0.900 to 0.990, as shown in Appendices 25 to 27 in 
Figures 135 to 137. 
 
One of the striking observations in this study was the discrepancy in the level of 
rhBMP-2 adsorption identified using the ELISA and FTCA labelling methodologies.  
FTCA-rhBMP-2 indicated higher adsorption than indicated by the ELISA both in PBS 
and MEM, but also at the physiological and pharmacological concentrations. 
This discrepancy could be due to the antibody sensitivity to protein conformation as the 
protein species was affected by the chemistry of the biomaterial. Also, the low or high 
BMP-2 concentration could be out of the calibration range. 
 
rhBMP-2 Adsorption at Physiological and Pharmacological concentrations 
 
Values generated from the ELISA were in the region of 0 to 60 ng/mL, while using 
FTCA-rhBMP-2 0 to 2000 ng/mL of growth factor was detected. This, thus, gave rise to 
a lower percentage of adsorbed amounts from the Quantikine kit, where at physiological 
concentration, SAG adsorbed 0.4 % of the growth factor and HAG 0.3 %, compared 
(see Figure 5.5A) to 36 % and 18 % (see Figure 5.8A) on SAG and HAG, respectively, 
using FTCA-rhBMP-2 in PBS. In MEM, a similar observation was seen from both 
methods with higher adsorbed amounts detected, just as previously seen in Chapter 4. 
An adsorbed percentage of 5 % and 3 % of rhBMP-2 were detected on SAG and HAG, 
respectively, as shown in Figure 5.5B, using the Quantikine kit compared to 46 % and 
44 % using FTCA-rhBMP-2 at the physiological concentration in MEM (see Figure 
5.8B). 
More growth factor was adsorbed at pharmacological concentration, which was as 
expected as the concentration was 1000-fold larger (4000 ng/mL to 300 ng/mL 
concentration); see Figure 5.5C and D for the Quantikine kit and Figure 5.8C and D for 
FTCA-rhBMP-2. The percentage of adsorbed rhBMP-2 was also very different between 
the ELISA kit and FTCA-rhBMP-2 at this level, where using the Quantikine kit only 2 
% and 0.8 % was adsorbed on SAG and HAG, respectively, compared to 26 % and 17% 
Chapter 5 
177 
using FTCA-rhBMP-2 in PBS. While in MEM, the percentages adsorbed were 2 % and 
1.5 %, SAG and HAG using the Quantikine kit compared to 57 % and 30 % using 
FTCA-rhBMP-2. This may suggest the influence of two factors affecting the adsorption 
and release process. The first would be that the Quantikine kit is too sensitive to the 
rhBMP-2 conformational changes when in contact with the biomaterials. Thus, only 
minimal amounts of rhBMP-2 were detectable, while the rest was ignored by the 
antibodies within the sandwich analysis, as the inappropriate conformation was adapted 
by the growth factor. This observation was further confirmed when looking at the rate 
of release of rhBMP-2 in PBS, especially during the physiological concentration 
experiment, where the percentage of desorbed amounts was apparently higher, at 
particular time points, compared to the percentage adsorbed for both SAG and HAG. 
For example, up to 151 % of rhBMP-2 was released from HAG at the end of the release 
period compared to 88% for SAG, while at the beginning of the release period 123 % 
was released from SAG, as shown in Figure 5.6A. This suggests that during the 
desorption period, the rhBMP-2‟s conformation changed to the preferred one for the 
Quantikine kit, and thus was detected by the antibodies and may indicate that the 
specificity of the antibodies has affected the recorded rhBMP-2 pattern of release, and 
that the data collected may not be truly representative.  
The second factor that may have an influence on the adsorbed and released amounts of 
rhBMP-2, especially at the physiological concentration, may be the presence of the 
different component of the media present in solution. In PBS, the medium has a more 
ionic character consisting of potassium chloride (KCl) and sodium chloride (NaCl) in 
contrast; MEM has a mixture of both inorganic and organic components such as amino 
acids, vitamins and salts. Clearly in MEM, higher adsorbed and desorbed amounts were 
detected by the Quantikine kit and FTCA-rhBMP-2. This may be due to the presence of 
the extra amino acids as demonstrated in the work of Dong et al (Dong, Wang, et al. 
2007) where via the use of computational study showed that rhBMP-2 adsorption to HA 
can be influenced by the presence of amino acids. The group showed that via a 
displacement study that non-adsorption residues like lysine (Lys) or proline (Pro) have 
no effect on the adsorption process, but fulcrum-adsorption residues such as asparagine 
(Asn) or glutamic acid (Glu) have. These fulcrum-adsorption residues are all present in 
the MEM at an average concentration of 0.0134 g/L, and therefore could have been 
responsible for the enhanced rhBMP-2 adsorption and release on the biomaterial‟s 
surface in MEM in this study also. 
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rhBMP-2 Desorption (release) at Physiological and Pharmacological 
concentrations 
 
The release of rhBMP-2 from the biomaterials into fresh PBS or MEM using both 
methods, ELISA and FTCA-rhBMP-2, are shown in Figure 5.6 and Figure 5.9, 
respectively. Depletion of the FTCA-rhBMP-2 was clearly evident from the solution by 
eye observation, as the labelled growth factor (light yellow in colour) diffused from the 
biomaterials into PBS and MEM to then be quantified. These observations confirmed 
the growth factor release at physiological and pharmacological concentrations, with 
both observed and quantified larger amounts at the pharmacological concentration as 
expected, as shown in Figure 5.7. 
At the physiological concentration in PBS, as a percentage of the growth factor 
adsorbed by a greater percentage of rhBMP-2 was released from the biomaterials as 
measured by the Quantikine kit (see Figure 5.6A) compared to FTCA-rhBMP-2 (see 
Figure 5.9A) with release percentages ranging from 68 % to 151% for HAG, and 123 % 
to 88% for SAG using the Quantikine kit, compared to an average of 18 % for HAG and 
5 % for SAG from FTCA-rhBMP-2. The release trend in PBS showed HAG desorbing 
more than SAG. While in MEM, an average of 13 % rhBMP-2 was released from HAG 
compared to 17 % from SAG using the Quantikine kit (see Figure 5.6B), compared to 
14 % from HAG and 13 % from SAG using FTCA-rhBMP-2 (see Figure 5.9B). This 
showed that in MEM when using the Quantikine kit SAG desorbed more than HAG, 
while the opposite trend was observed when using FTCA-rhBMP-2. However 
considering that release values of over 100 % were obtained when using the kit, it is 
likely that data so obtained is unreliable as compared to the data obtained from FTCA-
rhBMP-2. These observations suggest that the Quantikine kit‟s detection behaviour has 
been influenced by a change in protein conformation which may be sensitive to the 
change in chemistry of the biomaterials. Thus, the data may not be representative of the 
actual adsorption and desorption behaviour, which further validates the use of FTCA-
rhBMP-2 as a more reliable method of monitoring the adsorption and release behaviour 
of the growth factor.  
Previous investigations into the nature of BMP-2 confirmation reported that BMP-2 
carries two negative charges that would be available for adsorption on biomaterials 
Chapter 5 
179 
surfaces. In the work of Dong et al., these charges were neutralised with sodium ions 
that limited the BMP-2 interactions with the HA surface due to the water-bridged H-
bonds that kept on forming and breaking changing the conformation. In this work, the 
charges were not neutralised, suggesting they may have been free to interact with ions 
present in solution, for example the amino acids, before interacting with the 
biomaterial‟s surfaces, and thus affected the growth factor‟s conformation, which would 
agree with Dong et al. (Dong, Wang, et al. 2007) This change in protein/cell 
conformation/morphology was also observed in the work of Guth et al. where the 
cytoskeletal arrangement of cells grown on the rough biomaterial surfaces against the 
control were different as judged by the actin filament labelled with FITC. (Guth, 
Campion, et al. "Effect of Silicate-Substitution on Attachment and Early Development 
of Human Osteoblast-Like Cells Seeded on Microporous Hydroxyapatite Discs" 2010) 
This suggests that morphology was affected by the surface roughness, but also the 
physiochemical properties of the biomaterials. 
At the pharmacological concentration, the release of rhBMP-2 was higher from FTCA-
rhBMP-2 compared to the Quantikine kit, and higher in MEM compared to PBS from 
both methods. HAG desorbed more in PBS and MEM compared to SAG. Again value 
discrepancies were observed at this level where an average of 5 % rhBMP-2 was 
released from HAG compared to 2 % from SAG into PBS and MEM using the kit. 
While when using FTCA-rhBMP-2, an average of 11 % of rhBMP-2 was released from 
HAG and 5 % from SAG in PBS, compared to 20 % from HAG and 2.0 % from SAG in 
MEM, showing HAG desorbed more than SAG.  
This study, therefore, suggests that the use of the FTCA-rhBMP-2 labelling 
methodologies gave rise to more reliable data than when the ELISA was used with an 
adsorption and release trend clearly showing SAG to have stronger affinity to the 
growth factor compared to HAG in both PBS and MEM at 37 
o
C. 
 
Interpretations of the Fluorescent Images 
 
Slightly more FTCA-rhBMP-2 was observed on the SA samples (see Figure 5.10 B and 
Figure 5.11B) compared to HA (see Figure 5.10A and Figure 5.11A). In PBS, the 
morphology of rhBMP-2 on HAD showed large globule, which clustered as immersion 
time elapsed heterogeneously (see Figure 5.10A). While on the SAD, FTCA-rhBMP-2 
observed showed to have smaller globules across the surface, evenly spread (see Figure 
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5.10B).  In MEM, there was an evident change in the protein morphology on HAD, as 
shown in Figure 5.11A from globular to sheet-like, heterogeneously spread across the 
surface. However, on the SA surface, as shown in Figure 5.11B, showed little 
morphological changes, where the globules seem smaller than on HAD in PBS and 
MEM, but not so compared to on the SAD surface in PBS. 
The images and changes in the growth factor‟s morphology further confirmed the 
dynamic behaviour of the rhBMP-2 adsorption process, which was also shown in 
Chapter 4 for BSA and Chapter 6 when in a competitive environment, but also the 
changes in protein conformation. This would agree with the work of Dong et al. but also 
Guth et al. (Dong, Wang, et al. 2007; Guth, Campion, et al. "Surface Physiochemistry 
Affects Protein Adsorption to Stoichiometric and Silicate-Substituted Microporous 
Hydroxyapatites" 2010) previously described in adsorption and release of rhBMP-2 
sub-section in this discussion. 
 
It is important to have a good understanding of the rhBMP-2 adsorption and desorption 
processes, in terms of the drug delivery system in which BMPs are expected to be kept 
in place at the site of delivery, so that the molecules can exert their biological action and 
then provide an initial substratum for growth and differentiation of bone forming cells. 
(Saito and Takaoka 2003) Also the use of the appropriate carrier for such system, and 
the ability to induce controlled bone growth, is essential (Luginbuehl, Meinel, et al. 
2004), thus this study showed that the porous granular form of the silicate-substituted 
hydroxyapatite (SAG) to be ideal, as it adsorbed more and released less in time, 
especially in MEM.  
Previous studies have shown that the most common carrier for BMP is collagen , others 
have used demineralised bone matrix (DBM) carrier (Wang, Rosen, et al. 1990), 
polymers (Lutolf, Weber, et al. 2003), ceramics (Ripamonti 1996) or a form of 
composite consisting of polymer/ceramics (Saito, Okada, et al. 2003) or 
collagen/ceramics (Hirata, Nomura, et al. 2007). The importance of the studies was to 
achieve reproducibility of the pharmacokinetics that would allow BMP to be retained 
and released effectively, for a more control bone formation. The work of Kaito et al. 
found that as little as 5 or 20 µg of BMP was required to have a complete repair of the 
bone defect with sufficient strength using a carrier which contain biodegradable 
polymer and interconnected-porous in calcium hydroxyapatite ceramics, compared to 
often suggested milligram amounts in other studies (Kaito, Myoui, et al. 2005). 
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(Nilsson, Urist, et al. 1986; Urist 1965; Urist and Strates 1971; Yasko, Lane, et al. 
1992). Although in the present study, the bone repair effect has not yet been determined, 
the study still showed that an even lower BMP concentration can be used for controlled 
adsorption and release of the growth factor on a one phase porous carrier at 37 
o
C. This 
could be advantageous if it shows to generate complete bone repair with sufficient 
strength, as it would lower the cost on BMP concentration required in relation to the 
carrier used. 
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5.5 Summary & Conclusions 
 
In this chapter, two methods, the ELISA using a rhBMP-2 specific kit (Quantikine) and 
the FTCA labelling methodologies were used.  
 
Quantikine data obtained clearly showed that the sensitivity of the antibodies to a 
specific rhBMP-2 conformation was a disadvantage. Adsorbed amounts were lower (see 
Figure 5.5) than desorbed amounts (see Figure 5.6), especially at the physiological (300 
ng/mL) level in PBS as shown in Figure 5.5A and Figure 5.6A. Although, the patterns 
still suggested that SAG adsorbed more than HAG; the data was found to be unreliable. 
 
FTCA-rhBMP-2 appeared to give more reliable data, than when using the ELISA with 
respect to quantification of the rhBMP-2 growth factor adsorbed (see Figure 5.8) and 
released (see Figure 5.9) of rhBMP-2 from the biomaterials. 
Changing medium from an ionic solution (PBS) to a more mixed inorganic and organic 
solution (MEM) showed an increase in rhBMP-2 adsorption on both biomaterials 
compared to PBS at both physiological (300 ng/mL) and pharmacological (4 µg/mL) 
concentrations, suggesting that MEM may have induced a stronger affinity to the 
biomaterials via its component interactions with rhBMP-2 during the adsorption 
process. The interactions between growth factor and medium (i.e. the amino acid or 
vitamin component) or those between growth factor and biomaterial (i.e. porosity, 
surface area and surface chemistry) may have been enhanced to create a stronger 
affinity. The study did not provide evidence to distinguish among the possibilities, but 
did look at the protein unfolding in Chapter 6 to show the change in protein 
conformation that may affect the interactions between biomaterials, component of 
solution and protein. Overall, the adsorption pattern showed that SAG adsorbed more 
than HAG, and desorbed less, suggesting that a greater affinity for the growth factor to 
adhere on SAG surfaces was revealed. 
 
Using the fluorometric analysis, also allowed for qualitative data to be collected where 
for the most part, more rhBMP-2 was evenly adsorbed on the SA surface compared to 
the HA surface, with little change in protein morphology on the biomaterial‟s surface in 
the two media  . 
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6.1 Background 
 
The competitive nature of protein adsorption has been of interest within the biomaterials 
community and the orthobiologics industries, as understanding or control of protein 
adsorption is key to the performance of many classes of implant while more recently the 
kinetics of protein adsorption and desorption have proved critical to the design of 
suitable drug delivery vehicles. 
 
Previous competitive studies analysed via different techniques and on various 
biomaterials, all showed that the competitive nature of proteins was strongly influenced 
by the protein concentration (Fabrizius-Homan and Cooper "Competitive adsorption of 
vitronectin with albumin, fibrinogen, and fibronectin on polymeric biomaterials" 1991), 
affinity to the biomaterial surface (Fabrizius-Homan and Cooper "A comparison of the 
adsorption of three adhesive proteins to biomaterial sufaces" 1991), and time (Green, 
Davies, et al. 1999), where the temporal dependence is usually known as the “Vroman” 
effect. The presence of secondary protein species has also been shown to affect 
adsorption of a primary protein through influence on conformational change of the 
primary species (Arai and Norde 1990).  
 
In this chapter, the aim was to quantitatively determining protein adsorption and 
desorption in a competitive environment using proteins directly coupled to fluorescent 
probes. The use of 2 fluorescent probes was initially undertaken to determine whether 
simultaneous quantification of two different protein species could be performed within 
the same experiment. However, the work revealed the phenomenon of auto-fluorescence 
plasticity in proteins, i.e. changes in protein auto-fluorescence on interaction with 
biomaterials.  
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This chapter includes three sets of experiments;  
 
Study A: the initial trial with two species of protein coupled to different fluorescent 
probes;  
 
Study B: the investigation of auto-fluorescence and finally,  
 
Study C: the revised work using a single species of coupled protein in MEM containing 
10 % FBS as the competitive environment.  
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6.2 Experimental Methodology 
 
All glassware and containers were used as received sterile from the manufacturer 
(VWR). All reagents, protein solutions were brought to 37 
o
C before use.  
 
6.2.1 Study A: Investigation of the competitive binding using two independently 
labelled protein species 
 
The aim of this study was to analyse the binding of fibronectin (FN) in competition with 
BSA by independently labelling both proteins with two distinct fluorophores. The 
labelling of the proteins was prepared as described in Chapter 3, section 3.3.1. 
 
Test solutions & Experiments 
 
Fibronectin, FN (341631, Calbiochem, UK) was thawed to yield a protein concentration 
of 3000 µg/mL. FN was then further diluted using water or PBS for the analysis. Bovine 
serum albumin, BSA (A9647, Sigma-Aldrich), lyophylised, was reconstituted in water 
or PBS when required to make a stock solution of 50 mg/mL concentration.  
 
Table 6.1 – Test solutions: buffer, medium and protein solution concentrations 
Test solutions Details Concentrations 
Phosphate Buffered 
Saline (PBS) 
PBS: dissolve one tablet in 200mL 
deionised water pH 7.4 (P4417) 
0.01 M 
Fibronectin (FN) 
FN, bovine plasma, liquid in NaCl 
and NaHPO4 buffer (341631) 
300 µg/mL 
stock solution 
Bovine serum albumin 
(BSA) 
BSA: Lyophilized bovine serum 
albumin (A9647) 
16.1 mg/mL 
stock solution 
 
Table 6.2 – Specimen and preliminary experiments undertaken in PBS (at 37 oC only) 
Specimen SAD HAD 
SR101-BSA √ √ 
FTCA-FN √ √ 
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Adsorption Protocol 
 
Using the 24-well plate with a plate layout illustrated in Figure 6.1 and dense discs 
(DD) form of the biomaterials, the competitive binding of FTCA-FN and SR101-BSA 
was determined. 
 
Figure 6.1 – Competitive binding layout in 24-well plates 
 
Experiments were conducted with the final dual labelled test solutions in 1.5 mL protein 
solution at two ratios, (1) the 50/50 ratio containing FTCA-FN at a concentration of 150 
µg/mL and SR101-BSA at a concentration of 4 mg/mL in PBS, near physiological 
levels, and (2) the 40/60 ratio with 120 µg/mL of FTCA-FN and 8 mg/mL SR101-BSA 
in PBS. Adsorption was then analysed by transfer of 1.5 mL of the dual labelled 
solution into clean glass vials and left to adsorb for 15 and 60 minutes. The serial 
dilutions of the stock solutions were made in PBS so as to generate high and low 
calibration curves for both the individually labelled protein solutions. Figure 6.2 shows 
the schematic of the 24-well plate layout. 
 
 
Figure 6.2 – 24-well plate layout for the dual label experiments 
 
Table 6.3 shows the actual protein amount used in the fibronectin calibrations. 
Calibrations generated for FN and BSA illustrated in Appendices 28 and 29 in Figures 
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138 and 139, respectively, showed good calibrations with high R
2
 values obtained, see 
Table 6.4. 
 
Table 6.3 – Amount of Protein per well used the calibration curves: high and low ranges 
FTCA-FN 
High) g 
FTCA-FN  
(Low) g 
SR101-BSA 
(High) mg 
SR101-BSA 
(Low) mg 
22.2 1.1 7 1 
16.7 0.88 6 0.8 
11.1 0.66 5 0.6 
5.5 0.44 4 0.4 
2.2 0.22 2 0.2 
1.1 0.11 1 0.1 
 
Table 6.4 – R2 values obtained from the Calibrations in PBS at 37 oC 
Protein Solutions High Low 
FTCA-FN 0.942 0.979 
SR101-BSA 0.924 0.990 
 
Although, the R
2
 values were higher than 0.900, the trend was clearly giving a negative 
correlation for BSA compared to FN, when labelled with SR101 showing that this 
labelling may not be suitable. 
 
 
6.2.2 Study B: Investigation of the Autofluorescence 
 
The data for this study were represented in terms of fluorescence intensity against time 
adsorbed, using dense discs of the biomaterials following a layout in 24-well plates as 
shown in Figure 6.3. Data obtained from the dual label study suggested that the 
fluorescence of SR101-BSA was influenced by external confounding factors.  Therefore 
a series of experiments were devised to assess whether BSA auto-fluorescence was 
sensitive to experimental conditions which may confound the quantitative data obtained.  
Fluorescence intensity was measured using a plate reader (GalaxyStar) at 
excitation/emission conditions of 576/606 and 494/520 nm.  
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Figure 6.3 – Layout for the Autofluorescence Study 
 
Experiments were first performed on both unlabeled BSA and FN solutions in PBS, at 
concentrations of 4 mg/mL and 300 µg/mL, respectively, to determine whether or not 
BSA exhibited auto-fluorescence under the conditions of excitation/emission relevant to 
the FTCA and SR101 labels. These experiments were then repeated on protein solutions 
that had been exposed to HA and SA discs for a 15 minute adsorption period at 37 
o
C.  
Further experiments were then performed to assess whether auto-fluorescence was also 
sensitive to the presence of other proteins in solution.  FTCA-BSA and SR101-BSA 
were combined with unlabelled FN at the physiological level for a 15 minute adsorption 
period at 37 
o
C, followed by the analysis of FTCA-FN and SR101-FN with unlabeled 
BSA at similar conditions denoted in the previous sentence. 
 
Fluorescence intensity and time resolved settings with excitation set at 494/576 nm and 
emission at 520/620 nm, respectively, was employed. 16 cycles time of 60 seconds with 
10 flashes, 0.5 seconds delay with orbital shaking set for 10 seconds before each cycle 
was used. 
 
Circular Dichroism (CD) Spectroscopy 
 
The folding or unfolding of the proteins was determined after contact with the dense 
discs. The CD spectra were obtained in the wavelength range from 190 to 260 nm, at 1 
nm bandwidth, 3 seconds per point, through a pathlength of 0.1 cm in triplicates, using 
Chirascan (Applied Photophysics, UK) and Prodata viewer software. 
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Figure 6.4 – CD 300 µL holder and Chirascan Instrument 
 
Using the CD spectra, the secondary protein structure for each protein was determined 
using DICHROWEB (Whitemore and Wallace 2004), an online server. The data was 
converted from ellipticity (θ in degree.cm2/mol), the unit given from the instrument, to 
epsilon (Δε in M-1 cm-1), the unit required to do the online analysis using Equation 6.1. 
 
   
                     
                             
 
Equation 6.1 
 
                          
   
                    
 
Equation 6.2 
 
Protein concentration was also converted from mass per volume to molar (M) 
concentration, using the relative molecular mass (RMM) of the proteins, and the 
number of residue, further information (mean residue weight in Equation 6.2) allowed 
for the secondary analysis to be undertaken.  
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6.2.3 Study C: Investigation of the competitive binding in MEM containing 10 % 
FBS 
 
Labelling of the BSA and rhBMP-2 with FTCA has been described previously in 
Chapter 3 section 3.3.1, and similarly for the labelling with SR101 to FN and OPN. 
 
The preparation of FTCA-BSA standards were as described in Chapter 4 and used to 
determine the unknown in MEM + 10 % FBS. Similarly for the preparation of FTCA-
rhBMP-2 standards in Chapter 5, the calibrations were prepared.  
The preparation of SR101-rmOPN standards were undertaken using the 50 ng/mL 
SR101-rmOPN stock solution, standards of known concentrations were made in fresh 
MEM + 10 % FBS, aliquots of 1 mL solutions, in order to determine protein amounts in 
unknown samples.  
 
Table 6.5 – Concentrations of the rmOPN in the SR101-rmOPN serial dilutions  
OPN Concentrations (pg) 
Original  10 µL 2 µL 
50000 500.0 100.0 
25000 250.0 50.0 
12500 125.0 25.0 
6250 62.5 12.5 
3125 31.25 6.25 
1562.5 15.625 3.125 
781.25 7.8125 1.5625 
0 0 0 
 
Serial dilutions were produced including the 50 ng/mL (50000 pg/mL) as the highest 
concentration and MEM + 10 % FBS only to generate the 0 pg/mL concentration, 
summarised in Table 6.5. 
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Test solutions & Experiments 
 
Bovine serum albumin, BSA (A9647, Sigma-Aldrich), lyophilised, was reconstituted in 
water the appropriate solvent when required to make a stock solution of 50 mg/mL 
concentration in MEM.  
 
The lyophilised recombinant human bone morphogenetic protein-2, rhBMP-2 (10 µg, 
RCYT-261, Sera Laboratories, UK) was reconstituted in acetic acid (AcOH, 20 mM, 
100 µL) at a concentration of 100 µg/mL, which was then stored below -18 
o
C for 
future use or further diluted in phosphate buffered saline, PBS (P4417; Sigma-Aldrich; 
pH7.4; 0.01 M), minimum essential medium, MEM (M3024, Sigma-Aldrich) and MEM 
+ 10 % fetal bovine serum, FBS (F9665, Sigma-Aldrich). rhBMP-2 was further diluted 
and incubated at 37 
o
C to make a concentration 3 times higher than that of the super 
physiological concentration at 4 µg/mL. The rhBMP-2A (12 µg/mL in 1 mL aliquot) 
was then used for the coupling (labelling) reaction.  
 
The lyophilised recombinant mouse osteopontin, rmOPN (50 µg, 499260, Calbiochem, 
UK) was reconstituted in PBS and MEM to yield 50 µg/mL concentration stock 
solutions (1 mL aliquots of each), from which lower stock solutions of 5 µg/mL in PBS, 
MEM and MEM + 10 % FBS were made. These stock solutions were then used to make 
150 ng/mL aliquots (1 mL) for the coupling reaction. All test solutions and 
concentrations are tabulated below (see Table 6.6). 
 
Tabulated below are the type of specimens (Table 6.7) used for the experiments 
undertaken within this chapter. All were prepared and characterised as previously 
described in Chapter 2. 
 
Table 6.8 shows the experiments undertaken for each protein solution in order to 
determine the competitive binding affinity with the specimen. 
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Table 6.6 – Test solutions: buffer, medium and protein solution concentrations 
Test solutions Details Concentrations 
Minimum essential 
Eagles‟ medium 
(MEM) 
MEM: containing inorganic 
components, amino acids and 
vitamins (product code: M3024) 
9.3 mg/mL 
Fetal Bovine Serum 
(FBS) 
FBS: Heat inactivated liquid 
(F9665) 
≤ 20mg/dL 
Hemoglobin 
Bovine serum albumin 
(BSA) 
BSA: Lyophilised bovine serum 
albumin (A9647) 
4 mg/mL 
Bone Morphogenetic 
protein-2 (rhBMP-2) 
rhBMP-2: lyophilised powder 
reconstituted in acetic acid to 
make 100 µg/mL stock solution 
(RCYT-261) 
300 ng/mL 
Recombinant mouse 
Osteopontin (rmOPN) 
rmOPN lyophilised powder 
reconstituted in MEM or PBS to  
make a 50 µg/mL stock solution 
(499260) 
50 ng/mL 
 
Table 6.7 – Specimen description and acronyms used throughout study 
Specimen description  Acronyms 
Silicate-substituted apatite porous granules SAG 
Silicate-substituted apatite dense discs SAD 
Hydroxyapatite porous granules HAG 
Hydroxyapatite dense discs HAD 
 
Table 6.8 – Specimen and revised experiments undertaken in  
MEM with 10 % FBS at 37 
o
C 
Specimen SAD SAG HAD HAG 
4 mg/mL FTCA-BSA √ √ √ √ 
300 ng/mL FTCA-rhBMP-2 √ √ √ √ 
50 ng/mL SR101-rmOPN √ √ √ √ 
 
The concentrations in Table 6.8 are the respective physiological concentrations for each 
of the protein solution used in this investigation. 
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Adsorption Protocol  
 
The work was then set up as described in previous chapters, where specimens and test 
solution were placed in vials, then the aliquots (1.5 mL) were analysed in 96-well plates 
with 200 µL of the MEM + 10 % FBS, standards and samples transferred into the each 
well, according to the plate layout as shown in Figure 6.5. 
 
 
Figure 6.5 – Adsorption and desorption plate layout for the revised work 
 
The competitive study was undertaken at physiological concentrations for all protein 
under investigation, previously stated in Table 4.2. 5 µL of original and adsorbed 
samples were placed in the wells according to the layout, followed by 20 µL of the wash 
and desorbed samples, and the standards for each method where 10 and 2 µL were 
added to each well, for the high and low calibrations, respectively. 
 
Fluorescence intensity and time resolved settings with excitation and emission were set 
at 494/576 and 520/620 nm, respectively. A cycle time of 60 seconds with 10 flashes, 
0.5 seconds delay with orbital shaking set for 10 seconds. 
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6.2.4 Fluorescence Microscopy 
 
This part of the study was done at physiological level of the protein solutions at 4 
mg/mL for the FTCA-BSA, 300 ng/mL for the FTCA-rhBMP-2 and 50 ng/mL for the 
SR101-rmOPN on dense discs of the biomaterials at 37 
o
C.  
The adsorption behaviour only was observed after samples were submerged in the 
labelled protein solution for particular time intervals (1, 5, 10, 15, 30 and 60 minutes).  
FM images here will be illustrated through all three filters of the fluorescence 
microscope, green, blue, and red as the FBS will have other proteins, amino acids, 
which may auto-fluoresce in all the three wavelengths. All images will be represented at 
a 200X magnification, unless stated otherwise, where the scale bar on the image 
represent a 10 µm size. 
 
Fluorescence microscopy was performed using a Zeiss Axioskop microscope, 
employing a mercury lamp UV source, and three filters with excitation/emission 
wavelengths of 450-490/515nm, 365/395nm and 546-512/598 which enable imaging of 
dyes that fluoresce in the green, blue or red, respectively. The images (micrographs) 
were taken at magnifications of 50, 100 or 200 and used for qualitative analysis of the 
protein adsorption on dense discs of the biomaterials with a working fixed exposure of 
695 ms. 
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6.3 Results  
6.3.1 Competitive Binding with two individually labelled proteins (Study A) 
 
The following two graphs showed the amount of independently labelled FTCA-FN and 
SR101-BSA adsorbed after 15 and 60 minutes on the biomaterials in the presence of 
each other in competition. 
There was an increase in intensity of the colour observed from the two labelled proteins, 
which was as expected with increasing protein concentration. For both labelled protein 
solutions, high and low calibrations concentrations were generated in order to determine 
the unknown adsorption behaviour (see Appendix 28 and Appendix 29, in Figure 138 
and 139). 
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Figure 6.6 – Amount of FTCA-FN adsorbed onto biomaterials in the presence of SR101-
BSA biomaterials (n= 3 ±s.d.) 
 
At the two protein ratios in solution,  FN adsorbed more with increasing amount of BSA 
especially on the SAD surfaces, as shown here in Figure 6.6, whereas increasing the 
amount of BSA proved to have little effect on the amount of BSA adsorbed on the 
biomaterials‟ surfaces, as seen here in Figure 6.7. 
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Figure 6.7 – Amount of SR101-BSA adsorbed onto the biomaterials in the presence of 
FTCA-FN biomaterials (n= 3 ±s.d.) 
 
However, the strange phenomena of decreasing fluorescence intensity with increasing 
SR101-BSA concentration suggested that further investigation of these confounding 
factors were necessary to ensure that the data collected for the BSA was in fact reliable, 
refering back to Appendix 29, Figure 139.  
 
 
6.3.2 Autofluorescence Investigation (Study B) 
 
Figure 6.8 and Figure 6.9 show the autofluorescence data of bovine serum albumin 
(BSA) and fibronectin (FN), respectively at physiological concentration, unlabelled in 
PBS excited at 494 and 576 nm at 37 
o
C. 
 
In both Figure 6.8 and Figure 6.9, the contact of the protein with the biomaterial 
surfaces induced autofluorescence, increased fluorescence intensity was observed from 
the unlabelled proteins excited at 494 nm compared to the unlabelled protein solution 
that had no contact with the biomaterials. There were no significant differences between 
the biomaterials from both solutions with FN having slightly more autofluorescence 
than BSA. 
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At 576 nm, the autofluorescence between the free protein solutions and the two contact 
solutions showed little differences. 
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Figure 6.8 – Autofluorescence Observed from unlabelled BSA excited at (a) 494 and (b) 
576 nm in PBS biomaterials (n= 3 ±s.d.) 
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Figure 6.9 – Autofluorescence Observed from unlabelled FN excited at (a) 494 and (b) 576 
nm in PBS biomaterials (n= 3 ±s.d.) 
 
The following graphs show the autofluorescence effect observed when BSA (see Figure 
6.10) and FN (see Figure 6.11) were labelled green in the presence of unlabelled FN and 
BSA, respectively. 
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Figure 6.10 – Autofluorescence of FTCA-BSA in the presence of unlabelled-FN excited at 
(a) 494 and (b) 576 nm biomaterials (n= 3 ±s.d.) 
 
Figure 6.10 showed that the presence of unlabelled FN may not have influenced the 
measuring of the FTCA-BSA intensity as high values were detected when excited at 
494 nm with more effect observed on contact with the SAD surface at all time points. 
At 576 nm (red emitting region) low fluorescence intensity was seen, still higher than 
those observed from the free protein solutions (BSA or FN), but with a large increase in 
fluorescence between the control and contact on the biomaterials. 
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Figure 6.11 – Autofluorescence of FTCA-FN in the presence of unlabelled-BSA excited at 
(a) 494 and (b) 576 nm biomaterials (n= 3 ±s.d.) 
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Figure 6.11 showed the autofluorescence on FN labelled green in the presence of the 
unlabelled BSA. Just like for the BSA a very high green fluorescence was observed for 
the FTCA-FN, especially once in contact with the biomaterials compared to the protein 
solution only when excited at 494 nm, with more seen from the SAD surface at all time 
points. At 576 nm, SAD surfaces showed higher red autofluorescence compared to 
HAD and control samples; as time elapsed increased autofluorescence was observed 
from HAD.  
 
Figure 6.12 showed the effect of labelling BSA red with SR101 in the presence of 
unlabelled FN, and when excited at 576 nm. Lower fluorescence intensity was observed 
compared to when BSA was labelled green. This may suggest that the red fluorophore 
with BSA was not compatible as seen from the negative correlation on the calibration in 
Appendix 29, Figure 139. 
While Figure 6.13 showed the effect of labelling FN red with SR101 in the presence of 
unlabelled BSA. A higher red intensity was observed at 576 nm compared to BSA 
labelled red, and more autofluorescence was seen in the green region (494 nm).  
 
0
20
40
60
80
100
120
60 300 600 900
Fn-BSAr HA-Fn-BSAr SA-Fn-BSAr
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
 a
t 
4
9
4
 n
m
 (
a
.u
.)
Adsorption Time (seconds)
A
0
1000
2000
3000
4000
5000
60 300 600 900
Fn-BSAr HA-Fn-BSAr SA-Fn-BSAr
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
 a
t 
5
7
6
 n
m
 (
a
.u
.)
Adsorption Time (seconds)
B
 
Figure 6.12 – Autofluorescence of SR101-BSA in the presence of unlabelled-FN excited at 
(a) 494 and (b) 576 nm biomaterials (n= 3 ±s.d.) 
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Figure 6.13 – Autofluorescence of SR101-FN in the presence of unlabelled-BSA excited at 
(a) 494 and (b) 576 nm biomaterials (n= 3 ±s.d.) 
 
6.3.2.1 The Circular Dichroism (CD) Analysis 
 
Due to the observations seen by the data from the autofluorescence, the CD work was 
used to show that the differences in fluorescence intensity are due to changes in protein 
conformation, from the measurements of proteins in solution. CD allowed for the 
illustration and quantification of this phenomenon in wavelength ranges of 190 to 250 
nm. Unfortunately, the analysis could not be done at physiological level due to the 
limitations of the instrumentation, where the sensitivity ranged from 0.1 to 0.02 mg/mL.  
However it clearly showed the changes in conformation from the free proteins or 
growth factor to when they were in contact with biomaterials in the two different media 
(PBS or MEM). The red line ( ) represents the line of no change in protein 
conformation in all spectra. In all following spectra Figure XA represents the CD 
values as the raw data, while Figure XB represents the effect of contact with the 
biomaterials on the protein conformation.  
 
There was definitely a conformational change on BSA in PBS and MEM, as shown in 
Figure 6.14 and Figure 6.15, respectively.  
The curves in MEM were much broader to those observed in PBS; however the effect 
was much larger in PBS than MEM. The larger effect was seen on the SA samples 
compared to HA, which was closer to zero (the red line). In PBS, the difference between 
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the biomaterials was larger than in MEM, the presence of the amino acids, vitamins and 
inorganic components in MEM may have influenced the BSA conformation once in 
contact with the biomaterials. 
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Figure 6.14 – BSA in PBS CD analysis (a) raw data and (b) effect of the biomaterials 
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Figure 6.15 – BSA in MEM CD analysis (a) raw data and (b) effect of the biomaterials 
 
When looking at the CD spectra for FN in PBS and MEM in Figure 6.16 and Figure 
6.17, respectively, clearly a different pattern was observed compared to that observed 
for BSA. 
More towards the positive side of the delta epsilon similarly in both medium, but a 
larger difference was observed between SAD and HAD in MEM. 
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Figure 6.16 – FN in PBS CD analysis (a) raw data and (b) effect of the biomaterials 
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Figure 6.17 – FN in MEM CD analysis (a) raw data and (b) effect of the biomaterials 
 
 
Figure 6.18 and Figure 6.19 show the CD spectra of rhBMP-2 in PBS and MEM, 
respectively. The pattern here in both media was different from previously seen with 
BSA and FN observations. In PBS, the change started positive for both biomaterials and 
with time become more negative with SAD having a larger effect on the conformation 
of rhBMP-2 compared to HAD. In contrast, the opposite effect was observed in MEM, 
but the conformational differences observed on both biomaterials were small yet 
similar; however, contact with SAD induced a greater response. 
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Figure 6.18 – rhBMP-2 in PBS CD analysis (a) raw data and (b) effect of the biomaterials 
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Figure 6.19 – rhBMP-2 in MEM CD analysis (a) raw data and (b) effect of the 
biomaterials 
 
 
For the OPN protein solution, the raw CD data both in PBS and MEM seemed similar in 
pattern, as shown in Figure 6.20 and Figure 6.21, respectively, but there was a larger 
difference between samples in MEM. In PBS, the presence of HAD had a very low 
influence on the OPN conformation as the curve was close to zero compared to SAD.  
However, in MEM, the OPN was affected by both biomaterials on either side of the 
circular dichroism, positive for HAD and negative for SAD. 
 
Chapter 6 
204 
-1.5 10
-10
-1 10
-10
-5 10
-11
0
5 10
-11
190 200 210 220 230 240 250
OPNinPBS
HA-OPraw
SA-OPraw
Wavelength (nm)
A

 
(M
-1
 c
m
-1
)
PBS
-2 10
-11
-1.5 10
-11
-1 10
-11
-5 10
-12
0
5 10
-12
190 200 210 220 230 240 250
HA-OPNinPBS
SA-OPNinPBS
Wavelength (nm)

 
(M
-1
 c
m
-1
)
B
PBS
 
Figure 6.20 – OPN in PBS CD analysis (A) raw data and (B) effect of the biomaterials 
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Figure 6.21 – OPN in MEM CD analysis (A) raw data and (B) effect of the biomaterials 
 
 
Using the CD spectroscopic data and DICHROWEB online server (Whitemore and 
Wallace 2004; Whitemore and Wallace 2007), the protein secondary structure analyses 
were further confirmed in terms of average length of helices and strands observed by the 
protein solutions on HAD and SAD compared to contact-free in the two media, shown 
in Table 6.9 and Table 6.10, respectively. 
 
All the remaining data for the dichroweb are illustrated in Appendices 30 to 47 in 
Figures 140 to 157. Table 6.9 and Table 6.10 confirmed the observations seen from the 
CD spectra for all proteins, where overall more changing in conformation was observed 
in MEM compared to PBS.  
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Table 6.9 – Average lengths of Helices and Strands of protein in PBS 
Proteins Helices Strands ΔHelix / % ΔStrand / % 
FN 6.51 4.89 - - 
rhBMP-2 8.41 0.438 - - 
rmOPN 10.2 3.36 - - 
HA-FN 6.30 5.08 ↓ 3.2 ↑ 3.9 
HA-rhBMP-2 10.21 4.92 ↑ 21.4  ↑ 930 
HA-rmOPN 10.22 3.37 - ↑0.09 
SA-FN 6.24 5.38 ↓ 4.1 ↑ 10.1 
SA-rhBMP-2 7.87 1.36 ↓ 6.5 ↑ 210 
SA-rmOPN 10.2 3.52 ↓ 0.05 ↓ 4.8 
 
Table 6.10 – Average lengths of Helices and Strands of protein in MEM 
Proteins Helices Strands ΔHelix / % ΔStrand / % 
FN 6.97 5.45 
↑ 6.4 
c.f. PBS 
↑ 11.6 
c.f. PBS 
rhBMP-2 7.42 4.84 ↓ 11.8 ↑ 1004 
rmOPN 10.2 3.55 ↓ 0.16 ↓ 5.6 
HA-FN 7.26 5.27 ↑ 4.3 ↓ 3.4 
HA-rhBMP-2 8.47 4.49 ↑ 14.0 ↓ 7.2 
HA-rmOPN 5.99 6.95 ↓ 41.2 ↑ 95.7 
SA-FN 5.76 5.69 ↓ 17.3 ↑ 4.4 
SA-rhBMP-2 9.09 5.74 ↑ 22.4 ↑ 18.7 
SA-rmOPN 6.01 6.95 ↓ 41.1 ↑ 95.7 
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6.3.3 Competitive binding with a labelled protein with 10 % FBS in MEM (Study C) 
 
These different competitive studies were performed in MEM with 10 % FBS, 
where the probes were selected to avoid issues with autofluorescence.  
The following study was illustrated as protein amounts actually determined; and 
as both percentage adsorbed from initial physiological concentration of each protein 
species, and percentage desorbed from the total actual adsorbed amounts. 
 
6.3.3.1 FTCA-BSA in MEM with 10 % FBS Analysis 
 
Calibrations for the FTCA-BSA protein solution in MEM + 10% FBS were illustrated, 
in Appendices 23 and 24, Figures 133 and 134, where the R
2
 values generated from 
these showed a good linear relationship, tabulated below.  
 
Table 6.11 – R2 values of the FTCA-BSA calibration curves in MEM + 10 % FBS at 37 oC 
Range Curves generated / µg/mL R
2
 values obtained 
High 0-158 0.955 
Low 0-31 0.940 
 
Results of the analysis of FTCA-BSA adsorption and desorption on dense discs and 
porous granules in competition with FBS are shown in Figure 6.22, with an initial 
FTCA-BSA concentration of 4 mg/mL.  
 
In competition with MEM + 10 % FBS, more FTCA-BSA was adsorbed on SAD 
compared to HAD, as shown in Figure 6.22A. On HAD the adsorption rate was slow, 
while fast and dynamic on SAD. HAD desorbed more FTCA-BSA compared to SAD, 
as shown in Figure 6.22B, suggesting that SAD had more binding affinity with BSA. 
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Figure 6.22 – FTCA-BSA in MEM with 10% FBS (a) adsorption and (b) desorption 
profiles from dense and (c) adsorption and (d) desorption profiles from porous 
biomaterial at 37 
o
C biomaterials (n= 3 ±s.d.) 
 
In the porous morphological form, SAG adsorbed more protein than HAG especially at 
the 15 minutes time point, as shown in Figure 6.22C, and compared to DD, as shown in  
Figure 6.22D, the desorption from both biomaterial was very similar. SA still had the 
higher binding affinity to BSA compared to HA in both morphological forms. 
 
The rate of adsorption of FTCA-BSA on both morphological forms of the biomaterials 
in competition was comparable to the rate found in the MEM only study in Chapter 4, 
Figure 4.13 and Figure 4.14 on page139 and 140, respectively. Higher adsorption on 
DD was found in MEM compared to MEM +10% FBS, while for PG, higher adsorption 
was found in competition compared to MEM. Very similar desorption pattern were 
obtained from both environment.  
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6.3.3.2 FTCA-BMP-2 in MEM with 10 % FBS Analysis 
 
Calibrations for the FTCA-rhBMP-2 protein solution in MEM + 10% FBS were 
illustrated in Appendices 26 and 27, Figures 136 and 137, where the R
2
 values 
generated from these showed a good linear relationship, tabulated below.  
 
Table 6.12 – R2 values of the FTCA-rhBMP-2 calibration curves in MEM + 10 % FBS at 
37 
o
C 
Range Curves generated / ng/mL R
2
 values obtained 
High 0-40 0.931 
Low 0-8 0.986 
 
Results of the analysis of FTCA-rhBMP-2 adsorption and desorption on dense discs and 
porous granules in competition with FBS are shown in Figure 6.23 with an initial 
FTCA-rhBMP-2 concentration of 300 ng/mL.  
 
In competition with MEM + 10 % FBS, FTCA-rhBMP-2 was adsorbed on both 
morphological forms at a relatively close range compared to differences observed for 
the FTCA-BSA.  
SAD adsorbed more than HAD at the 15 minutes time point and end of the adsorption 
period, only, as shown in Figure 6.23A, which was the expected trend because of the 
morphological form of the biomaterial and further confirmed in previous study with the 
FTCA-BSA and FTCA-rhBMP-2 analyses observed in Chapter 4 and 5, respectively. 
Less rhBMP-2 was adsorbed overall in competition compared to in PBS or MEM. 
The rate of desorption on DD was fast then plateaued for both SAD and HAD (Figure 
6.23B) throughout the desorption period with very little difference in release between 
the biomaterials. 
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Figure 6.23 - The FTCA-BMP-2 in MEM with 10% FBS (a) adsorption and (b) desorption 
profiles from dense and (c) adsorption and (d) desorption profiles from the porous 
biomaterial at 37 
o
C biomaterials (n= 3 ±s.d.) 
 
In the porous morphological form (Figure 6.23C and D), SAG adsorbed and desorbed 
more than HAG with a rapid rate of adsorption for the first three time points, followed 
by a slow decline. More desorption was observed from the porous samples compared to 
the dense samples, as shown in Figure 6.23C. 
 
Only the porous granules were investigated in the MEM only study as seen in Chapter 
5, Figure 5.8 and Figure 5.9 on pages 171 and 173. Less FTCA-rhBMP-2 was adsorbed 
in competition compared to MEM with very different rate and pattern of adsorption. 
While for the desorption, both the rate and pattern were similar in both environment, the 
only difference observed was the amounts; where more was released in competition. 
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6.3.3.3 SR101-rmOPN in MEM with 10 % FBS 
 
Calibrations for the SR101-rmOPN protein solution in MEM + 10% FBS were 
illustrated in Appendix 48, Figure 158, where the R
2
 values generated from these 
showed a good linear relationship, tabulated below.  
 
Table 6.13 – R2 values of the SR101-OPN calibration curves in MEM + 10 % FBS at 37 oC 
Range 
Curves generated / 
pg/mL 
R
2
 values 
obtained 
High 0-500 0.964 
Low 0-100 0.997 
 
Results of the analysis of SR101-rmOPN adsorption and desorption on dense discs and 
porous granules in competition with FBS are shown in Figure 6.24 with an initial 
SR101-OPN concentration of 50 ng/mL.   
 
In competition with MEM + 10 % FBS, SR101-rmOPN was adsorbed more on HAD 
compared to SAD in Figure 6.24A. On HAD the adsorption rate was fast while showing 
a dynamic behaviour, compared to SAD, which had a fast rate that then plateau. 
Contrary to previous observations, in this instance SAD desorbed more SR101-rmOPN 
than HAD. RmOPN seemed to have more affinity to the stoichiometric HA than SA. 
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Figure 6.24 - The SR101-rmOPN in MEM with 10 % FBS (a) adsorption and (b) 
desorption profiles from dense , and (c) adsorption and (d) desorption profiles from 
porous biomaterials at 37 
o
C biomaterials (n= 3 ±s.d.) 
 
In the porous morphological form, SAG and HAG adsorption capacities were quite 
similar, see Figure 6.24C. However, SAG seemed to adsorb more at the early time 
points, but after the 15 minutes, HAG adsorbed more. 
The desorption pattern in Figure 6.24D showed HAG desorbed more than SAG, which 
was as expected, suggesting SR101-rmOPN has more affinity to the porous SA 
compared to the dense form. 
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6.3.4 Fluorescence Microscopy (FM) 
 
The following fluorescence microscope (FM) images have been visualised using 3 
filters, resulting in green, blue and red emitting images of the protein species on the 
biomaterial‟s surface. For the BSA, the green images are the most important while; the 
blue could represent the presence of the amino acids within the medium on the surface: 
and the red ones may suggest autofluorescence.  
 
FTCA-BSA in MEM + 10 % FBS FM Images 
 
The following two pages represent the fluorescence images obtained from the 
competitive binding of FTCA-BSA in MEM + 10 % FBS on the morphologically dense 
disc form of the biomaterials HAD and SAD, in Figure 6.25 and Figure 6.26. 
 
Overall, larger clusters of FTCA-BSA were observed on the HAD surface compared to 
that on the SAD. For both specimen protein amounts adsorbed on the surfaces increased 
with increased immersion time. Protein was more heterogeneously spread on HAD 
compared to more homogeneously on the SAD surface with similar fluorescence 
intensity. 
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Figure 6.25 – FM images of FTCA-BSA with 10 % FBS on HAD at 37 oC in competition, 
scale bar representing 10 µm 
1 min 
5 min 
10 min 
15 min 
30 min 
60 min 
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Figure 6.26 - FM images of FTCA-BSA with 10 % FBS on SAD at 37 
o
C in competition, 
scale bar representing 10 µm 
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The following fluorescence microscope (FM) images have been visualised using 3 
filters, resulting in green, blue and red emitting images of the protein species on the 
biomaterial‟s surface. For the rhBMP-2 the green images are the most important while, 
the blue could represent the presence of the amino acids within the medium on the 
surface: and the red ones may suggest autofluorescence.  
 
FTCA-rhBMP-2 in MEM + 10 % FBS FM Images 
 
The next set of images represent the labelled growth factor, FTCA-rhBMP-2 adsorbed 
on the biomaterials, competitively, in the presence of 10 % FBS, in Figure 6.27 and 
Figure 6.28 on HAD and SAD, respectively. 
 
Overall, larger clusters of FTCA-rhBMP-2 were observed on the HAD surface 
compared to that on the SAD. For both specimen protein amounts adsorbed on the 
surfaces increased with increased immersion time. Protein was more heterogeneously 
spread on HAD compared to more homogeneously on the SAD surface with some 
similarity to fluorescence intensity pattern. 
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Figure 6.27 - FM images of FTCA-rhBMP2 with 10 % FBS on HAD at 37 
o
C in 
competition, scale bar representing 10 µm  
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Figure 6.28 - FM images of FTCA-rhBMP2 with 10 % FBS on SAD at 37 
o
C in 
competition, scale bar representing 10 µm 
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The following fluorescence microscope (FM) images have been visualised using 3 
filters, resulting in green, blue and red emitting images of the protein species on the 
biomaterial‟s surface. For the OPN, the red images are the most important while, the 
blue could represent the presence of the amino acids within the medium on the surface: 
and the green ones may suggest autofluorescence of other protein within competitive 
environment. 
 
SR101-rmOPn in MEM + 10 % FBS FM Images 
 
Figure 6.29 and Figure 6.30 show the FM images of SR101-rmOPN adsorbed onto the 
biomaterials competitively with 10 % FBS.  
 
Overall, it was slightly more difficult to qualitatively image the protein morphology of 
SR101-rmOPN on HAD compared to SAD. For both specimen protein amounts 
adsorbed on the surfaces increased with increased immersion time, more significantly 
on SAD than HAD. Protein was heterogeneously spread on both HAD and SAD, but 
centered in the middle of the biomaterial‟ surface. A lot more was seen through the 
green and blue emission, however, this could also be due to the fact that the physiology 
amount of rmOPN was quite small relative to BSA and rhBMP-2. Hence, the 
fluorescence on the competitive proteins in solution was more easily observed 
compared to rmOPN. However, some red emitting was seen and enough to construct an 
adsorption observation pattern. 
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Figure 6.29 - FM images of SR101-rmOPN with 10 % FBS on HAD at 37 
o
C in 
competition, scale bar representing 10 µm 
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Figure 6.30 - FM images of SR101-rmOPN with 10 % FBS on SAD at 37 
o
C in 
competition, scale bar representing 10 µm 
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6.4 Discussions 
6.4.1 Competitive Binding with two individually labelled proteins (Study A) 
 
Previous studies using FTCA-BSA worked well, as shown in Chapter 4. This showed 
that the fluorophore labelling technique was reliable, it generated good calibrations and 
good data were collected, analysed and interpreted.  
This lead to the labelling of both fibronectin (FN) and bovine serum albumin (BSA) to 
be undertaken with FTCA and SR101, respectively. The labelling methodologies were 
further confirmed as the protein solutions were isolated, FTCA-FN and SR101-BSA, 
calibrations generated and data collected. 
The calibration curves generated by FTCA-FN were linear and positive, i.e. 
fluorescence intensity increased with protein concentration, as observed with FTCA-
BSA and FTCA-rhBMP-2 in Chapters 4 and 5, respectively. However, the calibrations 
generated by SR101-BSA were linear and negative, i.e. fluorescence intensity decreased 
with protein concentration. This observation was unexpected as it may suggest that 
quenching of the fluorophore may be occurring with increasing protein concentration, 
which may further suggest a change in the protein conformation dependency in solution.   
 
FTCA-FN analysis in the presence of SR101-BSA 
 
The data collected from FTCA-FN showed that increasing BSA promoted FN 
adsorption on HAD and SAD, as shown in Figure 6.6. The main interest in this study 
was in the analysis of FN adsorption under near physiological conditions to evaluate 
whether or not enhanced FN affinity may contribute to a biomaterial‟s relative 
osteogenic potential in vivo. FTCA-FN was stabilised on HAD in the presence of 8 
mg/mL SR101-BSA, whereas on SAD the FTCA-FN adsorption was stable 
indifferently to the presence of 4 or 8 mg/mL SR101-BSA. In the presence of this 
adhesive protein, it seemed that FN had maximised its interactions with the HA surface, 
which agreed with the work of Fabrizius-Homan et al. (Fabrizius-Homan and Cooper 
"Competitive adsorption of vitronectin with albumin, fibrinogen, and fibronectin on 
polymeric biomaterials" 1991) FN was often shown to adsorb better individually than 
BSA on biomaterials, especially on titanium surfaces as shown in the work of Yang et 
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al. (Yang, Cavin, et al. 2003), thus in competition a similar behaviour could be 
expected, and this was true in the present study. 
Most studies have reported the use of low concentration of FN to demonstrate the 
“Vroman Effect”, which is based on the desire to optimise FN adsorption to 
biomaterials‟ surfaces to facilitate cell adhesion. (Kowalczynska, Nowak-
Wyrzykowska, et al. 2005; McFarland, Thomas, et al. 2000)  Others have started to 
investigate the competitive behaviour of FN, still at low concentration, as in the work of 
Guth et al.(Guth, Campion, et al. "Surface Physiochemistry Affects Protein Adsorption 
to Stoichiometric and Silicate-Substituted Microporous Hydroxyapatites" 2010) in the 
presence of 10 % FCS; FN showed a dynamic adsorption behaviour over a 24 hour 
period at 37
 o
C with SA adsorbing more than HA. The worked also showed that in the 
presence of more adhesive proteins, FN adsorption was increased, which agreed with 
the finding in this study.  
 
SR101-BSA analysis in the presence of FTCA-FN 
 
The data collected from the SR101-BSA was inconsistent. When protein solutions were 
isolated as shown in Figure 6.7, the presence of FTCA-FN at 150 or 120 µg/mL did not 
affect the amount of SR101-BSA adsorbed onto the biomaterials. Amounts of SR101-
BSA adsorbed on HAD and SAD were similar, there seemed to be little influence of 
chemistry on the adsorption behaviour, this could possibly be due to the inconsistency 
and the possible influence of quenching. Therefore the data was deemed unreliable. 
 
Study A showed that the analysis of FTCA-FN in the presence of SR 101-BSA has 
worked, but not for the quantification of SR101-BSA. This may be due to the influence 
of protein conformational changes observed by the BSA in contact with the 
biomaterials, therefore the selection of the probe may be dependent on the 
autofluorescence potential of each protein. 
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6.4.2 Autofluorescence Investigation (Study B) 
 
Thus, the phenomenon seen in Study A has led to the investigation of the 
autofluorescence of the proteins in solution, as shown in Figure 6.8 and Figure 6.9 for 
the unlabelled BSA and FN studies, respectively.  
This was then followed by the analysis of the FTCA labelled BSA and FN in the 
presence of unlabelled FN and BSA, as shown in Figure 6.10 and Figure 6.11, 
respectively. And finally, the analysis of SR101 labelled BSA and FN in the presence of 
unlabelled FN and BSA, respectively, as shown in Figure 6.12 and Figure 6.13. 
 
Initially, the study was undertaken in PBS, an ionic solution with no organic 
component. Figure 6.8 and Figure 6.9 clearly demonstrated that autofluorescence did 
occur in both proteins, BSA and FN. In contact with the biomaterials, higher levels of 
autofluorescence were observed from both proteins, especially when the protein 
solutions were excited at 494nm, the green emitting region compared to when excited at 
576 nm, the red region. This occurred in the absence of the fluorophore, clearly 
indicating an effect has taken place, and using CD work supported this possibility and 
allowed it to be quantified as a change in the protein conformation in solution, as shown 
in Figure 6.14 and Figure 6.16 for BSA and FN in PBS, respectively. Evidently, there 
must be interactions between the components of the PBS and proteins, in which the 
resulting effect is a change in conformation after the protein solution comes in contact 
with the biomaterials.  
A similar observation was seen when BSA and FN in MEM solution were investigated 
(see Figure 6.15 and Figure 6.17). The influences of the extra components in the 
medium such as amino acids and vitamins in MEM may have also induced changes in 
the protein conformation. In BSA little change occurred in the presence of MEM, the 
HA CD pattern seemed to match the SA one more so compared to PBS, whereas for FN 
in MEM solutions, reduced CD patterns were seen in contact with both biomaterials, 
suggesting a change in conformation. The influences on media on the CD spectra on 
different proteins were further investigated, as shown from Figure 6.18 to Figure 6.21, 
clearly showing that a change in medium did affect the protein conformation of both 
rhBMP-2 and rmOPN, and thus would show to exhibit the autofluorescence 
phenomenon. 
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The autofluorescence phenomenon was also investigated on the labelled BSA and FN 
solutions in PBS, as shown from Figure 6.10 to Figure 6.13, FTCA and SR101, 
respectively. For both proteins, large green fluorescence was observed  from FN (see 
Figure 6.11) more than BSA (see Figure 6.10) when labelled with FTCA, but a larger 
red fluorescence was observed from the FTCA-FN solution, higher than both BSA and 
FN only spectra. Interestingly, when the proteins were labelled with SR10, as shown in 
Figure 6.12 and Figure 6.13, for BSA and FN, respectively, FN showed a larger red 
fluorescence than BSA with little effect upon contact with the biomaterials when 
excited at 494 nm (green region). However, on BSA the effect upon the excitation at 
494 nm was lower upon contact with biomaterials compared to the control, clearly 
showing a loss of fluorescence, which would account for the loss of fluorescence 
observed in the calibrations undertaken in Study A (see Appendix 29, Figure 139) that 
resulted in a negative correlation. 
 
The CD work that followed was used to further understand the nature of the change in 
the auto-fluorescence of proteins when in contact with the biomaterials surface. The CD 
analysis, further confirmed the change in conformation of the proteins upon contact 
with the biomaterials compared to the free protein solutions in the various media. 
The overall effect on BSA in PBS and MEM (Figure 6.14 and Figure 6.15) was clearly 
negative for both biomaterials, where according to Drake (Drake 1994) this suggested 
that a low energy electronic configuration was observed, which is preferred by the right 
circularly polarized light (RCPL). Thus, the conformation of BSA can be expected to be 
α-helix, H-bonded, which may be (Drake 1994). 
The effect of the biomaterials on the FN in PBS and MEM (Figure 6.16 and Figure 
6.17) was also different indicating a more positive circular dichroism, which is usually 
associated with the left circularly polarized light (LCPL), suggesting a high energy 
electronic configuration. This type of pattern, according to Drake, is usually associated 
with a helix configuration, but not H-bonded. 
The CD spectra of rhBMP-2 were strongly affected by the different media as shown in 
Figure 6.18 and Figure 6.19. In PBS, the effect of the biomaterials resulted in a more 
positive circular dichroism similarly to FN, compared to that in MEM, which was more 
negative similar to BSA. This suggests that the conformation of the growth factor would 
also be different and BMP-2 would be expected to behave differently in PBS and MEM, 
and even more likely in a competitive environment with 10 % FBS. 
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And finally, for OPN in PBS and MEM (see Figure 6.20 and Figure 6.21) the greater 
conformational change was observed on SAD more than HAD, more positive but close 
to zero on HAD and negative on SAD in both media. This suggests a large proportion of 
the protein on SAD to be helical compared to its conformation on HAD. (Drake 1994) 
 
Overall, the CD analysis suggested that the larger proteins showed conformational 
changes in both media in a very similar manner, whereas the smaller proteins showed 
different conformational changes in the two media with distinct behaviour seen. 
Table 6.9 and Table 6.10 depicted the differences in protein conformation observed in 
term of percentages in relation to the control (contact-free protein solutions), and thus 
confirming that the proteins, both free and in contact, were mainly in a helical 
conformation, and that contact either reduced or increased the average lengths observed 
by the helices or strands of the proteins in solutions. Therefore a loss of secondary 
structure was observed, this apparent transformation of the α helix into a more random 
coil is known to increase the bond mobility within the proteins (Wilson, Clegg, et al. 
2005), which could explain the change in fluorescence intensity but also the different 
protein morphologies observed later in this study through the fluorescent images on the 
biomaterials. Therefore, as a result, this change in conformation could also affect the 
adsorption and desorption processes of the proteins in different ways in a competitive 
environment. This would be further quantified and explained in the following sub-
section that depicts the findings and interpretation found in Study C. 
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6.4.3 Competitive binding with a labelled protein with 10 % FBS (Study C) 
 
FTCA-BSA Competitive Study 
 
The study of FTCA-BSA with 10 % FBS showed SA to adsorb more than HA, as 
shown in Figure 6.22A and C for the two morphological forms, which was similarly 
observed in the MEM only study, as shown in Figure 4.13B and Figure 4.14B pages 
139 and 140 in Chapter 4. However, the amount adsorbed in competition was lower 
than that found in MEM only study, and the patterns of adsorption were similar with a 
slower rate of adsorption observed. This was expected as the introduction of 10 % FBS, 
would introduce to the system various sized proteins that would be able to compete for 
both the surface, but also the protein-protein and protein-medium interactions.  
Dense discs (DD) of the biomaterials showed SAD adsorbing more than HAD in MEM 
(see Figure 4.13B), and a similar observation was seen with the 10 % FBS study (see 
Figure 6.22A) and further showed more inhibition of the FTCA-BSA to adsorb on 
HAD, 4 % compared to 11 % in competition and MEM, respectively. In this instance, 
the change in chemistry between SAD and HAD showed silicate-substituted 
hydroxyapatite to have a stronger affinity with FTCA-BSA both in MEM and in 
competition with 10 % FBS with an obvious gap between the pattern of adsorption and 
a slower rate observed in competition due to the dynamic nature of the environment. 
The differences in adsorption were also evident when looking at the FM images in 
Figure 6.25 and Figure 6.26 in competition with 10 % FBS, compared to those observed 
in Figure 4.16A and C in MEM only study in Chapter 4 page 145,  for HAD and SAD, 
respectively. Although, images observed in competition were more fluorescent 
compared to MEM only, some fluorescence could be due to a little autofluorescence 
from the 10 % FBS, as proteins more naturally fluoresce in the green emitting region. 
The amino acids were expected to emit within the blue region, which agreed with 
Herman (Herman 1998). The addition of 10 % FBS enlarged the protein morphology on 
both HAD and SAD with larger clusters formed across the surface of the HAD 
compared to SAD, more intense on the SAD surfaces as time elapsed. These 
observations confirmed the influence of chemistry of the FTCA-BSA adsorption 
observed in the dynamic behaviour of the quantitative data. 
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The introduction of porosity (PG), increased the amount of FTCA-BSA adsorbed both 
in the MEM only (see Figure 4.14B), but also in competition with 10 % FBS compared 
to the DD study. This was expected as the surface area of the biomaterials was 
increased. On DD SA and HA adsorbed 15 % and 11 % of the protein from the initial 4 
mg/mL FTCA-BSA solution, respectively, whereas on PG SA and HA adsorbed 26 % 
and 25 %, respectively. Thus the influence of chemistry has been overcome by porosity, 
and even more so in competition with the presence of 10 % FBS, where on DD SA and 
HA adsorbed 11 % and 4 % of FTCA-BSA in solution, while on PG both SA and HA 
adsorbed an average of 35 % of the FTCA-BSA in solution. The introduction of the 
pore structure has clearly facilitated protein adsorption, also due to the change in fluid 
shear experienced by PG instead of DD within a static with flow experiments. The 
possibilities of adsorbing on PG depending on the protein conformation and size, but 
also the availability of pores and their size where for example: 
(1) large labelled BSA (FTCA-BSA) could adsorb on the surface of a pore, as if 
attached to a wall in a cavern, or adsorb across a pore, like a web across a door 
(2) the smaller proteins could do the same as above 
(3)  both FTCA-BSA and small protein could adsorb on the wall of a pore and 
anchor to the surface by a process of exchange, then slowly layer across the 
surface to then finally accommodate for the 
(4) loosely anchored proteins either small or FTCA-BSA within the pore, that may 
have weaker interactions (protein-protein) 
(5) or any combination of the above possibilities that would result in a dynamic 
behaviour. 
This would thus lead to an enrichment of proteins to be observed, and as a result the rate 
of adsorption behaviour was slow, and the dynamic behaviour not as defined compared 
to MEM only study. 
 
For the desorption, FTCA-BSA in MEM with 10 % FBS HA desorbed more than SA, as 
shown in Figure 6.22B and D for the two morphological forms, which was similar to 
values found for the MEM only study, as shown in Figure 4.13D and Figure 4.14D in 
Chapter 4, pages 139 and 140. Differences between amounts desorbed from the dense 
discs (DD) biomaterials were large in the competitive environment compared to in the 
MEM only study, where 5 % and 16 % of adsorbed FTCA-BSA was desorbed from SA 
and HA DD in MEM with 10 % FBS, compared to 9% desorbed from both biomaterials 
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in MEM. This suggests that BSA affinity to HA was lower than SA in MEM. This was 
further confirmed when in competitive environment due to the presence of other protein 
species.  
The introduction of porosity resulted also in an increased amount of FTCA-BSA 
desorbed from the biomaterials (see Figure 6.22D) with HAG desorbing more than 
SAG. This implied that a similar dynamic behaviour may also be observed during the 
desorption process in a fresh solution of MEM with 10 % FBS, the balance of labelled 
(FTCA-BSA) to unlabelled now was slightly biased towards the FBS, so protein-protein 
interactions may be increased that may lead to the increase release of the FTCA-BSA in 
solution. Significantly higher percentage of adsorbed BSA was desorbed from PG as 
compared to DD, which further supports the hypothesis that the presence of porosity 
facilitated BSA enrichment at the surface as loosely bound protein within the pores can 
now be quantified through the desorption analysis. 
 
In summary, these studies show that BSA adsorption was sensitive to chemistry but 
more greatly influenced by porosity.  
 
 
FTCA-rhBMP-2 Competitive Study 
 
The growth factor (FTCA-rhBMP-2) adsorption process showed a similar pattern to that 
observed for the FTCA-BSA where SA adsorbed more than HA in the porous granule 
(PG) form with more observed in MEM (see Figure 5.8B in Chapter 5, page 171) 
compared to in MEM with 10 % FBS (see Figure 6.23C). As seen for FTCA-BSA in 
competition, it seemed the influence of porosity with FTCA-rhBMP-2, also overcame 
the influence of chemistry, as the percentage adsorbed on HAG and SAG were similar, 
45 and 46 %, respectively, in MEM. Likewise observed in MEM with 10 % FBS but at 
lower adsorbed amounts of 23 and 25 % on HAG and SAG, respectively. Here FBS has 
strongly influenced the adsorption behaviour of FTCA-rhBMP-2 on the biomaterials.  
The differences in adsorption were also evident when looking at the FM images in 
Figure 6.27 and Figure 6.28 in competition with 10 % FBS, compared to those observed 
in Figure 5.11A and B in MEM only study in Chapter 5,  for HAD and SAD, 
respectively. Although quantitatively half the amount was detected in competition, the 
images were more fluorescent; this could be due to the microscope picking up a wide 
Chapter 6 
229 
range of bands. The FTCA-rhBMP-2 protein morphology did not alter, large clusters 
were observed on HAD compared to smaller ones on SAD, as previously seen in the 
MEM only study in Chapter 5, with some autofluorescence in the blue emitting region 
and very little in the red. This further suggests that the addition of FBS had a strong 
influence on the adsorption interactions of the growth factor to the biomaterial surfaces. 
In competition (MEM with 10 % FBS) SA adsorbed more than HA in both 
morphological forms. Dense discs (DD) adsorption was marginally lower than PG. 
There was an apparent influence of chemistry on DD where less FTCA-rhBMP-2 was 
adsorbed on HAD (14 %) compared to SAD (23 %), which was overcome by the 
introduction of porosity in the PG study, especially for HA samples, where only 23 and 
25 % was adsorbed on HAG and SAG, respectively.  
It has been previously discussed in Chapter 5 that the amino acid component of the 
MEM had strong affinity with rhBMP-2 to enhance adsorption, which was also 
observed for BSA. However, here with rhBMP-2, the extra proteins in solution inhibited 
the effect of MEM adsorption enhancement.  
This implies that the dynamic behaviour with the growth factor is more related to 
protein-protein interaction influence over the protein-surface one in its porous form, 
compared to BSA where it could be combinations of either. Another explanation could 
be that an increase in the protein isoelectric point (pI) in solution due to the extra 
smaller proteins resulted in higher retention of the growth factor in solution (Uludag, 
Gao, et al. 2008). 
 
FTCA-rhBMP-2 release showed similar levels of desorption between biomaterials, 
where in MEM 14 % and 13 % of FTCA-rhBMP2 was desorbed from HAG and SAG, 
while in competition 55 %  and 59 % was desorbed from HAG and SAG, respectively, 
as shown in Figure 5.9B and Figure 6.23D. A higher percentage release was observed 
from MEM with 10 % FBS solution, which would support the previous hypothesis that 
the presence of 10 % FBS inhibits the effect of MEM on the FTCA-rhBMP-2 
adsorption enhancement observed in Chapter 5. 
 
In summary, this study clearly showed the importance of porosity in adsorbing more 
FTCA-rhBMP-2 with SA as the bone graft substitute, but also that the influence of 
MEM on its adsorption was a factor that inhibited by half the amounts of FTCA-
rhBMP-2 adsorbed in a competitive environment.  
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SR101-rmOPN Competitive Study 
 
Osteopontin is a protein known to inhibit apatite nucleation and crystal growth. (George 
and Veis 2008) rmOPN is generally researched for the purpose of showing that it has 
various functions as detailed in the review by Denhardt et al. (Denhardt and Guo 1993) 
such as binding to cells, regulating formation and remodelling of mineralised tissue; 
interacting with Ca
2+
 and inhibiting HA formation (Hunter, Hauschka, et al. 1996). The 
aim was to investigate this protein to show that, as an inhibitor of osteogenesis, whether 
it may have a different affinity with HA and SA.  
Labelling rmOPN with the red emitting fluorophore, SR101, gave rise to good 
calibrations, as shown in Appendix 48, Figure 36, and tabulated in Table 6.13. 
More SR10-rmOPN was adsorbed on porous granule (PG) specimen compared to the 
dense disc (DD) specimen. However, contrary to what was observed for both FTCA-
BSA and FTCA-rhBMP-2, HA adsorbed more than SA in both morphological forms, as 
shown in Figure 6.24. 
In this instance, OPN adsorption was indifferent to chemistry and porosity, the 
differences in the adsorbed percentages were quantitatively low and relatively similar 
on the biomaterials, i.e. 0.3 and 0.2 % from HAD and SAD, respectively, compared to 
0.4 and 0.3 % for HAG and SAG in MEM with 10 % FBS. 
This was further confirmed by the FM images, as shown in Figure 6.29 and Figure 6.30 
for HAD and SAD, respectively. 
 
As no significant difference was found, this suggests that OPN interactions with HA 
and SA does not affect bioactivity, but BSA and BMP-2 may be involved. 
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6.5 Summary & Conclusions 
 
The two independently labelled protein studies showed FTCA-FN to adsorb more on 
SAD than HAD with increasing amount of SR101-BSA present, which often was the 
observed behaviour in previous studies. However due to the phenomenon of 
autofluorescence of BSA when labelled with the red emitting fluorophore (SR101), this 
study required changes. 
 
The autofluorescence distinctively showed that an increase of fluorescence was 
observed for all proteins upon contact with the biomaterial surface when excited at both 
494 and 576 nm, green and red regions, respectively. In conjunction with the CD work, 
changes of protein conformation were showed to be the cause of this phenomenon, thus 
the importance of selecting the fluorophore that showed the least effect was very 
important. Direct labelling with FTCA or SR101 allowed monitoring and imaging of the 
adsorption and desorption processes, to reveal the importance of selecting a fluorophore 
and that proteins were subject to conformational changes upon contact with the 
biomaterials. The changes thus influenced the interactions between components of the 
media with the protein, which then influenced the interactions with the biomaterials. 
 
The competitive binding of dense discs and porous granules was determined and 
showed different patterns of behaviour to amounts of protein adsorbed on the surface in 
the presence of 10 % FBS. The presence of the serum affected the adsorption and 
release, lowering adsorption of FTCA- BSA and FTCA-BMP-2, but no effect on 
SR101-OPN, however, even under competitive conditions higher affinity to SA was still 
observed with FTCA-FN, FTCA-BSA and FTCA-rhBMP-2. 
The introduction of porosity increased adsorption affinity for both HA and SA in some 
cases it was more influential than the material chemistry. 
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7.1 Protein Adsorption and Desorption Behaviour (BSA only) 
 
Using the Quant-IT kit for determining the adsorption and desorption behaviour of BSA 
showed to be unreliable for very low or high BSA concentrations. At physiological 
levels, the work was comparable to values found when using the fluorophore labelling 
methodologies. Calibrations generated from the kit and FTCA-BSA both in PBS and 
MEM showed good linearity. Overall more FTCA-BSA was adsorbed on SA compared 
to HA in both morphological forms at RT and 37 
o
C in PBS and MEM. Differences 
observed were usually seen through the pattern of adsorption, when using FTCA-BSA a 
more dynamic pattern was observed compared to a static behaviour from the kit. 
 
The findings for this study showed to be relevant to the pre-clinical studies towards 
osteoinduction, as real samples were used. This was the novelty of this study as samples 
were not manipulated to maximise surface chemistry, area or binding contact through 
grinding, polishing or etching.  The samples were synthesised, heat-treated and used 
similarly to specimen used in clinical trials (i.e. Apatech procedures); thus the 
behaviour observed and quantified can be directly related to possible effects seen during 
real pre-clinical studies. 
 
7.2 Growth Factor (rhBMP-2) Study 
 
One of the striking observations in this study was the discrepancy in the level of 
rhBMP-2 adsorption identified using the ELISA and FTCA labelling methodologies.  
FTCA-rhBMP-2 adsorbed more than with the ELISA both in PBS and MEM, but also at 
the physiological and pharmacological concentrations with respect to the original 
amounts used to be detected.  
 
Chapter 7. SUMMARY OF FINDINGS, FUTURE WORK AND PERSONAL 
TRAINING 
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Quantikine data obtained clearly showed that the sensitivity of the antibodies to a 
specific rhBMP-2 conformation was a disadvantage, as values generated were too low 
and inconsistent.  
 
FTCA-rhBMP-2 showed more reliable data, which could be used to distinctively 
comment on the pattern and amounts adsorbed and released of rhBMP-2 from the 
biomaterials. The adsorption behaviour of FTCA-rhBMP-2 on the biomaterials was not 
affected whether physiological or pharmacological levels were used. The influence of 
concentration was more significant on the desorption process where less was desorbed 
from pharmacological level.  In addition, the influence of chemistry was more obvious 
in the pharmacological compared to the physiological levels. Overall, more FTCA-
rhBMP-2 was adsorbed onto porous SA than HA both in PBS and MEM, thus clearly 
showing a stronger affinity with SA. 
Due to the presence of the amino acid component of the MEM more adsorption and less 
release was observed, especially at pharmacological levels.  
 
The findings for this study also showed to be relevant to the pre-clinical studies towards 
osteoinduction, as real samples were used, which further emphasises the research 
potential of this study, as shown in Chapter 4; and also throughout this thesis. This 
study was aimed to show the importance of the influence of rhBMP-2 adsorption and 
desorption processes from the porous granular biomaterials, not its mechanistic view. 
This in vitro study showed selection of appropriate test conditions are critical to 
adsorption and desorption behaviour of rhBMP-2.This could further translate to 
behaviour seen in vivo and allow for better understanding of the osteoinduction 
phenomenon. Furthermore, silicate substitution (SA) increased affinity between 
rhBMP-2 and HA. 
 
7.3 Competitive Binding Studies 
 
The autofluorescence distinctively showed that an increase of fluorescence was 
observed for all proteins upon contact with the biomaterials. In conjunction with the CD 
work, changes of protein conformation were shown to be the cause of this phenomenon, 
and thus selecting the fluorophore that showed the least effect was very important. 
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In the competitive environment (MEM with 10 % foetal bovine serum (FBS)), the target 
protein affinity was lower than in MEM, especially for FTCA-BSA and FTCA-rhBMP-
2, but not for SR101-rmOPN, with more of the protein species adsorbed on SA 
compared to HA. 
The introduction of porosity in the competitive environment reduced the influence of 
chemistry. This suggests that porosity and conformational effects may have a big impact 
on bioactivity. 
 
The findings for this study showed to be relevant to the pre-clinical studies towards 
osteoinduction, as real samples were used. Further emphasis on test environment 
conditions suggest that this factor was more pronounced throughout this study, as seen 
in Chapters 4 and 5. The research potential of this study suggests that pre-clinical 
procedures for more effective protein species adsorption on the biomaterials should be 
done in cell culture medium, not ionic as often required, at 37 
o
C. Silicate-substituted 
hydroxyapatite specimens should be favoured over stoichiometric hydroxyapatite, as 
they would adsorbed similar amounts, but retain more with a slower rate of release, 
which could possibly  be more controlled with the addition of other adhesive protein 
species. 
 
Overall, this in vitro study showed the importance of test conditions that are critical to 
adsorption and release behaviour of the protein species in competition. This could 
further translate to behaviour seen in vivo; and allow for better understanding of the 
osteoinduction phenomenon.  
 
7.4 Future Work 
 
Silicate substitution increases affinity between FN, BSA and BMP-2 and HA. 
Selection of an appropriate media can raise protein loading efficiency and effects 
protein delivery kinetics, which should be considered when translating laboratory 
data to the in vivo situation. 
 
Initially, further work would be to expand on Chapter 4‟s fluorescence images study 
where the protein conformation of the labelled bovine serum albumin, BSA, (FTCA-
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BSA) could be visualied over time on the same area on the surface of the 
biomaterials. Will the protein surface resemble the previous one obtained when 
using different samples for the different time points? Will accumulation or 
displacement of thr protein species on the surface be observed?  
Similarly experiments could then be set up for recombinant human bone 
morphogenetic protein-2 (rhBMP-2) in Chapter 5, fibronectin (FN) and osteopontin 
(OPN). 
 
Futher work would be required to determine whether these differences translate to a 
significant variation in cell response to HA and SA grafts after treatment with FN, 
BSA or rhBMP-2, specifically to look at the impact of the conformational changes 
on protein activity at their respective physiological amounts. 
Autofluorescence of the protein species may need more investigating and be better 
defined per protein, to further understand the interactions between protein and 
biomaterials, possibly at physiological levels, as the CD work was limited to the 
sensitivity of the instrument. The influences of temperatures could be included in 
this work would also be advantageous in collecting representative data comparable 
to the studies experimental set ups undertaken in cell culture medium and in 
competition with 10 % fetal bovine serum (FBS). 
The influence of porosity should be further investigated with rhBMP-2 in competition at 
the pharmacological levels to look at the impact of the stronger affinity observed from 
SA due to observed low release, which could then also translate to significant variation 
in cell response. 
 
7.5 Notes 
 
Publications and awards are included in Appendix 49, and courses, conferences, visits 
and training attended during the course of this study are tabulated in Tables 74 and 75 
(see Appendices 50 and 51). 
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APPENDICES 
 
CHAPTER 2 
Appendix 1 
 
XRD spectra for the HA from CERAM - two PDF files (A) the first trial with 5% CaO 
impurity and (B) the second attempt with no impurities, respectively on the CD.  
 
Appendix 2 
Table 14 – SA-DD dimensions, weight and density at all sintering temperature 
pressed at 75.8 MPa, using micrometer 
Sintering 
Temperature 
/ 
o
C 
Diameter (±ζ) / 
cm 
Thickness (±ζ) 
/ cm 
Weight (±ζ) / g 
Density (±ζ) / 
gcm
-3
 
1200 11.70 (±0.06) 3.05 (±0.05) 0.9461 (±0.004) 2.887 (±0.06) 
1225 11.71 (±0.09) 3.04 (±0.06) 0.9391 (±0.004) 2.865 (±0.06) 
1250 11.63 (±0.05) 3.02 (±0.02) 0.9432 (±0.002) 2.944 (±0.09) 
1275 11.82 (±0.04) 2.98 (±0.02) 0.9405 (±0.003) 2.876 (±0.04) 
1300 11.77(±0.03) 3.06 (±0.07) 0.9408 (±0.007) 2.831 (±0.06) 
1325 11.82 (±0.05) 3.00 (±0.04) 0.9362 (±0.001) 2.843 (±0.05) 
1350 11.74 (±0.06) 3.06 (±0.07) 0.9393 (±0.005) 2.844 (±0.07) 
1375 11.75 (±0.05) 3.04 (±0.04) 0.9419 (±0.001) 2.863 (±0.05) 
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Figure 31 – Density of sintered SA at different pressures 75.8 (1.50), 90.9 (1.75) and 101.1 
(2.00) MPa, calculated using a micrometer  
 
Appendix 4 
Table 15 – SA-DD dimensions, weight and density at all sintering temperature pressed at 
90.9 MPa, using micrometer 
Sintering 
Temperature 
/ 
o
C 
Diameter (±ζ) / 
cm 
Thickness (±ζ) / 
cm 
Weight (±ζ) / g 
Density (±ζ) / 
gcm
-3
 
1200 11.98 (±0.08) 2.99 (±0.07) 0.9458 (±0.006) 2.834 (±0.06) 
1225 11.86 (±0.07) 3.04 (±0.07) 0.9446 (±0.007) 2.816 (±0.05) 
1250 11.85 (±0.09) 3.02 (±0.02) 0.9374 (±0.003) 2.819 (±0.05) 
1275 11.95 (±0.07) 2.91 (±0.07) 0.9362 (±0.0030 2.870 (±0.08) 
1300 11.95 (±0.04) 2.96 (±0.04) 0.9340 (±0.003) 2.812 (±0.04) 
1325 11.99 (±0.01) 2.97 (±0.05) 0.9343 (±0.005) 2.789 (±0.05) 
1350 11.95 (±0.05) 2.97 (±0.07) 0.9375(±0.001) 2.846 (±0.07) 
1375 11.97 (±0.03) 2.94 (±0.09) 0.9357 (±0.008) 2.837 (±0.11) 
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Table 16 – SA-DD dimensions, weight and density at all sintering temperature pressed at 
101.1 MPa, using micrometer 
Sintering 
Temperature 
/ 
o
C 
Diameter 
(±ζ) / cm 
Thickness (±ζ) 
/ cm 
Weight (±ζ) / g 
Density (±ζ) / 
gcm
-3
 
1200 12.06 (±0.05) 2.88 (±0.10) 0.9431 (±0.008) 2.871 (±0.09) 
1225 12.03 (±0.05) 2.92 (±0.08) 0.9355 (±0.006) 2.824 (±0.07) 
1250 12.04 (±0.04) 2.88 (±0.09) 0.9403 (±0.006) 2.873 (±0.07) 
1275 12.02 (±0.02) 2.89 (±0.06) 0.9411 (±0.006) 2.878 (±0.07) 
1300 12.04(±0.04) 2.92 (±0.09) 0.9360 (±0.004) 2.821 (±0.09) 
1325 12.05 (±0.04) 2.87 (±0.10) 0.9347 (±0.004) 2.862 (±0.12) 
1350 12.07 (±0.05) 2.76 (±0.05) 0.9332 (±0.005) 2.962 (±0.07) 
1375 12.07 (±0.02) 2.76 (±0.07) 0.9299 (±0.008) 2.950 (±0.09) 
 
Appendix 6 
Table 17 – HA-DD dimensions, weight and density at all sintering temperature pressed at 
75.8 MPa, using micrometer 
Sintering 
Temperature 
/ 
o
C 
Diameter (±ζ) / 
cm 
Thickness (±ζ) 
/ cm 
Weight (±ζ) / g 
Density (±ζ) / 
gcm
-3
 
1150 12.07 (±0.04) 2.77 (±0.02) 0.9535 (±0.008) 3.008 (±0.04) 
1175 12.02 (±0.04) 2.90 (±0.03) 0.9499 (±0.03) 2.893 (±0.10) 
1200 12.02 (± 0.04) 2.81 (±0.04) 0.9536 (±0.00) 2.900 (±0.03) 
1225 12.00 (±0.06) 2.91 (±0.03) 0.9601 (±0.02) 2.926 (±0.07) 
1250 12.00 (±0.03) 2.82 (±0.09) 0.9363 (±0.01) 2.945 (±0.09) 
1275 11.99 (±0.03) 2.87 (±0.09) 0.9445 (±0.00) 2.922 (±0.09) 
1300 11.98 (±0.03) 2.91 (±0.09) 0.9413 (±0.01) 2.874 (±0.08) 
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Figure 32 – Density of sintered HA at different pressures 75.8 (1.50) and 90.9 (1.75) MPa, 
calculated using a micrometer  
 
Appendix 8 
Table 18 – HA-DD dimensions, weight and density at all sintering temperature pressed at 
90.9 MPa, using micrometer 
Sintering 
Temperature 
/ 
o
C 
Diameter (±ζ) 
/ cm 
Thickness (±ζ) 
/ cm 
Weight (±ζ) / g 
Density (±ζ) / 
gcm
-3
 
1150 12.29 (±0.11) 2.81 (±0.06) 0.9686 (±0.007) 2.914 (±0.07) 
1175 12.22 (±0.07) 2.80 (±0.22) 0.9372 (±0.05) 2.754 (±0.16) 
1200 12.25 (±0.09) 2.81 (±0.050 0.9830 (±0.01) 2.875 (±0.05) 
1225 12.20 (±0.09) 2.79 (±0.04) 0.9492 (±0.03) 2.800 (±0.07) 
1250 12.12 (±0.05) 2.79 (±0.06) 0.9483 (±0.01) 2.951 (±0.07) 
1275 12.07 (±0.04) 2.84 (±0.07) 0.9467 (±0.006) 2.914 (±0.07) 
1300 12.07 (±0.04) 2.83 (±0.070 0.9518 (±0.009) 2.941 (±0.09) 
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Table 19 – Average SA-DD dimensions, weight and density at optimum sintering 
temperature of 1300 
o
C, using micrometer 
Pressure / 
MPa 
Diameter (±ζ) 
/ cm 
Thickness (±ζ) / 
cm 
Weight (±ζ) / g 
Density (±ζ) / 
gcm
-3
 
75.8 11.77 (±0.03) 3.06 (±0.07) 0.9408 (±0.007) 2.831 (±0.06) 
90.9 11.95 (±0.04) 2.96 (±0.04) 0.9340 (±0.003) 2.812 (±0.04) 
101.1 12.04 (±0.04) 2.92 (±0.09) 0.9360 (±0.004) 2.821 (±0.09) 
 
Appendix 10 
Table 20 – Average HA-DD dimensions, weight and density at optimum sintering 
temperature of 1250 
o
C, using micrometer 
Pressure / 
MPa 
Diameter (±ζ) 
/ cm 
Thickness 
(±ζ) / cm 
Weight (±ζ) / g 
Density (±ζ) / 
gcm
-3
 
75.8 12.00 (±0.03) 2.82 (±0.09) 0.9363 (±0.01) 2.945 (±0.09) 
90.9 12.12 (±0.05) 2.79 (±0.06) 0.9483 (±0.01) 2.951 (±0.07) 
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Table 21 - Tabulated representations of attempted synthetic routes 
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Table 22 - Tabulated representations of attempted synthetic routes (continued) 
 
 
  
 Appendices 
ii. 8 
Table 23 – Synthetic route (continued) 
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Appendix 12 
 
Figure 33- Mass spectrum of the synthesised FTCA 
 
Appendix 13  
Table 24 – Tabulated Excitation & Emission of the FTCA in spectroscopic grade ethanol 
Concentration / M Excitation / nm Emission in Ethanol / nm Emission in Water / nm 
2.845 x 10
-8
 494 522 518 
2.845 x 10
-7
 494 523 516 
2.845 x 10
-8
 494 524 516 
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Figure 34 - The emission Spectra at 3 distinct concentrations of the FTCA compound in 
ethanol 
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Figure 35 - Emission Spectra at 3 distinct concentrations of the FTCA compound in water 
 
Appendix 16 
Table 25- Absorbance of the FTCA compound related to the concentration used in 
Ethanol 
Concentration / M Absorbance (A.U.) Extinction Coefficient / L mol
-1
cm
-1
 
2.845 x 10
-8
 0.06534 (λ=501 nm) 23,000 
2.845 x 10
-7
 -0.03269 (λ=500 nm) -115,000 
2.845 x 10
-8
 -0.007385 (λ=486 nm) -260,000 
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Table 26- Absorbance of the FTCA compound related to the concentration used in Water 
Concentration / M Absorbance (A.U.) Extinction Coefficient / L mol
-1
cm
-1
 
2.845 x 10
-8
 0.09057 (λ=489 nm) 32,000 
2.845 x 10
-7
 0.01812 (λ=490 nm) 64,000 
2.845 x 10
-8
 0.007744 (λ=486 nm) 272,000 
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Figure 36– Structure of the Texas Red (TXR) 
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Appendix 19 
 
Figure 37– Calibration curves for the 0-5 µg range concentration in all media and 
temperature using the Quant-it kit 
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Figure 38 – Calibration curves for the 0-1 µg range concentration in all media and 
temperature using the Quant-it kit 
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Figure 39 - Calibration curves for the 0-500 µg range concentration in all media and 
temperature using the Quant-it kit 
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Figure 40- Calibration curves for the 0-100 µg range concentration in all media and 
temperature using the Quant-it kit 
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Figure 41– Calibration curves for the high range concentration in all media and 
temperature using FTCA-BSA 
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Figure 42– Calibration curves for the low range concentration in all media and 
temperature using FTCA-BSA 
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Appendix 25 
 
Figure 43 – Calibration curves for the BMP-2 standards in all media at 37 oC using 
Quantikine kit 
 
Appendix 26 
 
Figure 55 – Calibration curves for the high BMP-2 range in all media at 37 oC using 
FTCA-BMP-2 
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Figure 56 – Calibration curves for the low BMP-2 range in all media at 37 oC using FTCA-
BMP-2 
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Appendix 28 
 
Figure 46 – Calibration curves for the high and low FN range in PBS at 37 oC using 
FTCA-FN 
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Figure 47 – Calibration curves for the high and low BSA range in PBS at 37 oC using 
SR101-BSA 
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Figure 48 - Dichroweb data for FN in PBS 
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Figure 49 - Dichroweb data for HA-FN in PBS 
 
Appendix 32 
 
Figure 50 - Dichroweb data for SA-FN in PBS 
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Figure 51 - Dichroweb data for FN in MEM 
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Figure 52 - Dichroweb data for HA-FN in MEM 
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Figure 53 - Dichroweb data for SA-FN in MEM 
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Figure 54 - Dichroweb data for rhBMP-2 in PBS 
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Figure 55 - Dichroweb data for HA-rhBMP-2 in PBS 
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Figure 56 - Dichroweb data for SA-rhBMP-2 in PBS 
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Figure 57 – Dichroweb data for rhBMP-2 in MEM 
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Figure 58 – Dichroweb data for HA-rhBMP-2 in MEM 
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Figure 59 – Dichroweb data for SA-rhBMP-2 in MEM 
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Figure 60 – Dichroweb data for rmOPN in PBS 
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Figure 61 – Dichroweb data for HA-rmOPN in PBS 
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Figure 62 – Dichroweb data for SA-rmOPN in PBS 
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Appendix 45 
 
Figure 63 – Dichroweb data for rmOPN in MEM 
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Figure 64 – Dichroweb data for HA-rmOPN in MEM 
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Figure 65 – Dichroweb data for SA-rmOPN in MEM 
 
 Appendices 
ii. 24 
 
Appendix 48 
 
Figure 66 – Calibration curves for the high and low OPN range in MEM with 10 % FBS 
at 37 
o
C using SR101-OPN 
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Appendix 49 
 
 European Cells & Materials, Vol. 18, Suppl. 2, 2009, page 73, ISSN: 1473-2262 
for the poster presentation in Glasgow at TCES 2008 
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 European Cells & Materials, Vol. 22, Suppl. 2, 2011, page 15, ISSN: 1473-2262 
for the talk given in Manchester at TCES 2010 
 
 Central Research Fund (CRF) from University London awarded in January 2010 
for the sum of £2,900 for the work on BMP-2 adsorption and desorption study.  
 Impact QM Scholarship awarded October 2010 to work three months at 
CERAM Research (24/01/11-24/04/11), Stoke-on-Trent £ 3,890 
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Table 27- Courses and Seminars 
Date Title/Description 
31/10/07 Starting your PhD R100 
01/11/07 Demonstrating in laboratory R180 
21/11/08 Labelling Proteins 
21/01/08 Managing a research Project from Start to Finish R121 
23/01/08 Writing development R168 
02/07/08 
A symposium for Postgraduates in Inorganic & Material 
Chemistry (ASPIC08) 
11/12/08 
RSC Seminars with speaker such as Catherine 
Housecroft 
26/11/09 Relax about Writing R202 
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Table 28- Training, Conferences and Presentations 
Date Title/Description 
24/10/07 FTIR (Photoacoustic) training with Monisha Phillips 
28/11/07 Grinding & Polishing with Dr  Karin 
14/12/07 SBCS 1
st
 year Postgraduate talk (15 minutes) 
10&11/03/08 SEM  training with Dr Zofia Luklinska 
16/04/08 
Visit to Apatech Ltd, followed by 2 months industrial 
work May 2008 & October 2009 
25/08/08 
60
th
 Anniversary Summer Symposium IAESTE-UK 
at Imperial College 
14/11/08 
SEMS 2
nd
 year symposium: Winner of the Becker 
prize 
8-10/07/09 
TCES 10
th
 Conference in Glasgow: Poster 
presentation 
15,20&29/05/09 AFM training with Dr Barber 
03/09/09 
AxioVision training at Charterhouse campus with Dr 
Paul Browne supervised by Dr Alex Sullivan 
7-11/09/09 
ESB 22
nd
 Conference in Lausanne: Poster 
presentation & workshops 
24/03/10 SEMS Industrial Forum: Poster presentation 
24/06/10 Presentation to Apatech: Chaman Chander 
28-30/07/10 TCES 11
th
 Conference in Manchester: Talk 
11-15/09/10 
ESB 23
rd
 Conference in Tampere: Talk & Poster 
presentations 
24/01-
24/04/2011 
ImpactQm at CERAM research trained on the 
Zetasizer (Electroacoustic) Stoke-on-Trent 
01-06/06/2012 
9
th
 World Congress of Biomaterial in China, 
Chendgu: Talk presentation 
 
